<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2026"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2026"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlabw="http://exascalelabs.ai/20260630"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="xlabw-20260630.xsd" xlink:type="simple"/>
    <context id="From2025-07-01to2026-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_ClassCommonStock0.0001ParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xlabw:ClassCommonStock0.0001ParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_WarrantsEachWholeWarrantExercisableForOneClassCommonStockAtExercisePriceOf11.50Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xlabw:WarrantsEachWholeWarrantExercisableForOneClassCommonStockAtExercisePriceOf11.50Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-09-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
        </entity>
        <period>
            <instant>2026-09-02</instant>
        </period>
    </context>
    <context id="AsOf2026-09-25_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xlabw:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-25</instant>
        </period>
    </context>
    <context id="AsOf2026-09-25_custom_ClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xlabw:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-25</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_CommonStockClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xlabw:CommonStockClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CommonStockClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xlabw:CommonStockClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_CommonStockClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xlabw:CommonStockClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CommonStockClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xlabw:CommonStockClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">xlabw:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">xlabw:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">xlabw:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">xlabw:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">xlabw:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">xlabw:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">xlabw:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_ClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">xlabw:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">xlabw:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_ClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">xlabw:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-01_custom_ExascaleLabsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">xlabw:ExascaleLabsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-01</instant>
        </period>
    </context>
    <context id="AsOf2022-07-01_custom_ExascaleLabsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">xlabw:ExascaleLabsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-01</instant>
        </period>
    </context>
    <context id="From2016-12-012016-12-16_custom_EvanaAlphaPteLtdMember_custom_ExascaleLabsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">xlabw:EvanaAlphaPteLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">xlabw:ExascaleLabsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-01</startDate>
            <endDate>2016-12-16</endDate>
        </period>
    </context>
    <context id="From2026-08-012026-08-27_custom_ExascaleLabsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">xlabw:ExascaleLabsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-01</startDate>
            <endDate>2026-08-27</endDate>
        </period>
    </context>
    <context id="From2026-08-012026-08-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
        </entity>
        <period>
            <startDate>2026-08-01</startDate>
            <endDate>2026-08-27</endDate>
        </period>
    </context>
    <context id="AsOf2026-01-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
        </entity>
        <period>
            <instant>2026-01-08</instant>
        </period>
    </context>
    <context id="AsOf2026-01-08_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xlabw:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-08</instant>
        </period>
    </context>
    <context id="AsOf2026-01-08_custom_ClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xlabw:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-08</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_ClassACommonStockMember22831156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xlabw:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_ClassBCommonStockMember22831156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xlabw:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember_custom_ReservedCapacityArrangementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">xlabw:RevenueFromIntelligentComputingPowerServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">xlabw:ReservedCapacityArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember_custom_ReservedCapacityArrangementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">xlabw:RevenueFromIntelligentComputingPowerServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">xlabw:ReservedCapacityArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember_custom_OnDemandArrangementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">xlabw:RevenueFromIntelligentComputingPowerServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">xlabw:OnDemandArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember_custom_OnDemandArrangementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">xlabw:RevenueFromIntelligentComputingPowerServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">xlabw:OnDemandArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">xlabw:RevenueFromIntelligentComputingPowerServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">xlabw:RevenueFromIntelligentComputingPowerServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_RevenueFromComprehensiveDataCenterServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">xlabw:RevenueFromComprehensiveDataCenterServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_RevenueFromComprehensiveDataCenterServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">xlabw:RevenueFromComprehensiveDataCenterServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerEMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerEMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerGMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerGMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerHMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerHMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerHMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerHMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:CustomerIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_PurchaseMember_custom_SupplierAMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">xlabw:PurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">xlabw:PurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">xlabw:PurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">xlabw:PurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">xlabw:PurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">xlabw:PurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">xlabw:PurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">xlabw:PurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierEMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">xlabw:PurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierEMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">xlabw:PurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierFMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierFMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierGMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierGMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierEMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierEMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">xlabw:SupplierEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:OtherPayableRelatedToTheEquityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:OtherPayableRelatedToTheEquityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:OtherPayableRelatedToTheEquityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:OtherPayableRelatedToTheEquityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:OtherPayableRelatedToTheEquityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:OtherPayableRelatedToTheEquityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:OtherPayableRelatedToTheEquityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">xlabw:OtherPayableRelatedToTheEquityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_USDTMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CryptoAssetAxis">xlabw:USDTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_USDCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CryptoAssetAxis">xlabw:USDCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_USDTMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CryptoAssetAxis">xlabw:USDTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_USDCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CryptoAssetAxis">xlabw:USDCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_USDTMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CryptoAssetAxis">xlabw:USDTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_USDCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CryptoAssetAxis">xlabw:USDCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_DigitalAssetsAndUSDCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CryptoAssetAxis">xlabw:DigitalAssetsAndUSDCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012026-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_DelawareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">xlabw:DelawareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_DelawareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">xlabw:DelawareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_EvanaAlphaPteLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">xlabw:EvanaAlphaPteLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_EvanaAlphaPteLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">xlabw:EvanaAlphaPteLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_EvanaAlphaPteLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">xlabw:EvanaAlphaPteLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_EmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">xlabw:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_HK">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_country_HK">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_OthersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">xlabw:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012026-06-30_custom_OthersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">xlabw:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-07-012026-09-28_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-28</endDate>
        </period>
    </context>
    <context id="AsOf2026-07-16_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-16</instant>
        </period>
    </context>
    <context id="From2026-08-012026-08-27_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-01</startDate>
            <endDate>2026-08-27</endDate>
        </period>
    </context>
    <context id="From2026-07-012026-07-15_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002109869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-07-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2025-07-01to2026-06-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2025-07-01to2026-06-30" id="Fact000004">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-07-01to2026-06-30" id="Fact000005">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2025-07-01to2026-06-30" id="Fact000006">0002109869</dei:EntityCentralIndexKey>
    <xlabw:U.s.DollarCoin
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0072"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2026-06-30"
      id="xdx2ixbrl0085"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0093"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2026-06-30"
      id="xdx2ixbrl0139"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-06-30_custom_CommonStockClassAMember"
      id="xdx2ixbrl0156"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-06-30_custom_CommonStockClassBMember"
      id="xdx2ixbrl0166"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0211"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0217"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-07-01to2026-06-30"
      id="xdx2ixbrl0218"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_custom_ClassACommonStockMember"
      id="xdx2ixbrl0246"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_custom_ClassBCommonStockMember"
      id="xdx2ixbrl0247"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_custom_ClassACommonStockMember"
      id="xdx2ixbrl0254"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_custom_ClassBCommonStockMember"
      id="xdx2ixbrl0256"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012025-06-30_custom_ClassACommonStockMember"
      id="xdx2ixbrl0259"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012025-06-30_custom_ClassBCommonStockMember"
      id="xdx2ixbrl0260"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0261"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0265"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012025-06-30_custom_ClassACommonStockMember"
      id="xdx2ixbrl0266"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012025-06-30_custom_ClassBCommonStockMember"
      id="xdx2ixbrl0267"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0269"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30_custom_ClassACommonStockMember"
      id="xdx2ixbrl0273"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30_custom_ClassBCommonStockMember"
      id="xdx2ixbrl0274"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_custom_ClassACommonStockMember"
      id="xdx2ixbrl0281"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_custom_ClassBCommonStockMember"
      id="xdx2ixbrl0283"
      unitRef="Shares"
      xsi:nil="true"/>
    <xlabw:RedesignationOfAuthorizedCommonStock
      contextRef="From2025-07-012026-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0288"
      unitRef="USD"
      xsi:nil="true"/>
    <xlabw:RedesignationOfAuthorizedCommonStock
      contextRef="From2025-07-012026-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0289"
      unitRef="USD"
      xsi:nil="true"/>
    <xlabw:RedesignationOfAuthorizedCommonStock
      contextRef="From2025-07-01to2026-06-30"
      id="xdx2ixbrl0290"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-012026-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0298"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-012026-06-30_custom_ClassACommonStockMember"
      id="xdx2ixbrl0299"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-012026-06-30_custom_ClassBCommonStockMember"
      id="xdx2ixbrl0300"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-012026-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0301"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0305"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0312"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2025-07-01to2026-06-30"
      id="xdx2ixbrl0331"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0336"
      unitRef="USD"
      xsi:nil="true"/>
    <xlabw:OtherOperatingActivitiesSettledInDigitalAssetsAndU.s.DollarCoin
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0339"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2025-07-01to2026-06-30"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <xlabw:ProceedsFromSaleOfDigitalAssetsAndU.s.DollarCoin
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0378"
      unitRef="USD"
      xsi:nil="true"/>
    <xlabw:PaymentForDeferredOfferingCosts
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0387"
      unitRef="USD"
      xsi:nil="true"/>
    <xlabw:ProceedsFromSimpleAgreementsForFutureEquity
      contextRef="From2025-07-01to2026-06-30"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaid
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0411"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaid
      contextRef="From2025-07-01to2026-06-30"
      id="xdx2ixbrl0412"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NoncashOrPartNoncashAcquisitionInventoryAcquired1
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0420"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember"
      id="xdx2ixbrl0661"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember"
      id="xdx2ixbrl0665"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerDMember"
      id="xdx2ixbrl0671"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerDMember"
      id="xdx2ixbrl0677"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerEMember"
      id="xdx2ixbrl0683"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFMember"
      id="xdx2ixbrl0687"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerGMember"
      id="xdx2ixbrl0691"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerHMember"
      id="xdx2ixbrl0693"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerIMember"
      id="xdx2ixbrl0697"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierAMember"
      id="xdx2ixbrl0708"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierDMember"
      id="xdx2ixbrl0718"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierEMember"
      id="xdx2ixbrl0722"
      unitRef="Ratio"
      xsi:nil="true"/>
    <xlabw:ConcentrationRiskPercentage
      contextRef="From2025-07-012026-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierFMember"
      id="xdx2ixbrl0730"
      unitRef="Ratio"
      xsi:nil="true"/>
    <xlabw:ConcentrationRiskPercentage
      contextRef="From2025-07-012026-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierGMember"
      id="xdx2ixbrl0734"
      unitRef="Ratio"
      xsi:nil="true"/>
    <xlabw:ConcentrationRiskPercentage
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierBMember"
      id="xdx2ixbrl0740"
      unitRef="Ratio"
      xsi:nil="true"/>
    <xlabw:ConcentrationRiskPercentage
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierEMember"
      id="xdx2ixbrl0744"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember"
      id="xdx2ixbrl0755"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember"
      id="xdx2ixbrl0757"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember"
      id="xdx2ixbrl0763"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember"
      id="xdx2ixbrl0765"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2026-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember"
      id="xdx2ixbrl0771"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2026-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember"
      id="xdx2ixbrl0773"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2026-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember"
      id="xdx2ixbrl0779"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2026-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember"
      id="xdx2ixbrl0781"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CryptoAssetFairValue
      contextRef="AsOf2025-06-30_custom_USDTMember"
      id="xdx2ixbrl0796"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CryptoAssetFairValue
      contextRef="AsOf2025-06-30_custom_USDCMember"
      id="xdx2ixbrl0798"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CryptoAssetFairValue
      contextRef="AsOf2026-06-30_custom_USDTMember"
      id="xdx2ixbrl0812"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0838"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsAndFinancingReceivableAllowanceForCreditLoss
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0846"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsAndFinancingReceivableAllowanceForCreditLoss
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0847"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0849"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsAndFinancingReceivableAllowanceForCreditLoss
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0852"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0959"
      unitRef="Ratio"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0992"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0995"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl1004"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2026-06-30"
      id="xdx2ixbrl1005"
      unitRef="USD"
      xsi:nil="true"/>
    <xlabw:ShareBasedCompensations
      contextRef="From2025-07-01to2026-06-30"
      id="xdx2ixbrl1111"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl1128"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl1131"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-07-01to2026-06-30"
      id="xdx2ixbrl1132"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2025-07-012026-06-30_custom_OthersMember"
      id="xdx2ixbrl1161"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2025-07-01to2026-06-30" id="Fact000012">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2025-07-01to2026-06-30" id="Fact000013">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2025-07-01to2026-06-30" id="Fact000014">2026-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-07-01to2026-06-30" id="Fact000015">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="From2025-07-01to2026-06-30" id="Fact000016">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2025-07-01to2026-06-30" id="Fact000017">001-43465</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2025-07-01to2026-06-30" id="Fact000018">EXASCALE LABS HOLDINGS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-07-01to2026-06-30" id="Fact000019">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-07-01to2026-06-30" id="Fact000020">42-3035215</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-07-01to2026-06-30" id="Fact000021">820 Gessner Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-07-01to2026-06-30" id="Fact000022">Suite 332</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-07-01to2026-06-30" id="Fact000023">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-07-01to2026-06-30" id="Fact000024">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-07-01to2026-06-30" id="Fact000025">77024</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-07-01to2026-06-30" id="Fact000026">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-07-01to2026-06-30" id="Fact000027">537-7553</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="From2025-07-012026-06-30_custom_ClassCommonStock0.0001ParValuePerShareMember"
      id="Fact000028">Class A Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-07-012026-06-30_custom_ClassCommonStock0.0001ParValuePerShareMember"
      id="Fact000029">XLAB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-07-012026-06-30_custom_ClassCommonStock0.0001ParValuePerShareMember"
      id="Fact000030">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-07-012026-06-30_custom_WarrantsEachWholeWarrantExercisableForOneClassCommonStockAtExercisePriceOf11.50Member"
      id="Fact000031">Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-07-012026-06-30_custom_WarrantsEachWholeWarrantExercisableForOneClassCommonStockAtExercisePriceOf11.50Member"
      id="Fact000032">XLABW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-07-012026-06-30_custom_WarrantsEachWholeWarrantExercisableForOneClassCommonStockAtExercisePriceOf11.50Member"
      id="Fact000033">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2025-07-01to2026-06-30" id="Fact000034">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2025-07-01to2026-06-30" id="Fact000035">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2025-07-01to2026-06-30" id="Fact000036">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2025-07-01to2026-06-30" id="Fact000037">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2025-07-01to2026-06-30" id="Fact000038">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2025-07-01to2026-06-30" id="Fact000039">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-07-01to2026-06-30" id="Fact000040">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2025-07-01to2026-06-30" id="Fact000041">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="From2025-07-01to2026-06-30" id="Fact000042">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2025-07-01to2026-06-30" id="Fact000043">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2025-07-01to2026-06-30" id="Fact000044">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2026-09-02"
      decimals="-3"
      id="Fact000045"
      unitRef="USD">87600000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2026-09-25_custom_ClassACommonStockMember"
      decimals="INF"
      id="Fact000046"
      unitRef="Shares">33689050</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2026-09-25_custom_ClassBCommonStockMember"
      decimals="INF"
      id="Fact000047"
      unitRef="Shares">30645739</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000048">None.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000049">

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Risk Management&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a newly public company, we have not yet formally
adopted a cybersecurity policy, although we have processes for assessing, identifying and managing material cybersecurity threats. We
routinely assess material risks from cybersecurity threats that may result in adverse effects on the confidentiality, integrity, or availability
of our information systems or any information residing therein.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20250701__20260630_zFPlx5KI7KKa"&gt;We conduct periodic risk assessments to identify cybersecurity threats, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats.&lt;/span&gt; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_907_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20250701__20260630_zlSh8mZOVzyl"&gt;These risk assessments include identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such risks, and the sufficiency of existing policies, procedures, systems, and safeguards in place to manage such risks.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Following these risk assessments, we re-design, implement, and maintain reasonable safeguards to minimize identified risks, reasonably address any identified gaps in existing safeguards, and regularly monitor the effectiveness of our safeguards. We devote significant resources and designate high-level personnel, including our Chief Executive Officer, to manage the risk assessment and mitigation process.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_906_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbT_c20250701__20260630_zhRWiCNg5t5f"&gt;We may engage consultants and other third parties as needed in connection with our risk assessment policies and processes. These service providers may assist us to design and implement our cybersecurity policies and procedures, as well as to monitor and test our safeguards.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="From2025-07-01to2026-06-30" id="Fact000050">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="From2025-07-01to2026-06-30" id="Fact000051">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="From2025-07-01to2026-06-30" id="Fact000052">true</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000053">

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Governance&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250701__20260630_zDRD37FaVuKa"&gt;One of the key functions of our Board is informed oversight of our risk management process, including risks from cybersecurity threats.&lt;/span&gt; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90E_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250701__20260630_zomvAOfy3f7i"&gt;Our Board is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. Our Board administers its cybersecurity risk oversight function primarily through the Audit Committee.&lt;/span&gt; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_c20250701__20260630_zXWmYXfdFi1i"&gt;Our Chief Executive Officer  provides periodic briefings to the &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_901_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20250701__20260630_zRtNAZ2ujRC2"&gt;Audit Committee&lt;/span&gt; regarding our cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, cybersecurity policies and procedures, activities of third parties, and the like.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Our research and development lead  oversees our cybersecurity processes, including those described in &#x201c;&lt;i&gt;&#x2014;Risk Management&lt;/i&gt;&#x201d; above. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_c20250701__20260630_zhva7EF2y7Oc"&gt;The processes by which our research and development lead  is informed of and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents include reports from our research and development team or reports received from network systems and applications if any unusual activity occurs, such as email system notification of items opened that could be malicious.&lt;/span&gt;&lt;/p&gt; </cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000054">One of the key functions of our Board is informed oversight of our risk management process, including risks from cybersecurity threats.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000055">Our Board is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. Our Board administers its cybersecurity risk oversight function primarily through the Audit Committee.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000056">Our Chief Executive Officer  provides periodic briefings to the &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_901_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20250701__20260630_zRtNAZ2ujRC2"&gt;Audit Committee&lt;/span&gt; regarding our cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, cybersecurity policies and procedures, activities of third parties, and the like.</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="From2025-07-01to2026-06-30" id="Fact000057">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000058">The processes by which our research and development lead  is informed of and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents include reports from our research and development team or reports received from network systems and applications if any unusual activity occurs, such as email system notification of items opened that could be malicious.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <dei:AuditorFirmId contextRef="From2025-07-01to2026-06-30" id="Fact000059">7000</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2025-07-01to2026-06-30" id="Fact000060">HTL International, LLC</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2025-07-01to2026-06-30" id="Fact000061">Houston, Texas</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000069"
      unitRef="USD">4231689</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000070"
      unitRef="USD">2693586</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <xlabw:U.s.DollarCoin
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000073"
      unitRef="USD">2160746</xlabw:U.s.DollarCoin>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000075"
      unitRef="USD">152536</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000076"
      unitRef="USD">1107210</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <xlabw:AdvanceToSuppliers
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000078"
      unitRef="USD">1030761</xlabw:AdvanceToSuppliers>
    <xlabw:AdvanceToSuppliers
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000079"
      unitRef="USD">112343</xlabw:AdvanceToSuppliers>
    <xlabw:RefundableDepositsReceivable
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000081"
      unitRef="USD">681125</xlabw:RefundableDepositsReceivable>
    <xlabw:RefundableDepositsReceivable
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000082"
      unitRef="USD">450000</xlabw:RefundableDepositsReceivable>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000084"
      unitRef="USD">1207626</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000087"
      unitRef="USD">7303737</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000088"
      unitRef="USD">6523885</us-gaap:AssetsCurrent>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000094"
      unitRef="USD">190000</us-gaap:DeferredOfferingCosts>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000096"
      unitRef="USD">19600</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000097"
      unitRef="USD">12840</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000099"
      unitRef="USD">19600</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000100"
      unitRef="USD">202840</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000102"
      unitRef="USD">7323337</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000103"
      unitRef="USD">6726725</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000111"
      unitRef="USD">90015</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000112"
      unitRef="USD">916422</us-gaap:AccountsPayableCurrent>
    <xlabw:SimpleAgreementsForFutureEquity
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000114"
      unitRef="USD">18243885</xlabw:SimpleAgreementsForFutureEquity>
    <xlabw:SimpleAgreementsForFutureEquity
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000115"
      unitRef="USD">29121268</xlabw:SimpleAgreementsForFutureEquity>
    <us-gaap:DepositContractsLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000117"
      unitRef="USD">432760</us-gaap:DepositContractsLiabilities>
    <us-gaap:DepositContractsLiabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000118"
      unitRef="USD">1070378</us-gaap:DepositContractsLiabilities>
    <xlabw:RefundableDepositsPayable
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000120"
      unitRef="USD">1445580</xlabw:RefundableDepositsPayable>
    <xlabw:RefundableDepositsPayable
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000121"
      unitRef="USD">359481</xlabw:RefundableDepositsPayable>
    <xlabw:OtherCurrentLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000123"
      unitRef="USD">107481</xlabw:OtherCurrentLiabilities>
    <xlabw:OtherCurrentLiabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000124"
      unitRef="USD">417951</xlabw:OtherCurrentLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000126"
      unitRef="USD">20319721</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000127"
      unitRef="USD">31885500</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000129"
      unitRef="USD">20319721</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000130"
      unitRef="USD">31885500</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000141"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000143"
      unitRef="Shares">1500</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000145"
      unitRef="Shares">1500</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000147"
      unitRef="Shares">1500</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000138"
      unitRef="USD">15</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-06-30_custom_CommonStockClassAMember"
      decimals="INF"
      id="Fact000149"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-06-30_custom_CommonStockClassAMember"
      decimals="INF"
      id="Fact000151"
      unitRef="Shares">303</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-06-30_custom_CommonStockClassAMember"
      decimals="INF"
      id="Fact000153"
      unitRef="Shares">303</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-06-30_custom_CommonStockClassAMember"
      decimals="INF"
      id="Fact000155"
      unitRef="Shares">303</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2026-06-30_custom_CommonStockClassAMember"
      decimals="0"
      id="Fact000157"
      unitRef="USD">3</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-06-30_custom_CommonStockClassBMember"
      decimals="INF"
      id="Fact000159"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-06-30_custom_CommonStockClassBMember"
      decimals="INF"
      id="Fact000161"
      unitRef="Shares">1197</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-06-30_custom_CommonStockClassBMember"
      decimals="INF"
      id="Fact000163"
      unitRef="Shares">1197</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-06-30_custom_CommonStockClassBMember"
      decimals="INF"
      id="Fact000165"
      unitRef="Shares">1197</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2026-06-30_custom_CommonStockClassBMember"
      decimals="0"
      id="Fact000167"
      unitRef="USD">12</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000169"
      unitRef="USD">220636</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000170"
      unitRef="USD">220636</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000172"
      unitRef="USD">-13217035</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000173"
      unitRef="USD">-25379426</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000175"
      unitRef="USD">-12996384</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000176"
      unitRef="USD">-25158775</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000178"
      unitRef="USD">7323337</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000179"
      unitRef="USD">6726725</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000181"
      unitRef="USD">7015512</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000182"
      unitRef="USD">14822799</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000184"
      unitRef="USD">5910315</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000185"
      unitRef="USD">12404546</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000187"
      unitRef="USD">1105197</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000188"
      unitRef="USD">2418253</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000193"
      unitRef="USD">989155</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000194"
      unitRef="USD">499392</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000196"
      unitRef="USD">362982</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000197"
      unitRef="USD">1229516</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000199"
      unitRef="USD">2797906</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000200"
      unitRef="USD">5490185</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000202"
      unitRef="USD">4150043</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000203"
      unitRef="USD">7219093</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000205"
      unitRef="USD">-3044846</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000206"
      unitRef="USD">-4800840</us-gaap:OperatingIncomeLoss>
    <xlabw:ChangeInFairValueOfSimpleAgreementsForFutureEquity
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000208"
      unitRef="USD">4614821</xlabw:ChangeInFairValueOfSimpleAgreementsForFutureEquity>
    <xlabw:ChangeInFairValueOfSimpleAgreementsForFutureEquity
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000209"
      unitRef="USD">7377383</xlabw:ChangeInFairValueOfSimpleAgreementsForFutureEquity>
    <us-gaap:OtherIncome
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000212"
      unitRef="USD">15832</us-gaap:OtherIncome>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000214"
      unitRef="USD">-7659667</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000215"
      unitRef="USD">-12162391</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000220"
      unitRef="USD">-7659667</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000221"
      unitRef="USD">-12162391</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000226"
      unitRef="USDPShares">-5106.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000228"
      unitRef="USDPShares">-5106.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000230"
      unitRef="USDPShares">-8108.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000232"
      unitRef="USDPShares">-8108.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000237"
      unitRef="Shares">1500</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000239"
      unitRef="Shares">1500</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000241"
      unitRef="Shares">1500</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000243"
      unitRef="Shares">1500</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000252"
      unitRef="Shares">1500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000245"
      unitRef="USD">15</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000248"
      unitRef="USD">67370</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000249"
      unitRef="USD">-5557368</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000250"
      unitRef="USD">-5489983</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000262"
      unitRef="USD">-7659667</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000263"
      unitRef="USD">-7659667</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000268"
      unitRef="USD">153266</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000270"
      unitRef="USD">153266</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000279"
      unitRef="Shares">1500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000272"
      unitRef="USD">15</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000275"
      unitRef="USD">220636</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000276"
      unitRef="USD">-13217035</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000277"
      unitRef="USD">-12996384</us-gaap:StockholdersEquity>
    <xlabw:RedesignationOfAuthorizedCommonStockShares
      contextRef="From2025-07-012026-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000292"
      unitRef="Shares">-1500</xlabw:RedesignationOfAuthorizedCommonStockShares>
    <xlabw:RedesignationOfAuthorizedCommonStock
      contextRef="From2025-07-012026-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000285"
      unitRef="USD">-15</xlabw:RedesignationOfAuthorizedCommonStock>
    <xlabw:RedesignationOfAuthorizedCommonStockShares
      contextRef="From2025-07-012026-06-30_custom_ClassACommonStockMember"
      decimals="INF"
      id="Fact000294"
      unitRef="Shares">303</xlabw:RedesignationOfAuthorizedCommonStockShares>
    <xlabw:RedesignationOfAuthorizedCommonStock
      contextRef="From2025-07-012026-06-30_custom_ClassACommonStockMember"
      decimals="0"
      id="Fact000286"
      unitRef="USD">3</xlabw:RedesignationOfAuthorizedCommonStock>
    <xlabw:RedesignationOfAuthorizedCommonStockShares
      contextRef="From2025-07-012026-06-30_custom_ClassBCommonStockMember"
      decimals="INF"
      id="Fact000296"
      unitRef="Shares">1197</xlabw:RedesignationOfAuthorizedCommonStockShares>
    <xlabw:RedesignationOfAuthorizedCommonStock
      contextRef="From2025-07-012026-06-30_custom_ClassBCommonStockMember"
      decimals="0"
      id="Fact000287"
      unitRef="USD">12</xlabw:RedesignationOfAuthorizedCommonStock>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-012026-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000302"
      unitRef="USD">-12162391</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000303"
      unitRef="USD">-12162391</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-06-30_custom_ClassACommonStockMember"
      decimals="INF"
      id="Fact000314"
      unitRef="Shares">303</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-06-30_custom_ClassACommonStockMember"
      decimals="0"
      id="Fact000306"
      unitRef="USD">3</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-06-30_custom_ClassBCommonStockMember"
      decimals="INF"
      id="Fact000316"
      unitRef="Shares">1197</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-06-30_custom_ClassBCommonStockMember"
      decimals="0"
      id="Fact000307"
      unitRef="USD">12</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000308"
      unitRef="USD">220636</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000309"
      unitRef="USD">-25379426</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000310"
      unitRef="USD">-25158775</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000321"
      unitRef="USD">-7659667</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000322"
      unitRef="USD">-12162391</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000327"
      unitRef="USD">6234</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000328"
      unitRef="USD">6760</us-gaap:Depreciation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000330"
      unitRef="USD">153266</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <xlabw:ChangeInFairValueOfSimpleAgreementsForFutureEquities
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000333"
      unitRef="USD">4614821</xlabw:ChangeInFairValueOfSimpleAgreementsForFutureEquities>
    <xlabw:ChangeInFairValueOfSimpleAgreementsForFutureEquities
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000334"
      unitRef="USD">7377383</xlabw:ChangeInFairValueOfSimpleAgreementsForFutureEquities>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000337"
      unitRef="USD">38022</us-gaap:ProvisionForDoubtfulAccounts>
    <xlabw:OtherOperatingActivitiesSettledInDigitalAssetsAndU.s.DollarCoin
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000340"
      unitRef="USD">567267</xlabw:OtherOperatingActivitiesSettledInDigitalAssetsAndU.s.DollarCoin>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000345"
      unitRef="USD">29204</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000346"
      unitRef="USD">992696</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <xlabw:IncreaseDecreaseInAdvanceToSuppliersAndPrepaidExpense
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000348"
      unitRef="USD">750264</xlabw:IncreaseDecreaseInAdvanceToSuppliersAndPrepaidExpense>
    <xlabw:IncreaseDecreaseInAdvanceToSuppliersAndPrepaidExpense
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000349"
      unitRef="USD">-918418</xlabw:IncreaseDecreaseInAdvanceToSuppliersAndPrepaidExpense>
    <xlabw:IncreaseDecreaseInRefundableDepositsReceivable
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000351"
      unitRef="USD">571125</xlabw:IncreaseDecreaseInRefundableDepositsReceivable>
    <xlabw:IncreaseDecreaseInRefundableDepositsReceivable
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000352"
      unitRef="USD">-231125</xlabw:IncreaseDecreaseInRefundableDepositsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000354"
      unitRef="USD">-1709568</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000355"
      unitRef="USD">-1707626</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000357"
      unitRef="USD">-38025</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000358"
      unitRef="USD">826407</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000360"
      unitRef="USD">337434</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000361"
      unitRef="USD">637618</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <xlabw:IncreaseDecreaseInRefundableDepositsPayable
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000363"
      unitRef="USD">1222375</xlabw:IncreaseDecreaseInRefundableDepositsPayable>
    <xlabw:IncreaseDecreaseInRefundableDepositsPayable
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000364"
      unitRef="USD">-1086099</xlabw:IncreaseDecreaseInRefundableDepositsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000366"
      unitRef="USD">-6212</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000367"
      unitRef="USD">310470</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000369"
      unitRef="USD">-1010799</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000370"
      unitRef="USD">-2754624</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000375"
      unitRef="USD">2138</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <xlabw:ProceedsFromSaleOfDigitalAssetsAndU.s.DollarCoin
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000379"
      unitRef="USD">1406521</xlabw:ProceedsFromSaleOfDigitalAssetsAndU.s.DollarCoin>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000381"
      unitRef="USD">-2138</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000382"
      unitRef="USD">1406521</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <xlabw:PaymentForDeferredOfferingCosts
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000388"
      unitRef="USD">190000</xlabw:PaymentForDeferredOfferingCosts>
    <xlabw:ProceedsFromSimpleAgreementsForFutureEquity
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000390"
      unitRef="USD">4275000</xlabw:ProceedsFromSimpleAgreementsForFutureEquity>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000393"
      unitRef="USD">4275000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000394"
      unitRef="USD">-190000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000396"
      unitRef="USD">3262063</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000397"
      unitRef="USD">-1538103</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000399"
      unitRef="USD">969626</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000400"
      unitRef="USD">4231689</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000402"
      unitRef="USD">4231689</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000403"
      unitRef="USD">2693586</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000409"
      unitRef="USD">800</us-gaap:IncomeTaxesPaid>
    <us-gaap:NotesAssumed1
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000417"
      unitRef="USD">32500</us-gaap:NotesAssumed1>
    <us-gaap:NotesAssumed1
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000418"
      unitRef="USD">500000</us-gaap:NotesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionInventoryAcquired1
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000421"
      unitRef="USD">3000000</us-gaap:NoncashOrPartNoncashAcquisitionInventoryAcquired1>
    <us-gaap:NatureOfOperations contextRef="From2025-07-01to2026-06-30" id="Fact000423">&lt;p id="xdx_809_eus-gaap--NatureOfOperations_zlN03fGSYqj3" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;1. &lt;span id="xdx_827_zYQrPRkG50Ta"&gt;Organization and principal activities&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On June&#160;1, 2022, Exascale Labs Inc. (the &#x201c;Company&#x201d;) was formally incorporated in the State of Delaware. In accordance with the Company&#x2019;s Certificate of Incorporation, the total authorized share capital of the Company consists of &lt;span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20220601__dei--LegalEntityAxis__custom--ExascaleLabsIncMember_zM2YxXm8UPvj" title="Common stock, shares authorized"&gt;1,500&lt;/span&gt; shares of common stock, with a par value of $&lt;span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220701__dei--LegalEntityAxis__custom--ExascaleLabsIncMember_zN6CzA8kuYcg" title="Common stock, par value"&gt;0.01&lt;/span&gt; per share, all of which are of one class. The governance structure of the Company stipulates that the business and affairs of the Company shall be managed by or under the direction of its board of directors.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On December&#160;16, 2025, the Company incorporated its wholly-owned subsidiary, Evana Alpha Pte. Ltd., in Singapore. The Company subscribed for all &lt;span id="xdx_908_ecustom--OrdinarySharesIssued_c20161201__20161216__srt--CounterpartyNameAxis__custom--EvanaAlphaPteLtdMember__dei--LegalEntityAxis__custom--ExascaleLabsIncMember_pd" title="Ordinary shares issued"&gt;1,000&lt;/span&gt; ordinary shares of the subsidiary, with a total issued share capital of Singapore Dollars &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20161201__20161216__srt--CounterpartyNameAxis__custom--EvanaAlphaPteLtdMember__dei--LegalEntityAxis__custom--ExascaleLabsIncMember_pd" title="Number of shares issued"&gt;1,000&lt;/span&gt;. The subsidiary&#x2019;s principal business activity is information technology consultancy (excluding cybersecurity).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company is a next-generation artificial intelligence (&#x201c;AI&#x201d;) infrastructure provider operating an asset-light, software-defined graphics processing unit (&#x201c;GPU&#x201d;) compute platform and related AI infrastructure solutions. The Company&#x2019;s core business includes GPU as a Service (&#x201c;GaaS&#x201d;), through which it provides reserved and on-demand access to high-performance GPU compute capacity sourced from third-party data centers globally, as well as GPU cluster management and optimization services for artificial intelligence data center (&#x201c;AIDC&#x201d;) operators. In addition, the Company has developed certain modular data center, high-density liquid cooling, high-voltage direct current (&#x201c;HVDC&#x201d;) power, data center interconnectivity and energy storage solutions that are designed to address deployment bottlenecks in AI infrastructure and that the Company believes are ready for commercial engagement in future. The platform is purpose-built for large-scale AI workloads, including large language model (&#x201c;LLM&#x201d;) training, fine-tuning, and high-concurrency inference.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In January&#160;2026, the Company adopted an Amended and Restated Certificate of Incorporation, which established a dual-class common stock structure. Under this new structure, the Company&#x2019;s equity is divided into 303 shares of Class A common stock and 1,197 shares of Class B common stock, which are entitled to one (1) vote and twenty (20) votes per share, respectively. Despite the differential in voting power, Class A common stock and Class B common stock rank pari passu in all other respects, sharing ratably in dividends and any distributions upon liquidation. Furthermore, all outstanding Simple Agreements for Future Equity (&#x201c;SAFEs&#x201d;) are designated to convert or settle exclusively into Class A common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On January&#160;11, 2026, D. Boral ARC Acquisition I Corp., a British Virgin Islands business company (&#x201c;BCAR&#x201d;) entered into an Agreement and Plan of Merger (the &#x201c;Business Combination Agreement&#x201d;), with D. Boral ARC Merger Corporation, a Delaware corporation and a wholly owned subsidiary of BCAR (&#x201c;PubCo&#x201d;), D. Boral Arc Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of BCAR (&#x201c;Merger Sub&#x201d;), and the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0; color: #24272F"&gt;On August&#160;27, 2026 (the &#x201c;Closing Date&#x201d;), PubCo consummated the transactions contemplated by the Business Combination Agreement
(the &#x201c;Business Combination&#x201d;). PubCo changed its name from &#x201c;D. Boral ARC Merger Corporation&#x201d; to &#x201c;Exascale
Labs Holdings Inc&#x201d;. Upon the closing of the Business Combination, Merger Sub merged with and into the Company, with the Company
surviving as a wholly owned subsidiary of PubCo. &lt;span id="xdx_900_ecustom--ClosingDateDescription_c20260801__20260827__dei--LegalEntityAxis__custom--ExascaleLabsIncMember_zxknGp9ZC0Pb" title="Closing date description"&gt;The Company&#x2019;s former securityholders received an aggregate of 19,354,261 PubCo Class A common stock and 30,645,739 PubCo Class B
common stock, representing aggregate merger consideration of $500.0 million based on a deemed value of $10.00 per share. The Class B common
stock have 20 votes per share, while the Class A common stock have one vote per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0; color: #24272F"&gt;The Business Combination was accounted for as a reverse recapitalization, with the Company identified as the accounting acquirer and BCAR identified as the accounting acquiree for financial reporting purposes (De-SPAC transaction).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of the &lt;span id="xdx_905_ecustom--ClosingDateDescription_c20260801__20260827_z1KRqtpruqJa" title="Closing date description"&gt;Closing Date and following the completion of the Business Combination, PubCo had approximately 64,334,789 shares of PubCo Common Stock
issued and outstanding, consisting of approximately 33,689,050 PubCo Class A common stock and 30,645,739 PubCo Class B common stock. In
addition, as of the Closing Date, PubCo had 14,099,992 warrants issued and outstanding, each whole warrant entitling the holder thereof
to purchase one share of PubCo Class A common stock at an exercise price of $11.50 per share.&lt;/span&gt;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:NatureOfOperations>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-01_custom_ExascaleLabsIncMember"
      decimals="INF"
      id="Fact000425"
      unitRef="Shares">1500</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-07-01_custom_ExascaleLabsIncMember"
      decimals="INF"
      id="Fact000427"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <xlabw:OrdinarySharesIssued
      contextRef="From2016-12-012016-12-16_custom_EvanaAlphaPteLtdMember_custom_ExascaleLabsIncMember"
      decimals="INF"
      id="Fact000429"
      unitRef="Shares">1000</xlabw:OrdinarySharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2016-12-012016-12-16_custom_EvanaAlphaPteLtdMember_custom_ExascaleLabsIncMember"
      decimals="INF"
      id="Fact000431"
      unitRef="Shares">1000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <xlabw:ClosingDateDescription
      contextRef="From2026-08-012026-08-27_custom_ExascaleLabsIncMember"
      id="Fact000433">The Company&#x2019;s former securityholders received an aggregate of 19,354,261 PubCo Class A common stock and 30,645,739 PubCo Class B
common stock, representing aggregate merger consideration of $500.0 million based on a deemed value of $10.00 per share. The Class B common
stock have 20 votes per share, while the Class A common stock have one vote per share.</xlabw:ClosingDateDescription>
    <xlabw:ClosingDateDescription contextRef="From2026-08-012026-08-27" id="Fact000435">Closing Date and following the completion of the Business Combination, PubCo had approximately 64,334,789 shares of PubCo Common Stock
issued and outstanding, consisting of approximately 33,689,050 PubCo Class A common stock and 30,645,739 PubCo Class B common stock. In
addition, as of the Closing Date, PubCo had 14,099,992 warrants issued and outstanding, each whole warrant entitling the holder thereof
to purchase one share of PubCo Class A common stock at an exercise price of $11.50 per share.</xlabw:ClosingDateDescription>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000438">&lt;p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zhCFPcR3xDpg" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;2. &lt;span id="xdx_822_zqpPQ9l2L9Ed"&gt;Summary of significant accounting policies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_848_ecustom--GoingConcernPolicyTextBlock_zf3k9joM6X7h" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;a. &lt;span id="xdx_86F_zCtlv3BwMvSl"&gt;Going concern&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of June&#160;30, 2026, the Company had cash and U.S. Dollar Coin (&#x201c;USDC&#x201d;) of $4.9 &lt;span id="xdx_900_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20260630_pp0p" style="display: none" title="Cash and cash equivalents"&gt;2,693,586&lt;/span&gt; million and current liabilities of $31.9 &lt;span id="xdx_90A_eus-gaap--LiabilitiesCurrent_c20260630_pp0p" style="display: none" title="Current liabilities"&gt;31,885,500&lt;/span&gt; million. For the years ended June&#160;30, 2025 and 2026, the Company used $1.0 &lt;span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_c20240701__20250630_pp0p" style="display: none" title="Cash for operating activities"&gt;(1,010,799)&lt;/span&gt; million and $2.8 &lt;span id="xdx_90A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_c20250701__20260630_pp0p" style="display: none" title="Cash for operating activities"&gt;(2,754,624)&lt;/span&gt; million in operating activities. The Company incurred net losses of $7.7 &lt;span id="xdx_90A_eus-gaap--NetIncomeLoss_c20240701__20250630_pp0p" style="display: none" title="Net losses"&gt;(7,659,667)&lt;/span&gt; million and $12.2 &lt;span id="xdx_90C_eus-gaap--NetIncomeLoss_c20250701__20260630_pp0p" style="display: none" title="Net losses"&gt;(12,162,391)&lt;/span&gt; million for these respective periods. Since inception, the Company has incurred recurring net losses from operations and negative cash flows from operating activities. As of June&#160;30, 2026, the Company had an accumulated deficit of $25.4 &lt;span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_c20260630_pp0p" style="display: none" title="Accumulated deficit"&gt;(25,379,426)&lt;/span&gt; million. These factors raised substantial doubt regarding the Company&#x2019;s ability to continue as a going concern within one year of the date these consolidated financial statements were issued.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On August&#160;27, 2026, the Company consummated the Business Combination. Upon the closing of the Business Combination, all outstanding SAFEs of the Company were converted into PubCo Class A common stock in accordance with their terms, eliminating SAFE liabilities that totaled approximately $&lt;span id="xdx_905_ecustom--SafeLiabilities_iI_pn5n6_c20260630_ztpnFXjZrxvl" title="Safe liabilities"&gt;29.1&lt;/span&gt; million as of June&#160;30, 2026. In connection with the closing of the Business Combination, the Company obtained access to cash proceeds of approximately $&lt;span id="xdx_909_eus-gaap--ProceedsFromSaleOfNotesReceivable_pn5n6_c20250701__20260630_zTdSMjCCptFa" title="Proceeds from safes"&gt;11.8&lt;/span&gt; million retained from the Business Combination. In addition, between July 1, 2026 and August&#160;27, 2026, an investor provided the Company with $1.0 million in the form of a SAFE, which was also converted into PubCo Class A common stock upon the closing of the Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;Management has prepared a cash flow forecast covering the twelve-month period following the date that these consolidated financial statements are issued. The forecast considers the liquidity provided by the De-SPAC transaction&lt;/span&gt;, conversion of SAFE instruments on the closing of the Business Combination, &lt;span style="font-size: 10pt"&gt;as well as management&#x2019;s operating plans and expectations, including the Company&#x2019;s continued focus on expanding its market presence and developing client relationships to drive revenue growth and managing operating expenses, with the objective of improving cash flows from operations over time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;Based on this forecast, management believes that the Company will have sufficient liquidity to fund its ongoing operations and anticipated working capital requirements for a period of at least twelve months after the date that these consolidated financial statements are issued. Accordingly,&lt;/span&gt; management has concluded &lt;span style="font-size: 10pt"&gt;that the substantial doubt about the Company&#x2019;s ability to continue as a going concern has been alleviated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These consolidated financial statements have been prepared on a going concern basis, and no adjustments are required to the carrying amounts or classification of assets and liabilities in the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zXXyuAiqNYbh" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;b. &lt;span id="xdx_861_zSk2kopUu1ac"&gt;Basis of presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;).&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84D_eus-gaap--UseOfEstimates_z7wWTQSaRMv5" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;c. &lt;span id="xdx_861_z5FUhMjaPHwk"&gt;Use of estimates and assumptions&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The preparation of consolidated
financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts
reported in the consolidated financial statements and accompanying notes. Management believes that the estimates used in preparing
the consolidated financial statements are reasonable and prudent; however, actual results could differ from these estimates under
different assumptions or conditions.&#160;Significant accounting estimates include recognition and measurement of SAFEs notes,
recognition and measurement of the allowance for expected credit losses, deferred tax assets and valuation allowance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_842_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zgPTPIQfyIa9" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;d. &lt;span id="xdx_863_zPInaBBTiDme"&gt;Fair value measurements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In accordance with FASB ASC 820&#160;&lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt;, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company uses a three-level hierarchy for fair value measurements of certain assets and liabilities for financial reporting purposes that distinguishes between market participant assumptions developed from market data obtained from outside sources (observable inputs) and the Company&#x2019;s own assumptions about market participant assumptions developed from the best information available to us in the circumstances (unobservable inputs).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Level 1: Quoted prices in active markets for identical assets or liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Level 2: Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Level 3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management during the years ended June&#160;30, 2025 and 2026. The carrying amount of cash and cash equivalents, accounts receivable, refundable deposits receivable, other receivables, accounts payable, refundable deposits payable and other current liabilities approximated their fair values as of June&#160;30, 2025 and 2026. For the years ended June&#160;30, 2025 and 2026, the Company carried SAFEs and digital assets at their fair value (see&#160;Note 4-Fair Value Measurements for fair value information).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84E_ecustom--FunctionalCurrencyPolicyTextBlock_zrp7ekne51Hj" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;e. &lt;span id="xdx_868_zRAdMkdpcuCb"&gt;Functional currency&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The accompanying consolidated financial statements are presented in the United States dollar (&#x201c;US$&#x201d;). The functional currency of the Company and its subsidiary is the US$.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;All transactions are measured and recorded in the Company&#x2019;s functional currency.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zIXz6kc0TXAi" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;f. &lt;span id="xdx_860_ziepQm8WLHJb"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company considers all highly liquid investments instruments purchased with a maturity period of three months or less to be cash or cash equivalents. The carrying amounts reported in the accompanying balance sheets for cash and cash equivalents approximate their fair value. As of June&#160;30, 2025 and 2026, the Company does &lt;span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0d_do_c20260630_z4eAkNGQ6a6d" title="Cash equivalents"&gt;&lt;span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0d_do_c20250630_zTlt5MngaPhb" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt;t have any cash equivalents.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84F_ecustom--CryptoAssets_zUiQiS97ympk" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;g. &lt;span id="xdx_865_zut5jpCF97ti"&gt;Crypto assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s crypto assets classified in current assets are held primarily for use in the ordinary course of business which is expected to be actively utilized or converted within the normal operating cycle and such crypto assets can be sold in a highly liquid marketplace. During the year ended June&#160;30, 2026, the Company only held crypto assets of Tether USD (&#x201c;USDT&#x201d;) and USDC, which are principally funded by SAFE investors and as a form of collection from revenue transactions. The Company&#x2019;s crypto assets are held with a qualified third-party custodian who provide secure storage and safeguarding of the Company&#x2019;s crypto assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;USDC&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;USDC is a stablecoin redeemable on a one-to-one basis for U.S. dollars and is accounted for as a financial instrument in the consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Crypto assets other than USDC&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On December&#160;13, 2023, the FASB issued ASU 2023-08, which addresses the accounting and disclosure requirements for certain cryptocurrencies. The new guidance requires entities to subsequently measure certain cryptocurrencies at fair value, with changes in fair value recorded in net income in each reporting period. The Company applied the ASU since its holding of crypto assets in December&#160;2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Digital assets that are received as noncash consideration in the Company&#x2019;s revenue arrangements and paid in purchases of professional service and others are presented as cash flows from operating activities in other operating activities settled in digital assets and USDC. Digital assets that are received in the Company&#x2019;s revenue arrangements and sold for cash within seven days are presented as cash flows from operating activities, while other digital asset activity held longer than seven days is reflected as cash flows from investing activities under disposal of digital assets and USDC held in the consolidated statements of cash flows. The Company presents crypto assets other than USDC separately from other intangible assets and USDC, recorded as digital assets on the consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For the year ended June&#160;30, 2026, the Company recorded receipt and disbursement of digital assets amounted to $&lt;span id="xdx_907_ecustom--ReceiptOfDigitalAssets_c20250701__20260630_pp0p" title="Receipt of digital assets"&gt;991,601&lt;/span&gt; and $&lt;span id="xdx_909_ecustom--DisbursementOfDigitalAssets_c20250701__20260630_pp0p" title="Disbursement of digital assets"&gt;991,601&lt;/span&gt;, respectively, which resulted in an ending balance of nil. The Company&#x2019;s balances related to digital assets and stablecoins during the period included USDT and USDC, both of which are USD-pegged stablecoins. &lt;span id="xdx_908_ecustom--FairValueGainOrLossOnDigitalAssets_pp0d_do_c20250701__20260630_zUdgefVa3Vkb" title="Fair value gain or loss on digital assets"&gt;No&lt;/span&gt; fair value gain or loss on digital assets was recognized for the year ended June&#160;30, 2026 considering the low volatility in the fair value of digital assets during the year ended June&#160;30, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84E_ecustom--ExpectedCreditLossAndAccountsReceivablePolicyTextBlock_zxywzRE1dhW7" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;h. &lt;span id="xdx_868_zBuB3h3e6BMj"&gt;Expected credit loss and accounts receivable&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company adopted Financial Standards Accounting Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 326 &#x201c;&lt;i&gt;Financial Instruments&#160;&#x2014;&#160;Credit Losses&lt;/i&gt;&#x201d; (&#x201c;ASC&#160;326&#x201d;) on July&#160;1, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s accounts receivable
are within the scope of ASC&#160;326. ASC&#160;326 introduces an approach based on expected credit losses on financial assets at
amortized cost. Upon adoption of ASC&#160;326, the Company estimates the expected credit losses for accounts receivable using the
roll-rate method on a collective basis when similar risk characteristics exist. Expected credit losses are included in general and
administrative expenses in the consolidated statements of operations and comprehensive loss. After all attempts to collect a
receivable have failed, the receivable is written off against the allowance.&lt;/p&gt;

























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Accounts receivable represents those receivables derived in the ordinary course of business, net of an allowance for any potentially uncollectible amounts. The Company makes estimates of expected credit and collectability trends for the allowance for credit losses based upon its assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions that may vary by geography, customer-type, or industry sub-vertical, and other factors that may affect its ability to collect from customers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Although the Company has historically not experienced significant credit losses, they may experience increasing credit loss risks from accounts receivable in future periods if its customers are adversely affected by economic pressures or uncertainty associated with local or global economic recessions, or other customer-specific factors, and actual experience in the future may differ from their past experiences or current assessment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_845_ecustom--DeferredOfferingCostsPolicyTextBlock_zlUviWCDZ81b" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;i. &lt;span id="xdx_86F_zcnZOfSBqq57"&gt;Deferred offering costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company follows the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic 5A &#x2014; &#x201c;Expenses of Offering&#x201d;. Deferred offering costs consist of underwriting, legal, and other professional expenses incurred through the balance sheet date that are directly related to the intended De-SPAC Transaction. These costs will be charged to shareholders&#x2019; equity, netted against the proceeds, upon the completion of the Business Combination. Should the transaction prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will be charged to the statements of operations and comprehensive loss. As of June&#160;30, 2025 and 2026, the Company deferred nil and $&lt;span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_pp0d_c20260630_zHx9TLOLVczf" title="Deferred offering costs"&gt;190,000&lt;/span&gt; of transaction costs, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_848_ecustom--AdvanceToSuppliersPolicyTextBlock_zOuWBT71QVdb" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;j. &lt;span id="xdx_867_zcfqK6LY4Po3"&gt;Advance to suppliers&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Advance to suppliers represent prepayments made to vendors in connection with the purchase of services. Advance is recorded at the amount paid and are classified as current assets when the related services are expected to be received within one year or the normal operating cycle.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_849_ecustom--RefundableDepositsReceivablePolicyTextBlock_zy7Ih9nHWEJ" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;k. &lt;span id="xdx_86E_zypnVQLTT0o1"&gt;Refundable deposits receivable&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Refundable deposits receivable mainly represents security deposits and refundable cooperation deposits paid to suppliers and business partners that are contractually recoverable upon the completion of services. These amounts are recorded as assets when paid, generally at the amount paid. Deposits expected to be recovered within one year are classified as current; otherwise, they are classified as non-current. Allowance should be assessed under CECL, and write off when not recoverable. The Company evaluates the credit risk of refundable deposits receivable and recognizes an allowance for credit losses based on the current expected credit losses (&#x201c;CECL&#x201d;) model. Specific balances are written off when they are deemed uncollectible and all collection efforts have been exhausted. As of June&#160;30, 2025 and 2026, &lt;span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0d_do_c20260630_zkmbTSswaEm" title="Allowance for expected credit losses"&gt;&lt;span id="xdx_906_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0d_do_c20250630_zGbTWOjTDI26" title="Allowance for expected credit losses"&gt;no&lt;/span&gt;&lt;/span&gt; allowance for credit losses was recorded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84D_ecustom--OtherReceivablesPolicyRextBlock_zLGBhdiXwjb4" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;l. &lt;span id="xdx_869_z8gPNWmqks8h"&gt;Other receivables&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Other receivables represent funds temporarily held in trust by an employee acting as the Company&#x2019;s behalf. As of June&#160;30, 2025 and 2026, the balance were $&lt;span id="xdx_90E_eus-gaap--OtherReceivables_iI_pp0d_c20250630_zylXnD6GCdVk" title="Other receivables"&gt;1,207,626&lt;/span&gt; and &lt;span id="xdx_901_eus-gaap--OtherReceivables_iI_pp0d_c20260630_zpmskdjRgFv9" style="display: none" title="Other receivables"&gt;0&lt;/span&gt; nil, respectively, primarily comprising proceeds from SAFEs agreements received via the employee and net of payments made to designated suppliers at the Company&#x2019;s direction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zNZNSuY2New1" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;m. &lt;span id="xdx_863_zKZhcB5PupK6"&gt;Equipment, net&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Equipment, net is stated at cost less accumulated depreciation and impairment, if any. Depreciation is computed using the straight-line method over the estimated useful lives of three or five years, depending on the asset category.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_848_ecustom--RefundableDepositsPayablePolicyTextBlock_zufCJVMeRUS5" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;n. &lt;span id="xdx_861_zcnJbj6qIyt5"&gt;Refundable deposits payable&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Refundable deposits payable represent security payments received from a third party and customers, which are required for certain intelligent computing power service arrangements. As of June&#160;30, 2025 and 2026, the balances were $&lt;span id="xdx_905_ecustom--RefundableDepositsPayable_iI_pp0d_c20250630_zyhJVI90jr6d" title="Refundable deposits payable"&gt;1,445,580&lt;/span&gt; and $&lt;span id="xdx_900_ecustom--RefundableDepositsPayable_iI_pp0d_c20260630_zVODggupN70c" title="Refundable deposits payable"&gt;359,481&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBfmPRmJMe9k" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;o. &lt;span id="xdx_86E_zfrzK7T32BH5"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company reviews its long-lived assets, equipment, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated from the use of the asset and its eventual disposition. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair value of the impaired assets. Assets to be disposed of are reported at the lower of their carrying amount or fair value less cost to sell. There was &lt;span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pp0d_do_c20240701__20250630_zoAXC7B71HRi" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pp0d_do_c20250701__20260630_zfvprjbijfke" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt; impairment of long-lived assets for the years ended June&#160;30, 2025 and 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_841_ecustom--SimpleAgreementsForFutureEquityPolicyTextBlock_zNlNgzK4mCIl" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;p. &lt;span id="xdx_869_zrlC6plXUsUf"&gt;Simple agreements for future equity&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;SAFEs issued by the Company are freestanding financial instruments. As they contain certain redemption or liquidation features that&#160;may&#160;require the Company to settle the obligation in cash upon the occurrence of defined events (e.g., a change of control or dissolution), the instruments&#160;create an obligation that meets the definition of a liability. Accordingly, the SAFEs are classified in their entirety as liabilities on the consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These liabilities are measured at fair value upon initial recognition and are subsequently remeasured at fair value at each reporting date. All changes in their fair value are recognized in&#160;the consolidated statement of operations and comprehensive loss in the period in which they occur.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84F_eus-gaap--RevenueRecognitionDeferredRevenue_zxlrb18xKx1i" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;q. &lt;span id="xdx_864_zvWKkSAesbfk"&gt;Revenue recognition&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company applied ASC Topic&#160;606 &#x201c;&lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;&#x201d; (&#x201c;ASC&#160;606&#x201d;) for all periods presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The five-step model defined by ASC&#160;606 requires the Company to (i)&#160;identify its contracts with clients, (ii)&#160;identify its performance obligations under those contracts, (iii)&#160;determine the transaction prices of those contracts, (iv)&#160;allocate the transaction prices to its performance obligations in those contracts, and (v)&#160;recognize revenue when each performance obligation under those contracts is satisfied. Revenue is recognized when promised goods or services are transferred to the client in an amount that reflects the consideration expected in exchange for those goods or services.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company reports all of its revenues on a gross basis.&#160;This determination is based on the Company&#x2019;s assessment that it is the principal in its revenue arrangements. The Company controls the service delivery platform and infrastructure before the service is provided to the customer. It is primarily responsible for fulfilling the service promise, has discretion in setting prices, and assumes the credit risk associated with the customer receivable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As a practical expedient, the Company elected to expense the incremental costs of obtaining a contract when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Pursuant to ASC 606, the Company recognizes revenue based on the transaction price, which is the amount of consideration it expects to be entitled to exchange for transferring services to customers. For Intelligent Computing Power Services, contract consideration is generally fixed and is typically stated as a fixed monthly fee determined by (i) the contractually specified number of GPUs (capacity) and (ii) the service period. Accordingly, the transaction price is generally the fixed contractual amount. The Company recognizes revenue over time as the services are provided throughout the contract term. The Company offers payment terms ranging from 0 to 6 months, depending on customers&#x2019; credit profiles and service requirements.&lt;/p&gt;

























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company does not provide warranties for its services and does not offer service-type warranty arrangements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The following is a description of the principal activities of the Company from which the Company generates its revenue under ASC 606.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;(i) Revenue for intelligent computing power service&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company leverages its expertise in high-performance computing and cloud-native architectures to build and operate stable, efficient, and scalable GPU computing platforms through modular data center design and liquid cooling technology. The Company uses these platforms to provide computing resources for large-scale AI training, model inference, and high-performance scientific computing to commercial enterprise clients with substantial GPU computing requirements. Supporting services include GPU server environment deployment, cluster scheduling and performance optimization, high-speed network interconnection, real-time monitoring and intelligent alerting systems, as well as industry-compliant security and regulatory assurance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company accounts for the above promises as a single performance obligation because they are highly integrated and not separately identifiable in the context of the contract. The Company provides an integrated, managed GPU computing platform in which computing capacity, deployment/configuration, scheduling, networking, monitoring, and security/compliance are interdependent and together deliver a single combined service&#x2014;continuous access to a functioning and secured platform over the contractual term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company provides intelligent computing power services under two pricing models: (i) reserved capacity arrangements and (ii) on-demand (pay-as-you-go) arrangements. The following table presents revenue recognized during the period by arrangement type:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfRevenueRecognitionTableTextBlock_zDbvLU3bg7eg" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B7_zLkCItVFLvu6" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of Revenue recognition&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Reserved capacity arrangements&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--Revenues_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember__us-gaap--TransactionTypeAxis__custom--ReservedCapacityArrangementsMember_pp0p" title="Revenues"&gt;6,501,569&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--Revenues_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember__us-gaap--TransactionTypeAxis__custom--ReservedCapacityArrangementsMember_pp0p" title="Revenues"&gt;14,652,429&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;On-demand arrangements&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--Revenues_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember__us-gaap--TransactionTypeAxis__custom--OnDemandArrangementsMember_pp0p" title="Revenues"&gt;44,680&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--Revenues_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember__us-gaap--TransactionTypeAxis__custom--OnDemandArrangementsMember_pp0p" title="Revenues"&gt;12,508&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90E_eus-gaap--Revenues_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember_pp0p" title="Revenues"&gt;6,546,249&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90C_eus-gaap--Revenues_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember_pp0p" title="Revenues"&gt;14,664,937&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A7_z5GFAm7eP7ea" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Reserved capacity arrangements&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company enters into reserved capacity arrangements, which generally provide committed intelligent computing power services for a defined service term ranging from 3 months to 3 years, with the majority of such arrangements having a one-year term. These contracts typically are non-cancelable, or may be canceled only under limited conditions with early notifications required. Payment terms generally range from 0-6 months upon the completion of services, and certain arrangements require prepayments. Any prepayments are recorded as contract liabilities and recognized over the service term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The performance obligation is satisfied over time because the customer simultaneously receives and consumes the benefits. Revenue is recognized using a time-elapsed output method over the contractual service period.&lt;/p&gt;

























&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On-demand (pay-as-you-go) arrangements&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company provides customers with on-demand access to intelligent computing power and GPU resources under pay-as-you-go model which requires advance payment. Customer advances are recorded as contract liabilities and recognized as revenue over the time during the provision of related services underlying the contract term. The revenue is recognized over time because the customer can simultaneously receive and consume the benefits during the service period. These arrangements generally do not include a fixed contractual term or minimum usage commitments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;(ii) Revenue from comprehensive data center service&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company leverages its project experience in infrastructure management, cluster optimization, and system monitoring to provide full-cycle operational support to data center asset owners. Services encompass facility environment deployment, network architecture implementation, security and compliance system development, daily operational monitoring, and emergency fault response. Revenue is recognized over time because the Company&#x2019;s services are performed throughout the contract term and the customer benefits as the services are provided.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For the years ended June&#160;30, 2025 and 2026, $&lt;span id="xdx_903_eus-gaap--Revenues_c20240701__20250630_pp0p" title="Revenues"&gt;7,015,512&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--Revenues_c20250701__20260630_pp0p" title="Revenues"&gt;14,822,799&lt;/span&gt; of the revenue of the Company was recognized over time, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Revenue disaggregated by service lines for the years ended June&#160;30, 2025 and 2026 was disclosed in the table below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_z3tZKdudbUfa" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B2_znQIM1QCbsj7" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of Revenue disaggregated&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Revenue from intelligent computing power service&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--Revenues_pp0d_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember_zPfi1ID18m69" title="Total"&gt;6,546,249&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--Revenues_pp0d_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember_zFiUkhgi7rYg" title="Total"&gt;14,664,937&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Revenue from comprehensive data center service&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--Revenues_pp0d_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromComprehensiveDataCenterServicesMember_zdQqF4JQfEyg" title="Total"&gt;469,263&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--Revenues_pp0d_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromComprehensiveDataCenterServicesMember_zVCWJHXeLUHh" title="Total"&gt;157,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90B_eus-gaap--Revenues_pp0d_c20240701__20250630_zjwZ3AlPjqJ1" title="Total"&gt;7,015,512&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90D_eus-gaap--Revenues_pp0d_c20250701__20260630_zMjhazGsFeEb" title="Total"&gt;14,822,799&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AD_zdG7n0moZg64" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_840_ecustom--ContractLiabilitiesPolicyTextBlock_zLGXmJl0t719" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;r. &lt;span id="xdx_86C_zdGFfT2aHq4h"&gt;Contract liabilities&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company receives advance payments from its customers for services to be provided in the future. These payments are recorded as&#160;contract liabilities&#160;on the balance sheet within &#x201c;Contract liabilities&#x201d;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Contract liabilities are recognized when consideration is received from a customer prior to the Company satisfying its related performance obligations. For these service contracts, the Company recognizes revenue, and reduces the contract liabilities,&#160;over time&#160;as the services are rendered and the performance obligations are satisfied. Revenue recognized during the years ended June&#160;30, 2025 and 2026 that was included in the contract liability balance at the beginning of the year was $&lt;span id="xdx_904_ecustom--RevenueRecognized_c20240701__20250630_pp0p" title="Revenue recognized"&gt;95,326&lt;/span&gt; and $&lt;span id="xdx_906_ecustom--RevenueRecognized_c20250701__20260630_pp0p" title="Revenue recognized"&gt;392,152&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84A_eus-gaap--CostOfSalesPolicyTextBlock_z0PWv6qsxH0k" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;s. &lt;span id="xdx_861_zslImOwYF0Z9"&gt;Cost of revenues&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s cost of revenues primarily includes computing power service, professional service fees and staff costs and employee benefits. All the cost of revenues are recognized in the period in which the related services occur or the benefits are received.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_843_ecustom--SellingAndMarketingExpensesPolicyTextBlock_z57y59h0eudj" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;t. &lt;span id="xdx_861_zvFWLQnB4DLj"&gt;Selling and marketing expenses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s selling and marketing expenses primarily include: (i) advertising and promotion expenses, (ii) staff costs, employee benefits and share-based compensation, and (iii) travel and other routine office expenses. All expenses are recognized in the period in which the related services occur or the benefits are received. The Company expenses advertising costs as incurred, and for the years ended June&#160;30, 2025 and 2026, the Company incurred advertising and promotion expenses of $&lt;span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20240701__20250630_pp0p" title="Advertising and promotion expenses"&gt;157,388&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--MarketingAndAdvertisingExpense_c20250701__20260630_pp0p" title="Advertising and promotion expenses"&gt;80,910&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84C_eus-gaap--ResearchAndDevelopmentExpensePolicy_zWBOcu83B1Fk" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;u. &lt;span id="xdx_864_zfUFuzfr4RKc"&gt;Research and development expenses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s research and
development expenses mainly consist of software development outsourcing service fees, server cost, staff costs and employee benefits, and testing expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84B_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zbQgwUalcG1" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;v. &lt;span id="xdx_86B_zpKuWnm2e2Tb"&gt;General and administrative expenses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s general and administrative expenses mainly consist of staff costs and employee benefits, professional service fees, depreciation expenses and other operating expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84B_ecustom--OtherIncomePolicyTextBlock_zf3pSqRT7svh" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;w. &lt;span id="xdx_869_z7ucoXFGERFg"&gt;Other income&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company safeguards its USDC through a third-party custodian. The Company&#x2019;s other income represents the yield of USDC the Company earned through participation in a third-party custodian service.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_z48c0If6Ihnl" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;x. &lt;span id="xdx_860_z60ilR38jjS3"&gt;Income tax&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Income taxes are determined in accordance with the provisions of ASC Topic 740, &#x201c;&lt;i&gt;Income Taxes&lt;/i&gt;&#x201d; (&#x201c;ASC Topic 740&#x201d;). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their consolidated financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the consolidated financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84B_ecustom--CapitalStructurePolicyTextBlock_zBdzy7uMKvz6" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;y. &lt;span id="xdx_86C_zXZDDqZzdoHj"&gt;Capital structure&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company is authorized to issue &lt;span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_c20250630_pd" title="Common stock, shares authorized"&gt;1,500&lt;/span&gt; shares of common stock of $&lt;span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_c20250630_pd" title="Common stock, par value"&gt;0.01&lt;/span&gt; par value each. As of June&#160;30, 2025, there were &lt;span id="xdx_908_eus-gaap--ExcessStockSharesIssued_iI_c20250630_zkXBVIxvBihf" title="Common stock, shares issued"&gt;&lt;span id="xdx_90C_eus-gaap--ExcessStockSharesOutstanding_iI_c20250630_zTAqOTctejHg" title="Common stock, shares outstanding"&gt;1,500&lt;/span&gt;&lt;/span&gt; shares issued and outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Pursuant to the resolution of the board of directors on January&#160;8, 2026, the authorized share capital of &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_c20260108_pd" title="Common stock, shares authorized"&gt;1,500&lt;/span&gt; shares of common stock was re-designated to &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_c20260108__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_pd" title="Common stock, shares authorized"&gt;303&lt;/span&gt; shares of Class A common stock and &lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_c20260108__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_pd" title="Common stock, shares authorized"&gt;1,197&lt;/span&gt; shares of Class B common stock. Holders of Class A common stock and Class B common stock have the same rights, except for voting and conversion rights. Each share of Class A common stock is entitled to one vote; and each share of Class B common stock is entitled to twenty votes and is convertible into one share of Class A common stock at any time by the holder thereof and upon transfer by the holder thereof other than certain permitted transfers. Class A common stock are not convertible into Class B common stock under any circumstances. Furthermore, all outstanding warrants, options, SAFEs and other convertible securities are designated to convert or settle exclusively into Class A common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of June&#160;30, 2026, there were &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_c20260630__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_pd" title="Common stock, shares authorized"&gt;303&lt;/span&gt; shares of Class A common stock and &lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_c20260630__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_pd" title="Common stock, shares authorized"&gt;1,197&lt;/span&gt; shares of Class B common stock outstanding.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zRGYz83lZsw7" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;z. &lt;span id="xdx_86B_zbeZlANnSNse"&gt;Share-based compensation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company grants share options of the Company to eligible employees and&#160;non-employees. The Company accounts for share-based awards issued to employees and&#160;non-employees in accordance with ASC Topic 718 &lt;i&gt;Compensation &#x2013; Stock Compensation. &lt;/i&gt;The Company recognizes forfeitures as they occur. The share-based compensation expenses have been categorized as either general and administrative expenses or selling and marketing expenses, depending on the job functions of the grantees.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s share-based compensation awards are expected to be settled through transfers of existing shares of common stock held by the controlling shareholder, rather than through the issuance of new shares by the Company. The underlying shares of common stock are included in issued and outstanding shares as of the balance sheet date; accordingly, such settlement is not expected to increase the Company&#x2019;s total issued and outstanding shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Employees&#x2019; share-based awards and non-employees&#x2019; share-based awards are measured at the grant date fair value of the awards and recognized as expenses a) immediately at grant date if no vesting conditions are required; or b) using graded vesting method, net of estimated forfeitures, over the requisite service period, which is the vesting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company employs discounted cash flow method to determine the fair value of the Company&#x2019;s share-based compensation arrangements, where the key valuation variables include risk free rate, discount rate, and perpetual rate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zxjRvFiJ7Mxb" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;aa. &lt;span id="xdx_86F_zMdYPsQ9khs7"&gt;Segment reporting&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;ASC 280, &#x201c;Segment Reporting&#x201d;, establishes standards for reporting information about operating segments on a basis consistent with the Company&#x2019;s internal organizational structure as well as information about geographical areas, business segments and major customers in consolidated financial statements for details on the Company&#x2019;s business segments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company uses the &#x201c;management approach&#x201d; in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;) for making operating decisions and assessing performance as the source for determining the Company&#x2019;s reportable segments. The Company&#x2019;s CODM is the chief executive officer. The CODM regularly reviews consolidated operating results and reviews consolidated revenues and net loss when making decisions about allocating resources and assessing performance of the segment, and hence, the Company has only&#160;one&#160;reportable segment. Therefore, as the Company has determined it operates as a single reportable segment, the CODM assesses the Company&#x2019;s performance and results of operations on a consolidated basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84C_ecustom--RelatedPartiesPolicyTextBlock_z3MZEseiFGQ2" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;bb. &lt;span id="xdx_867_z5B8pRtoVaD7"&gt;Related parties&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or significant influence, such as a family member or relative, shareholder, or a related corporation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84E_ecustom--ComprehensiveLossPolicyTextBlock_zaCjbmCsKtJ3" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;cc. &lt;span id="xdx_864_z7RXSHQ4NBFj"&gt;Comprehensive loss&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Comprehensive loss is defined as a change in equity during a period from transactions and other events and circumstances&#160;from&#160;non-owner&#160;sources.&#160;The Company&#x2019;s comprehensive loss was the same as its reported net loss for all periods presented.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zjMmp9xznNIk" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;dd. &lt;span id="xdx_86E_z5H9qZKxzoA"&gt;Loss per share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Basic net loss per share of common stock attributable to common shareholders is calculated by dividing net loss attributable to common shareholders by the weighted-average shares of common stock outstanding for the period. Potentially dilutive shares, which are based on the weighted-average shares of common stock underlying outstanding share-based awards or options using the treasury stock method or the if-converted method, as applicable, are included when calculating diluted net income per share of common stock attributable to common shareholders when their effect is dilutive.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Diluted net loss per share attributable to common shareholders is computed by adjusting the weighted-average number of shares of common stock outstanding for the dilutive effect of all potential common stock equivalents.  These potential shares are included in the diluted earnings per share calculation only when their effect is&#160;dilutive.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In periods where the Company reports
a&#160;net loss, diluted net loss per share is calculated in the same manner as basic net loss per share because the inclusion of
any potential common stock would have an&#160;anti-dilutive&#160;effect. The Company had no potential common stock equivalents
outstanding during the periods presented. Consequently, no potential common stock equivalents were included in the calculation
for the years in which a net loss was incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_842_eus-gaap--RevenueRecognitionDividends_zelDKTQQNWwk" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;ee. &lt;span id="xdx_86E_zk18D0KqTFZ2"&gt;Dividends&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Dividends are recognized when declared. &lt;span id="xdx_906_eus-gaap--Dividends_pp0d_do_c20240701__20250630_z2uSjClb45o4" title="Dividends"&gt;&lt;span id="xdx_908_eus-gaap--Dividends_pp0d_do_c20250701__20260630_zitpAwkCIt8l" title="Dividends"&gt;No&lt;/span&gt;&lt;/span&gt; dividends were declared for the year ended June&#160;30, 2025 and 2026, respectively. The Company does not have any present plan to pay any dividends on its common stock in the foreseeable future. The Company currently intends to retain the available funds and any future earnings to operate and expand its business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_842_ecustom--EmergingGrowthCompanyPolicyTextBlock_zM4C3e9TZkrj" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;ff&lt;/i&gt;&lt;/b&gt;. &lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zzmFxUhSus62"&gt;Emerging growth company&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company intends to operate as an &#x201c;emerging growth company,&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;). The JOBS Act permits companies with emerging growth company status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until such time as those standards would apply to private companies. The Company elected to use this extended transition period to enable it to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i)&#160;is no longer an emerging growth company or (ii)&#160;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the Company&#x2019;s consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zgpIsbPz6Fjf" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;gg. &lt;span id="xdx_86B_z3BtKFh06ZFa"&gt;Recently accounting pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In December&#160;2023, the FASB issued ASU&#160;No.&#160;2023-09,&#160;Improvements to Income Tax Disclosures&#160;(&#x201c;ASU&#160;2023-09&#x201d;),&#160;which requires entities to make incremental income tax disclosures on an annual basis. The amendments require that public business entities disclose specific categories in the rate reconciliation and provide additional information for reconciling items meeting a quantitative threshold. The amendments also require disclosure of income taxes paid to be disaggregated by jurisdiction, and the disclosure of income tax expense disaggregated by federal, state, and foreign. Amendments are effective for annual periods beginning after December&#160;15, 2025 and thereafter, with early adoption permitted. The Company is currently evaluating the impact of the new accounting pronouncements or guidance on the consolidated financial statements.&#160;The Company will adopt this ASU for the fiscal year beginning July&#160;1, 2026.&lt;/p&gt;

























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In July&#160;2025, the FASB issued Accounting Standards Update (ASU) No. 2025-05, &lt;i&gt;Financial Instruments &#x2014; Credit Losses&lt;/i&gt; (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendment provides (1) all entities with a practical expedient to assume that current conditions as of the balance sheet date do not change for the remaining life of the assets and (2) entities other than public business entities with an accounting policy election to consider collection activity after the balance sheet date when estimating expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under Topic 606. This guidance is effective for annual reporting periods beginning after December&#160;15, 2025 and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the impact of the new accounting pronouncements or guidance on the consolidated financial statements. The Company will adopt this ASU for the fiscal year beginning July&#160;1, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In November&#160;2024, the FASB issued ASU 2024-03 &#x201c;&lt;i&gt;Income Statement&#x2014;Reporting comprehensive (loss) income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&lt;/i&gt;&#x201d; (&#x201c;ASU 2024-03&#x201d;). The amendments in this update intend to improve the disclosures about a public business entity&#x2019;s expenses and address requests from investors for more detailed information about the types of expenses (including purchases of inventory, employee compensation, depreciation, amortization, and depletion) in commonly presented expense captions (such as cost of sales, selling, general and administrative expenses, and research and development). ASU 2024-03 is effective for fiscal years beginning after December&#160;15, 2026, and interim periods beginning after December&#160;15, 2027. The Company is currently evaluating the impact from the adoption of this ASU on its consolidated financial statements. The Company will adopt this ASU for its annual report for the fiscal year beginning July&#160;1, 2027 and for interim reports for periods beginning July&#160;1, 2028.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In January&#160;2025, the FASB issued Accounting Standards Update (ASU) No. 2025-01, Income Statement &#x2014; Reporting comprehensive (loss) income &#x2014; Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. The amendment clarifies the effective date of ASU No. 2024-03 that all public business entities are required to adopt the guidance in annual reporting periods beginning after December&#160;15, 2026, and interim periods within annual reporting periods beginning after December&#160;15, 2027. Early adoption of Update 2024-03 is permitted. The Company is currently evaluating the impact of the above new accounting pronouncements or guidance on the consolidated financial statements.&#160;The Company will adopt this ASU for its annual report for the fiscal year beginning July&#160;1, 2027 and for interim reports for periods beginning July&#160;1, 2028.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In September&#160;2025, the FASB issued&#160;&lt;i&gt;ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Accounting for and Disclosure of Software Costs&#160;&lt;/i&gt;(&#x201c;ASU 2025-06&#x201d;), which amends certain aspects of the accounting for and disclosure of internal-use software costs. ASU 2025-06 is effective for annual reporting periods beginning with the year ending December&#160;31, 2028, with early adoption permitted. The Company is currently evaluating the impact of the above new accounting pronouncements or guidance on the consolidated financial statements. The Company will adopt this ASU for the fiscal year beginning July 1, 2028.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Except as mentioned above, the Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the balance sheets, statements of income and comprehensive loss and cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:SignificantAccountingPoliciesTextBlock>
    <xlabw:GoingConcernPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000440">&lt;p id="xdx_848_ecustom--GoingConcernPolicyTextBlock_zf3k9joM6X7h" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;a. &lt;span id="xdx_86F_zCtlv3BwMvSl"&gt;Going concern&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of June&#160;30, 2026, the Company had cash and U.S. Dollar Coin (&#x201c;USDC&#x201d;) of $4.9 &lt;span id="xdx_900_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20260630_pp0p" style="display: none" title="Cash and cash equivalents"&gt;2,693,586&lt;/span&gt; million and current liabilities of $31.9 &lt;span id="xdx_90A_eus-gaap--LiabilitiesCurrent_c20260630_pp0p" style="display: none" title="Current liabilities"&gt;31,885,500&lt;/span&gt; million. For the years ended June&#160;30, 2025 and 2026, the Company used $1.0 &lt;span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_c20240701__20250630_pp0p" style="display: none" title="Cash for operating activities"&gt;(1,010,799)&lt;/span&gt; million and $2.8 &lt;span id="xdx_90A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_c20250701__20260630_pp0p" style="display: none" title="Cash for operating activities"&gt;(2,754,624)&lt;/span&gt; million in operating activities. The Company incurred net losses of $7.7 &lt;span id="xdx_90A_eus-gaap--NetIncomeLoss_c20240701__20250630_pp0p" style="display: none" title="Net losses"&gt;(7,659,667)&lt;/span&gt; million and $12.2 &lt;span id="xdx_90C_eus-gaap--NetIncomeLoss_c20250701__20260630_pp0p" style="display: none" title="Net losses"&gt;(12,162,391)&lt;/span&gt; million for these respective periods. Since inception, the Company has incurred recurring net losses from operations and negative cash flows from operating activities. As of June&#160;30, 2026, the Company had an accumulated deficit of $25.4 &lt;span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_c20260630_pp0p" style="display: none" title="Accumulated deficit"&gt;(25,379,426)&lt;/span&gt; million. These factors raised substantial doubt regarding the Company&#x2019;s ability to continue as a going concern within one year of the date these consolidated financial statements were issued.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On August&#160;27, 2026, the Company consummated the Business Combination. Upon the closing of the Business Combination, all outstanding SAFEs of the Company were converted into PubCo Class A common stock in accordance with their terms, eliminating SAFE liabilities that totaled approximately $&lt;span id="xdx_905_ecustom--SafeLiabilities_iI_pn5n6_c20260630_ztpnFXjZrxvl" title="Safe liabilities"&gt;29.1&lt;/span&gt; million as of June&#160;30, 2026. In connection with the closing of the Business Combination, the Company obtained access to cash proceeds of approximately $&lt;span id="xdx_909_eus-gaap--ProceedsFromSaleOfNotesReceivable_pn5n6_c20250701__20260630_zTdSMjCCptFa" title="Proceeds from safes"&gt;11.8&lt;/span&gt; million retained from the Business Combination. In addition, between July 1, 2026 and August&#160;27, 2026, an investor provided the Company with $1.0 million in the form of a SAFE, which was also converted into PubCo Class A common stock upon the closing of the Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;Management has prepared a cash flow forecast covering the twelve-month period following the date that these consolidated financial statements are issued. The forecast considers the liquidity provided by the De-SPAC transaction&lt;/span&gt;, conversion of SAFE instruments on the closing of the Business Combination, &lt;span style="font-size: 10pt"&gt;as well as management&#x2019;s operating plans and expectations, including the Company&#x2019;s continued focus on expanding its market presence and developing client relationships to drive revenue growth and managing operating expenses, with the objective of improving cash flows from operations over time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;Based on this forecast, management believes that the Company will have sufficient liquidity to fund its ongoing operations and anticipated working capital requirements for a period of at least twelve months after the date that these consolidated financial statements are issued. Accordingly,&lt;/span&gt; management has concluded &lt;span style="font-size: 10pt"&gt;that the substantial doubt about the Company&#x2019;s ability to continue as a going concern has been alleviated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These consolidated financial statements have been prepared on a going concern basis, and no adjustments are required to the carrying amounts or classification of assets and liabilities in the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:GoingConcernPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000442"
      unitRef="USD">2693586</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000444"
      unitRef="USD">31885500</us-gaap:LiabilitiesCurrent>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000446"
      unitRef="USD">-1010799</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000448"
      unitRef="USD">-2754624</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000450"
      unitRef="USD">-7659667</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000452"
      unitRef="USD">-12162391</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000454"
      unitRef="USD">-25379426</us-gaap:RetainedEarningsAccumulatedDeficit>
    <xlabw:SafeLiabilities
      contextRef="AsOf2026-06-30"
      decimals="-5"
      id="Fact000456"
      unitRef="USD">29100000</xlabw:SafeLiabilities>
    <us-gaap:ProceedsFromSaleOfNotesReceivable
      contextRef="From2025-07-01to2026-06-30"
      decimals="-5"
      id="Fact000458"
      unitRef="USD">11800000</us-gaap:ProceedsFromSaleOfNotesReceivable>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000460">&lt;p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zXXyuAiqNYbh" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;b. &lt;span id="xdx_861_zSk2kopUu1ac"&gt;Basis of presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;).&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2025-07-01to2026-06-30" id="Fact000465">&lt;p id="xdx_84D_eus-gaap--UseOfEstimates_z7wWTQSaRMv5" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;c. &lt;span id="xdx_861_z5FUhMjaPHwk"&gt;Use of estimates and assumptions&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The preparation of consolidated
financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts
reported in the consolidated financial statements and accompanying notes. Management believes that the estimates used in preparing
the consolidated financial statements are reasonable and prudent; however, actual results could differ from these estimates under
different assumptions or conditions.&#160;Significant accounting estimates include recognition and measurement of SAFEs notes,
recognition and measurement of the allowance for expected credit losses, deferred tax assets and valuation allowance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:UseOfEstimates>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000467">&lt;p id="xdx_842_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zgPTPIQfyIa9" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;d. &lt;span id="xdx_863_zPInaBBTiDme"&gt;Fair value measurements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In accordance with FASB ASC 820&#160;&lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt;, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company uses a three-level hierarchy for fair value measurements of certain assets and liabilities for financial reporting purposes that distinguishes between market participant assumptions developed from market data obtained from outside sources (observable inputs) and the Company&#x2019;s own assumptions about market participant assumptions developed from the best information available to us in the circumstances (unobservable inputs).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Level 1: Quoted prices in active markets for identical assets or liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Level 2: Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Level 3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management during the years ended June&#160;30, 2025 and 2026. The carrying amount of cash and cash equivalents, accounts receivable, refundable deposits receivable, other receivables, accounts payable, refundable deposits payable and other current liabilities approximated their fair values as of June&#160;30, 2025 and 2026. For the years ended June&#160;30, 2025 and 2026, the Company carried SAFEs and digital assets at their fair value (see&#160;Note 4-Fair Value Measurements for fair value information).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <xlabw:FunctionalCurrencyPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000469">&lt;p id="xdx_84E_ecustom--FunctionalCurrencyPolicyTextBlock_zrp7ekne51Hj" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;e. &lt;span id="xdx_868_zRAdMkdpcuCb"&gt;Functional currency&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The accompanying consolidated financial statements are presented in the United States dollar (&#x201c;US$&#x201d;). The functional currency of the Company and its subsidiary is the US$.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;All transactions are measured and recorded in the Company&#x2019;s functional currency.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:FunctionalCurrencyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000471">&lt;p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zIXz6kc0TXAi" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;f. &lt;span id="xdx_860_ziepQm8WLHJb"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company considers all highly liquid investments instruments purchased with a maturity period of three months or less to be cash or cash equivalents. The carrying amounts reported in the accompanying balance sheets for cash and cash equivalents approximate their fair value. As of June&#160;30, 2025 and 2026, the Company does &lt;span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0d_do_c20260630_z4eAkNGQ6a6d" title="Cash equivalents"&gt;&lt;span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0d_do_c20250630_zTlt5MngaPhb" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt;t have any cash equivalents.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000473"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000475"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <xlabw:CryptoAssets contextRef="From2025-07-01to2026-06-30" id="Fact000480">&lt;p id="xdx_84F_ecustom--CryptoAssets_zUiQiS97ympk" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;g. &lt;span id="xdx_865_zut5jpCF97ti"&gt;Crypto assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s crypto assets classified in current assets are held primarily for use in the ordinary course of business which is expected to be actively utilized or converted within the normal operating cycle and such crypto assets can be sold in a highly liquid marketplace. During the year ended June&#160;30, 2026, the Company only held crypto assets of Tether USD (&#x201c;USDT&#x201d;) and USDC, which are principally funded by SAFE investors and as a form of collection from revenue transactions. The Company&#x2019;s crypto assets are held with a qualified third-party custodian who provide secure storage and safeguarding of the Company&#x2019;s crypto assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;USDC&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;USDC is a stablecoin redeemable on a one-to-one basis for U.S. dollars and is accounted for as a financial instrument in the consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Crypto assets other than USDC&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On December&#160;13, 2023, the FASB issued ASU 2023-08, which addresses the accounting and disclosure requirements for certain cryptocurrencies. The new guidance requires entities to subsequently measure certain cryptocurrencies at fair value, with changes in fair value recorded in net income in each reporting period. The Company applied the ASU since its holding of crypto assets in December&#160;2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Digital assets that are received as noncash consideration in the Company&#x2019;s revenue arrangements and paid in purchases of professional service and others are presented as cash flows from operating activities in other operating activities settled in digital assets and USDC. Digital assets that are received in the Company&#x2019;s revenue arrangements and sold for cash within seven days are presented as cash flows from operating activities, while other digital asset activity held longer than seven days is reflected as cash flows from investing activities under disposal of digital assets and USDC held in the consolidated statements of cash flows. The Company presents crypto assets other than USDC separately from other intangible assets and USDC, recorded as digital assets on the consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For the year ended June&#160;30, 2026, the Company recorded receipt and disbursement of digital assets amounted to $&lt;span id="xdx_907_ecustom--ReceiptOfDigitalAssets_c20250701__20260630_pp0p" title="Receipt of digital assets"&gt;991,601&lt;/span&gt; and $&lt;span id="xdx_909_ecustom--DisbursementOfDigitalAssets_c20250701__20260630_pp0p" title="Disbursement of digital assets"&gt;991,601&lt;/span&gt;, respectively, which resulted in an ending balance of nil. The Company&#x2019;s balances related to digital assets and stablecoins during the period included USDT and USDC, both of which are USD-pegged stablecoins. &lt;span id="xdx_908_ecustom--FairValueGainOrLossOnDigitalAssets_pp0d_do_c20250701__20260630_zUdgefVa3Vkb" title="Fair value gain or loss on digital assets"&gt;No&lt;/span&gt; fair value gain or loss on digital assets was recognized for the year ended June&#160;30, 2026 considering the low volatility in the fair value of digital assets during the year ended June&#160;30, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:CryptoAssets>
    <xlabw:ReceiptOfDigitalAssets
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000482"
      unitRef="USD">991601</xlabw:ReceiptOfDigitalAssets>
    <xlabw:DisbursementOfDigitalAssets
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000484"
      unitRef="USD">991601</xlabw:DisbursementOfDigitalAssets>
    <xlabw:FairValueGainOrLossOnDigitalAssets
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000486"
      unitRef="USD">0</xlabw:FairValueGainOrLossOnDigitalAssets>
    <xlabw:ExpectedCreditLossAndAccountsReceivablePolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000488">&lt;p id="xdx_84E_ecustom--ExpectedCreditLossAndAccountsReceivablePolicyTextBlock_zxywzRE1dhW7" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;h. &lt;span id="xdx_868_zBuB3h3e6BMj"&gt;Expected credit loss and accounts receivable&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company adopted Financial Standards Accounting Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 326 &#x201c;&lt;i&gt;Financial Instruments&#160;&#x2014;&#160;Credit Losses&lt;/i&gt;&#x201d; (&#x201c;ASC&#160;326&#x201d;) on July&#160;1, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s accounts receivable
are within the scope of ASC&#160;326. ASC&#160;326 introduces an approach based on expected credit losses on financial assets at
amortized cost. Upon adoption of ASC&#160;326, the Company estimates the expected credit losses for accounts receivable using the
roll-rate method on a collective basis when similar risk characteristics exist. Expected credit losses are included in general and
administrative expenses in the consolidated statements of operations and comprehensive loss. After all attempts to collect a
receivable have failed, the receivable is written off against the allowance.&lt;/p&gt;

























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Accounts receivable represents those receivables derived in the ordinary course of business, net of an allowance for any potentially uncollectible amounts. The Company makes estimates of expected credit and collectability trends for the allowance for credit losses based upon its assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions that may vary by geography, customer-type, or industry sub-vertical, and other factors that may affect its ability to collect from customers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Although the Company has historically not experienced significant credit losses, they may experience increasing credit loss risks from accounts receivable in future periods if its customers are adversely affected by economic pressures or uncertainty associated with local or global economic recessions, or other customer-specific factors, and actual experience in the future may differ from their past experiences or current assessment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:ExpectedCreditLossAndAccountsReceivablePolicyTextBlock>
    <xlabw:DeferredOfferingCostsPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000495">&lt;p id="xdx_845_ecustom--DeferredOfferingCostsPolicyTextBlock_zlUviWCDZ81b" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;i. &lt;span id="xdx_86F_zcnZOfSBqq57"&gt;Deferred offering costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company follows the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic 5A &#x2014; &#x201c;Expenses of Offering&#x201d;. Deferred offering costs consist of underwriting, legal, and other professional expenses incurred through the balance sheet date that are directly related to the intended De-SPAC Transaction. These costs will be charged to shareholders&#x2019; equity, netted against the proceeds, upon the completion of the Business Combination. Should the transaction prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will be charged to the statements of operations and comprehensive loss. As of June&#160;30, 2025 and 2026, the Company deferred nil and $&lt;span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_pp0d_c20260630_zHx9TLOLVczf" title="Deferred offering costs"&gt;190,000&lt;/span&gt; of transaction costs, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:DeferredOfferingCostsPolicyTextBlock>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000497"
      unitRef="USD">190000</us-gaap:DeferredOfferingCosts>
    <xlabw:AdvanceToSuppliersPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000499">&lt;p id="xdx_848_ecustom--AdvanceToSuppliersPolicyTextBlock_zOuWBT71QVdb" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;j. &lt;span id="xdx_867_zcfqK6LY4Po3"&gt;Advance to suppliers&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Advance to suppliers represent prepayments made to vendors in connection with the purchase of services. Advance is recorded at the amount paid and are classified as current assets when the related services are expected to be received within one year or the normal operating cycle.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:AdvanceToSuppliersPolicyTextBlock>
    <xlabw:RefundableDepositsReceivablePolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000501">&lt;p id="xdx_849_ecustom--RefundableDepositsReceivablePolicyTextBlock_zy7Ih9nHWEJ" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;k. &lt;span id="xdx_86E_zypnVQLTT0o1"&gt;Refundable deposits receivable&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Refundable deposits receivable mainly represents security deposits and refundable cooperation deposits paid to suppliers and business partners that are contractually recoverable upon the completion of services. These amounts are recorded as assets when paid, generally at the amount paid. Deposits expected to be recovered within one year are classified as current; otherwise, they are classified as non-current. Allowance should be assessed under CECL, and write off when not recoverable. The Company evaluates the credit risk of refundable deposits receivable and recognizes an allowance for credit losses based on the current expected credit losses (&#x201c;CECL&#x201d;) model. Specific balances are written off when they are deemed uncollectible and all collection efforts have been exhausted. As of June&#160;30, 2025 and 2026, &lt;span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0d_do_c20260630_zkmbTSswaEm" title="Allowance for expected credit losses"&gt;&lt;span id="xdx_906_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0d_do_c20250630_zGbTWOjTDI26" title="Allowance for expected credit losses"&gt;no&lt;/span&gt;&lt;/span&gt; allowance for credit losses was recorded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:RefundableDepositsReceivablePolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000503"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000505"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <xlabw:OtherReceivablesPolicyRextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000507">&lt;p id="xdx_84D_ecustom--OtherReceivablesPolicyRextBlock_zLGBhdiXwjb4" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;l. &lt;span id="xdx_869_z8gPNWmqks8h"&gt;Other receivables&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Other receivables represent funds temporarily held in trust by an employee acting as the Company&#x2019;s behalf. As of June&#160;30, 2025 and 2026, the balance were $&lt;span id="xdx_90E_eus-gaap--OtherReceivables_iI_pp0d_c20250630_zylXnD6GCdVk" title="Other receivables"&gt;1,207,626&lt;/span&gt; and &lt;span id="xdx_901_eus-gaap--OtherReceivables_iI_pp0d_c20260630_zpmskdjRgFv9" style="display: none" title="Other receivables"&gt;0&lt;/span&gt; nil, respectively, primarily comprising proceeds from SAFEs agreements received via the employee and net of payments made to designated suppliers at the Company&#x2019;s direction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:OtherReceivablesPolicyRextBlock>
    <us-gaap:OtherReceivables
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000509"
      unitRef="USD">1207626</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000511"
      unitRef="USD">0</us-gaap:OtherReceivables>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000513">&lt;p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zNZNSuY2New1" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;m. &lt;span id="xdx_863_zKZhcB5PupK6"&gt;Equipment, net&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Equipment, net is stated at cost less accumulated depreciation and impairment, if any. Depreciation is computed using the straight-line method over the estimated useful lives of three or five years, depending on the asset category.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <xlabw:RefundableDepositsPayablePolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000518">&lt;p id="xdx_848_ecustom--RefundableDepositsPayablePolicyTextBlock_zufCJVMeRUS5" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;n. &lt;span id="xdx_861_zcnJbj6qIyt5"&gt;Refundable deposits payable&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Refundable deposits payable represent security payments received from a third party and customers, which are required for certain intelligent computing power service arrangements. As of June&#160;30, 2025 and 2026, the balances were $&lt;span id="xdx_905_ecustom--RefundableDepositsPayable_iI_pp0d_c20250630_zyhJVI90jr6d" title="Refundable deposits payable"&gt;1,445,580&lt;/span&gt; and $&lt;span id="xdx_900_ecustom--RefundableDepositsPayable_iI_pp0d_c20260630_zVODggupN70c" title="Refundable deposits payable"&gt;359,481&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:RefundableDepositsPayablePolicyTextBlock>
    <xlabw:RefundableDepositsPayable
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000520"
      unitRef="USD">1445580</xlabw:RefundableDepositsPayable>
    <xlabw:RefundableDepositsPayable
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000522"
      unitRef="USD">359481</xlabw:RefundableDepositsPayable>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000524">&lt;p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBfmPRmJMe9k" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;o. &lt;span id="xdx_86E_zfrzK7T32BH5"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company reviews its long-lived assets, equipment, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated from the use of the asset and its eventual disposition. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair value of the impaired assets. Assets to be disposed of are reported at the lower of their carrying amount or fair value less cost to sell. There was &lt;span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pp0d_do_c20240701__20250630_zoAXC7B71HRi" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pp0d_do_c20250701__20260630_zfvprjbijfke" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt; impairment of long-lived assets for the years ended June&#160;30, 2025 and 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000526"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000528"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <xlabw:SimpleAgreementsForFutureEquityPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000530">&lt;p id="xdx_841_ecustom--SimpleAgreementsForFutureEquityPolicyTextBlock_zNlNgzK4mCIl" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;p. &lt;span id="xdx_869_zrlC6plXUsUf"&gt;Simple agreements for future equity&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;SAFEs issued by the Company are freestanding financial instruments. As they contain certain redemption or liquidation features that&#160;may&#160;require the Company to settle the obligation in cash upon the occurrence of defined events (e.g., a change of control or dissolution), the instruments&#160;create an obligation that meets the definition of a liability. Accordingly, the SAFEs are classified in their entirety as liabilities on the consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These liabilities are measured at fair value upon initial recognition and are subsequently remeasured at fair value at each reporting date. All changes in their fair value are recognized in&#160;the consolidated statement of operations and comprehensive loss in the period in which they occur.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:SimpleAgreementsForFutureEquityPolicyTextBlock>
    <us-gaap:RevenueRecognitionDeferredRevenue contextRef="From2025-07-01to2026-06-30" id="Fact000532">&lt;p id="xdx_84F_eus-gaap--RevenueRecognitionDeferredRevenue_zxlrb18xKx1i" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;q. &lt;span id="xdx_864_zvWKkSAesbfk"&gt;Revenue recognition&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company applied ASC Topic&#160;606 &#x201c;&lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;&#x201d; (&#x201c;ASC&#160;606&#x201d;) for all periods presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The five-step model defined by ASC&#160;606 requires the Company to (i)&#160;identify its contracts with clients, (ii)&#160;identify its performance obligations under those contracts, (iii)&#160;determine the transaction prices of those contracts, (iv)&#160;allocate the transaction prices to its performance obligations in those contracts, and (v)&#160;recognize revenue when each performance obligation under those contracts is satisfied. Revenue is recognized when promised goods or services are transferred to the client in an amount that reflects the consideration expected in exchange for those goods or services.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company reports all of its revenues on a gross basis.&#160;This determination is based on the Company&#x2019;s assessment that it is the principal in its revenue arrangements. The Company controls the service delivery platform and infrastructure before the service is provided to the customer. It is primarily responsible for fulfilling the service promise, has discretion in setting prices, and assumes the credit risk associated with the customer receivable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As a practical expedient, the Company elected to expense the incremental costs of obtaining a contract when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Pursuant to ASC 606, the Company recognizes revenue based on the transaction price, which is the amount of consideration it expects to be entitled to exchange for transferring services to customers. For Intelligent Computing Power Services, contract consideration is generally fixed and is typically stated as a fixed monthly fee determined by (i) the contractually specified number of GPUs (capacity) and (ii) the service period. Accordingly, the transaction price is generally the fixed contractual amount. The Company recognizes revenue over time as the services are provided throughout the contract term. The Company offers payment terms ranging from 0 to 6 months, depending on customers&#x2019; credit profiles and service requirements.&lt;/p&gt;

























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company does not provide warranties for its services and does not offer service-type warranty arrangements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The following is a description of the principal activities of the Company from which the Company generates its revenue under ASC 606.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;(i) Revenue for intelligent computing power service&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company leverages its expertise in high-performance computing and cloud-native architectures to build and operate stable, efficient, and scalable GPU computing platforms through modular data center design and liquid cooling technology. The Company uses these platforms to provide computing resources for large-scale AI training, model inference, and high-performance scientific computing to commercial enterprise clients with substantial GPU computing requirements. Supporting services include GPU server environment deployment, cluster scheduling and performance optimization, high-speed network interconnection, real-time monitoring and intelligent alerting systems, as well as industry-compliant security and regulatory assurance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company accounts for the above promises as a single performance obligation because they are highly integrated and not separately identifiable in the context of the contract. The Company provides an integrated, managed GPU computing platform in which computing capacity, deployment/configuration, scheduling, networking, monitoring, and security/compliance are interdependent and together deliver a single combined service&#x2014;continuous access to a functioning and secured platform over the contractual term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company provides intelligent computing power services under two pricing models: (i) reserved capacity arrangements and (ii) on-demand (pay-as-you-go) arrangements. The following table presents revenue recognized during the period by arrangement type:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfRevenueRecognitionTableTextBlock_zDbvLU3bg7eg" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B7_zLkCItVFLvu6" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of Revenue recognition&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Reserved capacity arrangements&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--Revenues_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember__us-gaap--TransactionTypeAxis__custom--ReservedCapacityArrangementsMember_pp0p" title="Revenues"&gt;6,501,569&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--Revenues_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember__us-gaap--TransactionTypeAxis__custom--ReservedCapacityArrangementsMember_pp0p" title="Revenues"&gt;14,652,429&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;On-demand arrangements&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--Revenues_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember__us-gaap--TransactionTypeAxis__custom--OnDemandArrangementsMember_pp0p" title="Revenues"&gt;44,680&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--Revenues_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember__us-gaap--TransactionTypeAxis__custom--OnDemandArrangementsMember_pp0p" title="Revenues"&gt;12,508&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90E_eus-gaap--Revenues_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember_pp0p" title="Revenues"&gt;6,546,249&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90C_eus-gaap--Revenues_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember_pp0p" title="Revenues"&gt;14,664,937&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A7_z5GFAm7eP7ea" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Reserved capacity arrangements&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company enters into reserved capacity arrangements, which generally provide committed intelligent computing power services for a defined service term ranging from 3 months to 3 years, with the majority of such arrangements having a one-year term. These contracts typically are non-cancelable, or may be canceled only under limited conditions with early notifications required. Payment terms generally range from 0-6 months upon the completion of services, and certain arrangements require prepayments. Any prepayments are recorded as contract liabilities and recognized over the service term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The performance obligation is satisfied over time because the customer simultaneously receives and consumes the benefits. Revenue is recognized using a time-elapsed output method over the contractual service period.&lt;/p&gt;

























&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On-demand (pay-as-you-go) arrangements&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company provides customers with on-demand access to intelligent computing power and GPU resources under pay-as-you-go model which requires advance payment. Customer advances are recorded as contract liabilities and recognized as revenue over the time during the provision of related services underlying the contract term. The revenue is recognized over time because the customer can simultaneously receive and consume the benefits during the service period. These arrangements generally do not include a fixed contractual term or minimum usage commitments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;(ii) Revenue from comprehensive data center service&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company leverages its project experience in infrastructure management, cluster optimization, and system monitoring to provide full-cycle operational support to data center asset owners. Services encompass facility environment deployment, network architecture implementation, security and compliance system development, daily operational monitoring, and emergency fault response. Revenue is recognized over time because the Company&#x2019;s services are performed throughout the contract term and the customer benefits as the services are provided.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For the years ended June&#160;30, 2025 and 2026, $&lt;span id="xdx_903_eus-gaap--Revenues_c20240701__20250630_pp0p" title="Revenues"&gt;7,015,512&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--Revenues_c20250701__20260630_pp0p" title="Revenues"&gt;14,822,799&lt;/span&gt; of the revenue of the Company was recognized over time, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Revenue disaggregated by service lines for the years ended June&#160;30, 2025 and 2026 was disclosed in the table below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_z3tZKdudbUfa" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B2_znQIM1QCbsj7" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of Revenue disaggregated&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Revenue from intelligent computing power service&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--Revenues_pp0d_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember_zPfi1ID18m69" title="Total"&gt;6,546,249&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--Revenues_pp0d_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember_zFiUkhgi7rYg" title="Total"&gt;14,664,937&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Revenue from comprehensive data center service&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--Revenues_pp0d_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromComprehensiveDataCenterServicesMember_zdQqF4JQfEyg" title="Total"&gt;469,263&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--Revenues_pp0d_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromComprehensiveDataCenterServicesMember_zVCWJHXeLUHh" title="Total"&gt;157,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90B_eus-gaap--Revenues_pp0d_c20240701__20250630_zjwZ3AlPjqJ1" title="Total"&gt;7,015,512&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90D_eus-gaap--Revenues_pp0d_c20250701__20260630_zMjhazGsFeEb" title="Total"&gt;14,822,799&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AD_zdG7n0moZg64" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:RevenueRecognitionDeferredRevenue>
    <xlabw:ScheduleOfRevenueRecognitionTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000539">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfRevenueRecognitionTableTextBlock_zDbvLU3bg7eg" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B7_zLkCItVFLvu6" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of Revenue recognition&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Reserved capacity arrangements&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--Revenues_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember__us-gaap--TransactionTypeAxis__custom--ReservedCapacityArrangementsMember_pp0p" title="Revenues"&gt;6,501,569&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--Revenues_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember__us-gaap--TransactionTypeAxis__custom--ReservedCapacityArrangementsMember_pp0p" title="Revenues"&gt;14,652,429&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;On-demand arrangements&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--Revenues_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember__us-gaap--TransactionTypeAxis__custom--OnDemandArrangementsMember_pp0p" title="Revenues"&gt;44,680&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--Revenues_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember__us-gaap--TransactionTypeAxis__custom--OnDemandArrangementsMember_pp0p" title="Revenues"&gt;12,508&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90E_eus-gaap--Revenues_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember_pp0p" title="Revenues"&gt;6,546,249&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90C_eus-gaap--Revenues_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember_pp0p" title="Revenues"&gt;14,664,937&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</xlabw:ScheduleOfRevenueRecognitionTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember_custom_ReservedCapacityArrangementsMember"
      decimals="0"
      id="Fact000541"
      unitRef="USD">6501569</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-012026-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember_custom_ReservedCapacityArrangementsMember"
      decimals="0"
      id="Fact000543"
      unitRef="USD">14652429</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember_custom_OnDemandArrangementsMember"
      decimals="0"
      id="Fact000545"
      unitRef="USD">44680</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-012026-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember_custom_OnDemandArrangementsMember"
      decimals="0"
      id="Fact000547"
      unitRef="USD">12508</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember"
      decimals="0"
      id="Fact000549"
      unitRef="USD">6546249</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-012026-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember"
      decimals="0"
      id="Fact000551"
      unitRef="USD">14664937</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000558"
      unitRef="USD">7015512</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000560"
      unitRef="USD">14822799</us-gaap:Revenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000562">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_z3tZKdudbUfa" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B2_znQIM1QCbsj7" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of Revenue disaggregated&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Revenue from intelligent computing power service&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--Revenues_pp0d_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember_zPfi1ID18m69" title="Total"&gt;6,546,249&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--Revenues_pp0d_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromIntelligentComputingPowerServiceMember_zFiUkhgi7rYg" title="Total"&gt;14,664,937&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Revenue from comprehensive data center service&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--Revenues_pp0d_c20240701__20250630__srt--ProductOrServiceAxis__custom--RevenueFromComprehensiveDataCenterServicesMember_zdQqF4JQfEyg" title="Total"&gt;469,263&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--Revenues_pp0d_c20250701__20260630__srt--ProductOrServiceAxis__custom--RevenueFromComprehensiveDataCenterServicesMember_zVCWJHXeLUHh" title="Total"&gt;157,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90B_eus-gaap--Revenues_pp0d_c20240701__20250630_zjwZ3AlPjqJ1" title="Total"&gt;7,015,512&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90D_eus-gaap--Revenues_pp0d_c20250701__20260630_zMjhazGsFeEb" title="Total"&gt;14,822,799&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember"
      decimals="0"
      id="Fact000564"
      unitRef="USD">6546249</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-012026-06-30_custom_RevenueFromIntelligentComputingPowerServiceMember"
      decimals="0"
      id="Fact000566"
      unitRef="USD">14664937</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_custom_RevenueFromComprehensiveDataCenterServicesMember"
      decimals="0"
      id="Fact000568"
      unitRef="USD">469263</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-012026-06-30_custom_RevenueFromComprehensiveDataCenterServicesMember"
      decimals="0"
      id="Fact000570"
      unitRef="USD">157862</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000572"
      unitRef="USD">7015512</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000574"
      unitRef="USD">14822799</us-gaap:Revenues>
    <xlabw:ContractLiabilitiesPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000576">&lt;p id="xdx_840_ecustom--ContractLiabilitiesPolicyTextBlock_zLGXmJl0t719" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;r. &lt;span id="xdx_86C_zdGFfT2aHq4h"&gt;Contract liabilities&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company receives advance payments from its customers for services to be provided in the future. These payments are recorded as&#160;contract liabilities&#160;on the balance sheet within &#x201c;Contract liabilities&#x201d;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Contract liabilities are recognized when consideration is received from a customer prior to the Company satisfying its related performance obligations. For these service contracts, the Company recognizes revenue, and reduces the contract liabilities,&#160;over time&#160;as the services are rendered and the performance obligations are satisfied. Revenue recognized during the years ended June&#160;30, 2025 and 2026 that was included in the contract liability balance at the beginning of the year was $&lt;span id="xdx_904_ecustom--RevenueRecognized_c20240701__20250630_pp0p" title="Revenue recognized"&gt;95,326&lt;/span&gt; and $&lt;span id="xdx_906_ecustom--RevenueRecognized_c20250701__20260630_pp0p" title="Revenue recognized"&gt;392,152&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:ContractLiabilitiesPolicyTextBlock>
    <xlabw:RevenueRecognized
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000578"
      unitRef="USD">95326</xlabw:RevenueRecognized>
    <xlabw:RevenueRecognized
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000580"
      unitRef="USD">392152</xlabw:RevenueRecognized>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000582">&lt;p id="xdx_84A_eus-gaap--CostOfSalesPolicyTextBlock_z0PWv6qsxH0k" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;s. &lt;span id="xdx_861_zslImOwYF0Z9"&gt;Cost of revenues&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s cost of revenues primarily includes computing power service, professional service fees and staff costs and employee benefits. All the cost of revenues are recognized in the period in which the related services occur or the benefits are received.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:CostOfSalesPolicyTextBlock>
    <xlabw:SellingAndMarketingExpensesPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000587">&lt;p id="xdx_843_ecustom--SellingAndMarketingExpensesPolicyTextBlock_z57y59h0eudj" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;t. &lt;span id="xdx_861_zvFWLQnB4DLj"&gt;Selling and marketing expenses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s selling and marketing expenses primarily include: (i) advertising and promotion expenses, (ii) staff costs, employee benefits and share-based compensation, and (iii) travel and other routine office expenses. All expenses are recognized in the period in which the related services occur or the benefits are received. The Company expenses advertising costs as incurred, and for the years ended June&#160;30, 2025 and 2026, the Company incurred advertising and promotion expenses of $&lt;span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20240701__20250630_pp0p" title="Advertising and promotion expenses"&gt;157,388&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--MarketingAndAdvertisingExpense_c20250701__20260630_pp0p" title="Advertising and promotion expenses"&gt;80,910&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:SellingAndMarketingExpensesPolicyTextBlock>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000589"
      unitRef="USD">157388</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000591"
      unitRef="USD">80910</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2025-07-01to2026-06-30" id="Fact000593">&lt;p id="xdx_84C_eus-gaap--ResearchAndDevelopmentExpensePolicy_zWBOcu83B1Fk" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;u. &lt;span id="xdx_864_zfUFuzfr4RKc"&gt;Research and development expenses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s research and
development expenses mainly consist of software development outsourcing service fees, server cost, staff costs and employee benefits, and testing expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000595">&lt;p id="xdx_84B_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zbQgwUalcG1" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;v. &lt;span id="xdx_86B_zpKuWnm2e2Tb"&gt;General and administrative expenses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s general and administrative expenses mainly consist of staff costs and employee benefits, professional service fees, depreciation expenses and other operating expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <xlabw:OtherIncomePolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000597">&lt;p id="xdx_84B_ecustom--OtherIncomePolicyTextBlock_zf3pSqRT7svh" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;w. &lt;span id="xdx_869_z7ucoXFGERFg"&gt;Other income&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company safeguards its USDC through a third-party custodian. The Company&#x2019;s other income represents the yield of USDC the Company earned through participation in a third-party custodian service.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:OtherIncomePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000599">&lt;p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_z48c0If6Ihnl" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;x. &lt;span id="xdx_860_z60ilR38jjS3"&gt;Income tax&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Income taxes are determined in accordance with the provisions of ASC Topic 740, &#x201c;&lt;i&gt;Income Taxes&lt;/i&gt;&#x201d; (&#x201c;ASC Topic 740&#x201d;). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their consolidated financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the consolidated financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:IncomeTaxPolicyTextBlock>
    <xlabw:CapitalStructurePolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000601">&lt;p id="xdx_84B_ecustom--CapitalStructurePolicyTextBlock_zBdzy7uMKvz6" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;y. &lt;span id="xdx_86C_zXZDDqZzdoHj"&gt;Capital structure&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company is authorized to issue &lt;span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_c20250630_pd" title="Common stock, shares authorized"&gt;1,500&lt;/span&gt; shares of common stock of $&lt;span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_c20250630_pd" title="Common stock, par value"&gt;0.01&lt;/span&gt; par value each. As of June&#160;30, 2025, there were &lt;span id="xdx_908_eus-gaap--ExcessStockSharesIssued_iI_c20250630_zkXBVIxvBihf" title="Common stock, shares issued"&gt;&lt;span id="xdx_90C_eus-gaap--ExcessStockSharesOutstanding_iI_c20250630_zTAqOTctejHg" title="Common stock, shares outstanding"&gt;1,500&lt;/span&gt;&lt;/span&gt; shares issued and outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Pursuant to the resolution of the board of directors on January&#160;8, 2026, the authorized share capital of &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_c20260108_pd" title="Common stock, shares authorized"&gt;1,500&lt;/span&gt; shares of common stock was re-designated to &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_c20260108__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_pd" title="Common stock, shares authorized"&gt;303&lt;/span&gt; shares of Class A common stock and &lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_c20260108__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_pd" title="Common stock, shares authorized"&gt;1,197&lt;/span&gt; shares of Class B common stock. Holders of Class A common stock and Class B common stock have the same rights, except for voting and conversion rights. Each share of Class A common stock is entitled to one vote; and each share of Class B common stock is entitled to twenty votes and is convertible into one share of Class A common stock at any time by the holder thereof and upon transfer by the holder thereof other than certain permitted transfers. Class A common stock are not convertible into Class B common stock under any circumstances. Furthermore, all outstanding warrants, options, SAFEs and other convertible securities are designated to convert or settle exclusively into Class A common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of June&#160;30, 2026, there were &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_c20260630__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_pd" title="Common stock, shares authorized"&gt;303&lt;/span&gt; shares of Class A common stock and &lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_c20260630__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_pd" title="Common stock, shares authorized"&gt;1,197&lt;/span&gt; shares of Class B common stock outstanding.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:CapitalStructurePolicyTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000603"
      unitRef="Shares">1500</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000605"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ExcessStockSharesIssued
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000607"
      unitRef="Shares">1500</us-gaap:ExcessStockSharesIssued>
    <us-gaap:ExcessStockSharesOutstanding
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000609"
      unitRef="Shares">1500</us-gaap:ExcessStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-01-08"
      decimals="INF"
      id="Fact000611"
      unitRef="Shares">1500</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-01-08_custom_ClassACommonStockMember"
      decimals="INF"
      id="Fact000613"
      unitRef="Shares">303</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-01-08_custom_ClassBCommonStockMember"
      decimals="INF"
      id="Fact000615"
      unitRef="Shares">1197</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-06-30_custom_ClassACommonStockMember22831156"
      decimals="INF"
      id="Fact000617"
      unitRef="Shares">303</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-06-30_custom_ClassBCommonStockMember22831156"
      decimals="INF"
      id="Fact000619"
      unitRef="Shares">1197</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000624">&lt;p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zRGYz83lZsw7" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;z. &lt;span id="xdx_86B_zbeZlANnSNse"&gt;Share-based compensation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company grants share options of the Company to eligible employees and&#160;non-employees. The Company accounts for share-based awards issued to employees and&#160;non-employees in accordance with ASC Topic 718 &lt;i&gt;Compensation &#x2013; Stock Compensation. &lt;/i&gt;The Company recognizes forfeitures as they occur. The share-based compensation expenses have been categorized as either general and administrative expenses or selling and marketing expenses, depending on the job functions of the grantees.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s share-based compensation awards are expected to be settled through transfers of existing shares of common stock held by the controlling shareholder, rather than through the issuance of new shares by the Company. The underlying shares of common stock are included in issued and outstanding shares as of the balance sheet date; accordingly, such settlement is not expected to increase the Company&#x2019;s total issued and outstanding shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Employees&#x2019; share-based awards and non-employees&#x2019; share-based awards are measured at the grant date fair value of the awards and recognized as expenses a) immediately at grant date if no vesting conditions are required; or b) using graded vesting method, net of estimated forfeitures, over the requisite service period, which is the vesting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company employs discounted cash flow method to determine the fair value of the Company&#x2019;s share-based compensation arrangements, where the key valuation variables include risk free rate, discount rate, and perpetual rate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000626">&lt;p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zxjRvFiJ7Mxb" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;aa. &lt;span id="xdx_86F_zMdYPsQ9khs7"&gt;Segment reporting&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;ASC 280, &#x201c;Segment Reporting&#x201d;, establishes standards for reporting information about operating segments on a basis consistent with the Company&#x2019;s internal organizational structure as well as information about geographical areas, business segments and major customers in consolidated financial statements for details on the Company&#x2019;s business segments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company uses the &#x201c;management approach&#x201d; in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;) for making operating decisions and assessing performance as the source for determining the Company&#x2019;s reportable segments. The Company&#x2019;s CODM is the chief executive officer. The CODM regularly reviews consolidated operating results and reviews consolidated revenues and net loss when making decisions about allocating resources and assessing performance of the segment, and hence, the Company has only&#160;one&#160;reportable segment. Therefore, as the Company has determined it operates as a single reportable segment, the CODM assesses the Company&#x2019;s performance and results of operations on a consolidated basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <xlabw:RelatedPartiesPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000628">&lt;p id="xdx_84C_ecustom--RelatedPartiesPolicyTextBlock_z3MZEseiFGQ2" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;bb. &lt;span id="xdx_867_z5B8pRtoVaD7"&gt;Related parties&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or significant influence, such as a family member or relative, shareholder, or a related corporation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:RelatedPartiesPolicyTextBlock>
    <xlabw:ComprehensiveLossPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000630">&lt;p id="xdx_84E_ecustom--ComprehensiveLossPolicyTextBlock_zaCjbmCsKtJ3" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;cc. &lt;span id="xdx_864_z7RXSHQ4NBFj"&gt;Comprehensive loss&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Comprehensive loss is defined as a change in equity during a period from transactions and other events and circumstances&#160;from&#160;non-owner&#160;sources.&#160;The Company&#x2019;s comprehensive loss was the same as its reported net loss for all periods presented.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:ComprehensiveLossPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000635">&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zjMmp9xznNIk" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;dd. &lt;span id="xdx_86E_z5H9qZKxzoA"&gt;Loss per share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Basic net loss per share of common stock attributable to common shareholders is calculated by dividing net loss attributable to common shareholders by the weighted-average shares of common stock outstanding for the period. Potentially dilutive shares, which are based on the weighted-average shares of common stock underlying outstanding share-based awards or options using the treasury stock method or the if-converted method, as applicable, are included when calculating diluted net income per share of common stock attributable to common shareholders when their effect is dilutive.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Diluted net loss per share attributable to common shareholders is computed by adjusting the weighted-average number of shares of common stock outstanding for the dilutive effect of all potential common stock equivalents.  These potential shares are included in the diluted earnings per share calculation only when their effect is&#160;dilutive.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In periods where the Company reports
a&#160;net loss, diluted net loss per share is calculated in the same manner as basic net loss per share because the inclusion of
any potential common stock would have an&#160;anti-dilutive&#160;effect. The Company had no potential common stock equivalents
outstanding during the periods presented. Consequently, no potential common stock equivalents were included in the calculation
for the years in which a net loss was incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:RevenueRecognitionDividends contextRef="From2025-07-01to2026-06-30" id="Fact000637">&lt;p id="xdx_842_eus-gaap--RevenueRecognitionDividends_zelDKTQQNWwk" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;ee. &lt;span id="xdx_86E_zk18D0KqTFZ2"&gt;Dividends&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Dividends are recognized when declared. &lt;span id="xdx_906_eus-gaap--Dividends_pp0d_do_c20240701__20250630_z2uSjClb45o4" title="Dividends"&gt;&lt;span id="xdx_908_eus-gaap--Dividends_pp0d_do_c20250701__20260630_zitpAwkCIt8l" title="Dividends"&gt;No&lt;/span&gt;&lt;/span&gt; dividends were declared for the year ended June&#160;30, 2025 and 2026, respectively. The Company does not have any present plan to pay any dividends on its common stock in the foreseeable future. The Company currently intends to retain the available funds and any future earnings to operate and expand its business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:RevenueRecognitionDividends>
    <us-gaap:Dividends
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000639"
      unitRef="USD">0</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000641"
      unitRef="USD">0</us-gaap:Dividends>
    <xlabw:EmergingGrowthCompanyPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000643">&lt;p id="xdx_842_ecustom--EmergingGrowthCompanyPolicyTextBlock_zM4C3e9TZkrj" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;ff&lt;/i&gt;&lt;/b&gt;. &lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zzmFxUhSus62"&gt;Emerging growth company&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company intends to operate as an &#x201c;emerging growth company,&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;). The JOBS Act permits companies with emerging growth company status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until such time as those standards would apply to private companies. The Company elected to use this extended transition period to enable it to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i)&#160;is no longer an emerging growth company or (ii)&#160;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the Company&#x2019;s consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000645">&lt;p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zgpIsbPz6Fjf" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;gg. &lt;span id="xdx_86B_z3BtKFh06ZFa"&gt;Recently accounting pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In December&#160;2023, the FASB issued ASU&#160;No.&#160;2023-09,&#160;Improvements to Income Tax Disclosures&#160;(&#x201c;ASU&#160;2023-09&#x201d;),&#160;which requires entities to make incremental income tax disclosures on an annual basis. The amendments require that public business entities disclose specific categories in the rate reconciliation and provide additional information for reconciling items meeting a quantitative threshold. The amendments also require disclosure of income taxes paid to be disaggregated by jurisdiction, and the disclosure of income tax expense disaggregated by federal, state, and foreign. Amendments are effective for annual periods beginning after December&#160;15, 2025 and thereafter, with early adoption permitted. The Company is currently evaluating the impact of the new accounting pronouncements or guidance on the consolidated financial statements.&#160;The Company will adopt this ASU for the fiscal year beginning July&#160;1, 2026.&lt;/p&gt;

























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In July&#160;2025, the FASB issued Accounting Standards Update (ASU) No. 2025-05, &lt;i&gt;Financial Instruments &#x2014; Credit Losses&lt;/i&gt; (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendment provides (1) all entities with a practical expedient to assume that current conditions as of the balance sheet date do not change for the remaining life of the assets and (2) entities other than public business entities with an accounting policy election to consider collection activity after the balance sheet date when estimating expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under Topic 606. This guidance is effective for annual reporting periods beginning after December&#160;15, 2025 and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the impact of the new accounting pronouncements or guidance on the consolidated financial statements. The Company will adopt this ASU for the fiscal year beginning July&#160;1, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In November&#160;2024, the FASB issued ASU 2024-03 &#x201c;&lt;i&gt;Income Statement&#x2014;Reporting comprehensive (loss) income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&lt;/i&gt;&#x201d; (&#x201c;ASU 2024-03&#x201d;). The amendments in this update intend to improve the disclosures about a public business entity&#x2019;s expenses and address requests from investors for more detailed information about the types of expenses (including purchases of inventory, employee compensation, depreciation, amortization, and depletion) in commonly presented expense captions (such as cost of sales, selling, general and administrative expenses, and research and development). ASU 2024-03 is effective for fiscal years beginning after December&#160;15, 2026, and interim periods beginning after December&#160;15, 2027. The Company is currently evaluating the impact from the adoption of this ASU on its consolidated financial statements. The Company will adopt this ASU for its annual report for the fiscal year beginning July&#160;1, 2027 and for interim reports for periods beginning July&#160;1, 2028.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In January&#160;2025, the FASB issued Accounting Standards Update (ASU) No. 2025-01, Income Statement &#x2014; Reporting comprehensive (loss) income &#x2014; Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. The amendment clarifies the effective date of ASU No. 2024-03 that all public business entities are required to adopt the guidance in annual reporting periods beginning after December&#160;15, 2026, and interim periods within annual reporting periods beginning after December&#160;15, 2027. Early adoption of Update 2024-03 is permitted. The Company is currently evaluating the impact of the above new accounting pronouncements or guidance on the consolidated financial statements.&#160;The Company will adopt this ASU for its annual report for the fiscal year beginning July&#160;1, 2027 and for interim reports for periods beginning July&#160;1, 2028.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In September&#160;2025, the FASB issued&#160;&lt;i&gt;ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Accounting for and Disclosure of Software Costs&#160;&lt;/i&gt;(&#x201c;ASU 2025-06&#x201d;), which amends certain aspects of the accounting for and disclosure of internal-use software costs. ASU 2025-06 is effective for annual reporting periods beginning with the year ending December&#160;31, 2028, with early adoption permitted. The Company is currently evaluating the impact of the above new accounting pronouncements or guidance on the consolidated financial statements. The Company will adopt this ASU for the fiscal year beginning July 1, 2028.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Except as mentioned above, the Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the balance sheets, statements of income and comprehensive loss and cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000652">&lt;p id="xdx_805_eus-gaap--ConcentrationRiskDisclosureTextBlock_zdbFMeKOpnlf" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;3. &lt;span id="xdx_82C_zIIh9apLMZVh"&gt;Concentration and risk&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Custodian Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s crypto assets are held exclusively with a single third-party custodian. Custodian risk refers to the potential loss, theft, or misappropriation of the Company&#x2019;s assets held with its sole third-party custodian, due to the custodian&#x2019;s operational failures, cybersecurity breaches, or financial difficulties experienced by the third-party custodian. The Company periodically monitor the financial health, insurance coverage, and security measures of the Company&#x2019;s custodians, reliance on such third parties inherently exposes the Company to risks that the Company cannot fully mitigate.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Concentration of credit risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and refundable deposits receivable. The Company performs ongoing credit evaluations of the customers&#x2019; financial condition and maintains an allowance for potential credit losses. This allowance consists of an amount identified for specific customers and an amount based on overall estimated exposure. The Company&#x2019;s overall estimated exposure excludes amounts covered by credit insurance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Concentration of customers&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s revenue was concentrated among a limited number of customers during the periods presented. The following table summarized customers with greater than 10% of the total revenue:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfConcentrationOfCustomersTableTextBlock_zWOLuJEiQWvd" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Concentration and risk (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B7_zaAzDlOB3GM4" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of concentration of customers&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer A&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zwLjQmmy8dU4" title="Concentration of credit risk"&gt;14.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zfmCN4AgasI9" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0661"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer B&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zLDJHmET6dI1" title="Concentration of credit risk"&gt;12.5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z9Ifwozhtlki" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0665"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer C&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zkY0ng0iNlqj" title="Concentration of credit risk"&gt;10.2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zPcvYkxF7bYg" title="Concentration of credit risk"&gt;20.1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer D&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zy2Qigtsa2X5" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0671"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zBbi7NxZq2X8" title="Concentration of credit risk"&gt;19.2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: justify"&gt;**:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;less than 10%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AF_zRGDO0264sLi" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s account receivable was concentrated among a limited number of customers during the periods presented. The following table summarized customers with greater than 10% of the total account receivable:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfAccountsReceivableTextBlock_ziayQFaJuVj1" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Concentration and risk (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B0_zEvWuNlnfBc2" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of account receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer D&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zINtdQPYALn2" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0677"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zprreXCI0uR5" title="Concentration of credit risk"&gt;10.2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer E&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zCJdQLGm9jE5" title="Concentration of credit risk"&gt;42.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zpAGLi3sCtJh" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0683"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer F&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFMember_z8yZzOm2FPo1" title="Concentration of credit risk"&gt;38.3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFMember_zUlHcZmxMLPa" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0687"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer G&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerGMember_zHtNiWVn2QR6" title="Concentration of credit risk"&gt;19.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerGMember_zK6B0yOYNZ5h" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0691"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer H&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerHMember_zGTGsiIpv4Sk" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0693"&gt;-&lt;/span&gt;&lt;/span&gt;*&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerHMember_zV6aTorEsG4" title="Concentration of credit risk"&gt;43.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer I&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerIMember_zPiEkngakvi3" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0697"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerIMember_zz4XAM4jivSf" title="Concentration of credit risk"&gt;12.8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: justify"&gt;*:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;nil, new customer for the year ended June&#160;30, 2026&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;**:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;less than 10%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A2_zZj5xj8lnZ5d" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Concentration of suppliers&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s purchases was concentrated among a limited number of suppliers during the periods presented. The following table summarized suppliers with greater than 10% of the total purchase:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfConcentrationOfSuppliersTableTextBlock_zz10HwyCEtJ9" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Concentration and risk (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BE_zNfM8fwaQzTg" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of concentration of suppliers&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt;Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier A&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--SupplierAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zH9F5waI4m3" title="Concentration of credit risk"&gt;41.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_zVajcz90AEGb" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0708"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier B&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zahwu298uSM1" title="Concentration of credit risk"&gt;31.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zebTzUUxA1Hi" title="Concentration of credit risk"&gt;31.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier C&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zDgYeSE8YJW4" title="Concentration of credit risk"&gt;18.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_z3Rjn71zWuQf" title="Concentration of credit risk"&gt;28.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier D&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierDMember_z8dXXrSgdeZc" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0718"&gt;-&lt;/span&gt;&lt;/span&gt;*&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierDMember_zVaOL512WDE" title="Concentration of credit risk"&gt;18.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier E&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zHsHcd4iHbch" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0722"&gt;-&lt;/span&gt;&lt;/span&gt;*&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zbmnUz0BQyok" title="Concentration of credit risk"&gt;11.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: justify"&gt;*:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;nil, new supplier for the year ended June&#160;30, 2026&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;**:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;less than 10%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A3_zExIRu828s04" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s account payable was concentrated among a limited number of suppliers during the periods presented. The following table summarized suppliers with greater than 10% of the total account payable:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zbZoIAgrDbGc" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Concentration and risk (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B9_zBbaImXxbqVl" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of account payable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier F&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ConcentrationRiskPercentage_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierFMember_zsqD3nXPrwh1" title="Concentration of credit risk"&gt;54.9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ConcentrationRiskPercentage_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierFMember_zxy1gSdE8uN6" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0730"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier G&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ConcentrationRiskPercentage_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierGMember_zNguTBqigok8" title="Concentration of credit risk"&gt;32.3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ConcentrationRiskPercentage_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierGMember_zJGRqAhPWAOb" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0734"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier C&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ConcentrationRiskPercentage_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zVXLgbhulOI1" title="Concentration of credit risk"&gt;12.1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ConcentrationRiskPercentage_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zmuGNJGLGnij" title="Concentration of credit risk"&gt;77.3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier B&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ConcentrationRiskPercentage_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zUvxym0ALr8g" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0740"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ConcentrationRiskPercentage_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zj8dpPLUkBg8" title="Concentration of credit risk"&gt;12.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier E&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ConcentrationRiskPercentage_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_z3IFqSdEnht3" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0744"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ConcentrationRiskPercentage_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zDRk0GL7Pt2f" title="Concentration of credit risk"&gt;10.3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: justify"&gt;**:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;less than 10%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A0_zQL9QS2NFvw8" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;











</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <xlabw:ScheduleOfConcentrationOfCustomersTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000657">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfConcentrationOfCustomersTableTextBlock_zWOLuJEiQWvd" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Concentration and risk (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B7_zaAzDlOB3GM4" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of concentration of customers&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer A&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zwLjQmmy8dU4" title="Concentration of credit risk"&gt;14.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zfmCN4AgasI9" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0661"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer B&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zLDJHmET6dI1" title="Concentration of credit risk"&gt;12.5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z9Ifwozhtlki" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0665"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer C&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zkY0ng0iNlqj" title="Concentration of credit risk"&gt;10.2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zPcvYkxF7bYg" title="Concentration of credit risk"&gt;20.1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer D&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zy2Qigtsa2X5" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0671"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zBbi7NxZq2X8" title="Concentration of credit risk"&gt;19.2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: justify"&gt;**:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;less than 10%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</xlabw:ScheduleOfConcentrationOfCustomersTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember"
      decimals="INF"
      id="Fact000659"
      unitRef="Ratio">0.140</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember"
      decimals="INF"
      id="Fact000663"
      unitRef="Ratio">0.125</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember"
      decimals="INF"
      id="Fact000667"
      unitRef="Ratio">0.102</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember"
      decimals="INF"
      id="Fact000669"
      unitRef="Ratio">0.201</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerDMember"
      decimals="INF"
      id="Fact000673"
      unitRef="Ratio">0.192</us-gaap:ConcentrationRiskPercentage1>
    <xlabw:ScheduleOfAccountsReceivableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000675">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfAccountsReceivableTextBlock_ziayQFaJuVj1" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Concentration and risk (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B0_zEvWuNlnfBc2" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of account receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer D&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zINtdQPYALn2" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0677"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zprreXCI0uR5" title="Concentration of credit risk"&gt;10.2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer E&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zCJdQLGm9jE5" title="Concentration of credit risk"&gt;42.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zpAGLi3sCtJh" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0683"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer F&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFMember_z8yZzOm2FPo1" title="Concentration of credit risk"&gt;38.3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFMember_zUlHcZmxMLPa" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0687"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer G&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerGMember_zHtNiWVn2QR6" title="Concentration of credit risk"&gt;19.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerGMember_zK6B0yOYNZ5h" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0691"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer H&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerHMember_zGTGsiIpv4Sk" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0693"&gt;-&lt;/span&gt;&lt;/span&gt;*&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerHMember_zV6aTorEsG4" title="Concentration of credit risk"&gt;43.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Customer I&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerIMember_zPiEkngakvi3" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0697"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerIMember_zz4XAM4jivSf" title="Concentration of credit risk"&gt;12.8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: justify"&gt;*:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;nil, new customer for the year ended June&#160;30, 2026&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;**:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;less than 10%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</xlabw:ScheduleOfAccountsReceivableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerDMember"
      decimals="INF"
      id="Fact000679"
      unitRef="Ratio">0.102</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerEMember"
      decimals="INF"
      id="Fact000681"
      unitRef="Ratio">0.427</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFMember"
      decimals="INF"
      id="Fact000685"
      unitRef="Ratio">0.383</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerGMember"
      decimals="INF"
      id="Fact000689"
      unitRef="Ratio">0.190</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerHMember"
      decimals="INF"
      id="Fact000695"
      unitRef="Ratio">0.437</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerIMember"
      decimals="INF"
      id="Fact000699"
      unitRef="Ratio">0.128</us-gaap:ConcentrationRiskPercentage1>
    <xlabw:ScheduleOfConcentrationOfSuppliersTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000704">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfConcentrationOfSuppliersTableTextBlock_zz10HwyCEtJ9" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Concentration and risk (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BE_zNfM8fwaQzTg" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of concentration of suppliers&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt;Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier A&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--SupplierAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zH9F5waI4m3" title="Concentration of credit risk"&gt;41.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_zVajcz90AEGb" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0708"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier B&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zahwu298uSM1" title="Concentration of credit risk"&gt;31.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zebTzUUxA1Hi" title="Concentration of credit risk"&gt;31.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier C&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zDgYeSE8YJW4" title="Concentration of credit risk"&gt;18.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_z3Rjn71zWuQf" title="Concentration of credit risk"&gt;28.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier D&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierDMember_z8dXXrSgdeZc" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0718"&gt;-&lt;/span&gt;&lt;/span&gt;*&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierDMember_zVaOL512WDE" title="Concentration of credit risk"&gt;18.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier E&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zHsHcd4iHbch" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0722"&gt;-&lt;/span&gt;&lt;/span&gt;*&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zbmnUz0BQyok" title="Concentration of credit risk"&gt;11.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: justify"&gt;*:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;nil, new supplier for the year ended June&#160;30, 2026&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;**:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;less than 10%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</xlabw:ScheduleOfConcentrationOfSuppliersTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_custom_PurchaseMember_custom_SupplierAMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      id="Fact000706"
      unitRef="Ratio">0.414</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierBMember"
      decimals="INF"
      id="Fact000710"
      unitRef="Ratio">0.317</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierBMember"
      decimals="INF"
      id="Fact000712"
      unitRef="Ratio">0.310</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierCMember"
      decimals="INF"
      id="Fact000714"
      unitRef="Ratio">0.184</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierCMember"
      decimals="INF"
      id="Fact000716"
      unitRef="Ratio">0.280</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierDMember"
      decimals="INF"
      id="Fact000720"
      unitRef="Ratio">0.184</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-07-012026-06-30_custom_PurchaseMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierEMember"
      decimals="INF"
      id="Fact000724"
      unitRef="Ratio">0.114</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000726">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zbZoIAgrDbGc" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Concentration and risk (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B9_zBbaImXxbqVl" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of account payable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier F&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ConcentrationRiskPercentage_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierFMember_zsqD3nXPrwh1" title="Concentration of credit risk"&gt;54.9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ConcentrationRiskPercentage_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierFMember_zxy1gSdE8uN6" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0730"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier G&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ConcentrationRiskPercentage_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierGMember_zNguTBqigok8" title="Concentration of credit risk"&gt;32.3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ConcentrationRiskPercentage_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierGMember_zJGRqAhPWAOb" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0734"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier C&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ConcentrationRiskPercentage_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zVXLgbhulOI1" title="Concentration of credit risk"&gt;12.1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ConcentrationRiskPercentage_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zmuGNJGLGnij" title="Concentration of credit risk"&gt;77.3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier B&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ConcentrationRiskPercentage_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zUvxym0ALr8g" style="color: White" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0740"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ConcentrationRiskPercentage_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zj8dpPLUkBg8" title="Concentration of credit risk"&gt;12.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplier E&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ConcentrationRiskPercentage_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_z3IFqSdEnht3" style="color: rgb(204,238,255)" title="Concentration of credit risk"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0744"&gt;-&lt;/span&gt;&lt;/span&gt;**&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ConcentrationRiskPercentage_dp_c20250701__20260630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zDRk0GL7Pt2f" title="Concentration of credit risk"&gt;10.3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: justify"&gt;**:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;less than 10%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <xlabw:ConcentrationRiskPercentage
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierFMember"
      decimals="INF"
      id="Fact000728"
      unitRef="Ratio">0.549</xlabw:ConcentrationRiskPercentage>
    <xlabw:ConcentrationRiskPercentage
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierGMember"
      decimals="INF"
      id="Fact000732"
      unitRef="Ratio">0.323</xlabw:ConcentrationRiskPercentage>
    <xlabw:ConcentrationRiskPercentage
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierCMember"
      decimals="INF"
      id="Fact000736"
      unitRef="Ratio">0.121</xlabw:ConcentrationRiskPercentage>
    <xlabw:ConcentrationRiskPercentage
      contextRef="From2025-07-012026-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierCMember"
      decimals="INF"
      id="Fact000738"
      unitRef="Ratio">0.773</xlabw:ConcentrationRiskPercentage>
    <xlabw:ConcentrationRiskPercentage
      contextRef="From2025-07-012026-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierBMember"
      decimals="INF"
      id="Fact000742"
      unitRef="Ratio">0.124</xlabw:ConcentrationRiskPercentage>
    <xlabw:ConcentrationRiskPercentage
      contextRef="From2025-07-012026-06-30_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_SupplierEMember"
      decimals="INF"
      id="Fact000746"
      unitRef="Ratio">0.103</xlabw:ConcentrationRiskPercentage>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000749">&lt;p id="xdx_801_eus-gaap--FairValueDisclosuresTextBlock_zvYXCwEt7fki" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;4. &lt;span id="xdx_827_zbowCy3Llirl"&gt;Fair value measurements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of June&#160;30, 2025 and 2026, information about inputs into the fair value measurement of the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis in periods subsequent to their initial recognition is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zhxYnM9H7Lt7" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair value measurements (Details)"&gt;
  &lt;tr&gt;
    &lt;td id="xdx_8B5_zjPjGVSH7fOe" style="font: 10pt Times New Roman; display: none; vertical-align: top; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Schedule of fair value assets and liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value measurement at reporting date using&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: left"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value &lt;br/&gt;as of&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Quoted Prices in&lt;br/&gt;Active Markets for&lt;br/&gt;Identical Assets &lt;br/&gt;(Level 1)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Significant Other&lt;br/&gt;Observable Inputs &lt;br/&gt;(Level 2)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Significant &lt;br/&gt;Unobservable Inputs &lt;br/&gt;(Level 3)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; background-color: #CCEEFF; text-align: left; padding-left: 0.125in; text-indent: -0.125in; width: 52%"&gt;Liabilities:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Simple agreements for future equity&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_z0S06p9rf5j9" title="Liability"&gt;18,243,885&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zulSkZKh1Ezi" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0755"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zNU0JeqVorsa" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0757"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zRV1LFttYZpd" title="Liability"&gt;18,243,885&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; background-color: #CCEEFF; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Other payable related to the equity option&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_zBhsJm0fT5q8" title="Liability"&gt;53,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_z1k9UHWpqHS6" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0763"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_zjZg7jiY44yc" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0765"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_ziOHelHtFwHj" title="Liability"&gt;53,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value measurement at reporting date using&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: left"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value &lt;br/&gt;as of&lt;br/&gt;June&#160;30, &lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Quoted Prices in&lt;br/&gt;Active Markets for&lt;br/&gt;Identical Assets &lt;br/&gt;(Level 1)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Significant Other&lt;br/&gt;Observable Inputs &lt;br/&gt;(Level 2)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Significant &lt;br/&gt;Unobservable Inputs &lt;br/&gt;(Level 3)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-left: 0.125in; text-indent: -0.125in; width: 52%"&gt;Liabilities:&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Simple agreements for future equity&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zAnEPtPYmin5" title="Liability"&gt;29,121,268&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zSyY3m3cap18" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0771"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zCyQInY6LRJ" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0773"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zGTXMwOg7hL8" title="Liability"&gt;29,121,268&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Other payable related to the equity option&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_zoxcbfG8aw48" title="Liability"&gt;53,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_zIS4i7rdirBb" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0779"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_zh0v94iFaG2" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0781"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_ziAW1Dx7hTu8" title="Liability"&gt;53,333&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F09_zu5TYSd8UFYe" style="font: 10pt Times New Roman; width: 0.25in; text-align: justify"&gt;(1)&lt;/td&gt;
    &lt;td id="xdx_F18_zcuWR4PfyQ44" style="text-align: justify"&gt; 
    
                    &lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company classifies its SAFEs as financial liabilities measured at fair value. The value of these agreements depends significantly on future financing activities, liquidity events, or other material milestones, and their valuation relies on significant inputs that are not observable in the public market. Accordingly, they are classified within Level 3 of the fair value hierarchy.&lt;/p&gt;
                    &lt;p style="font: 10pt Times New Roman; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
                    &lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value measurement is based on an integrated framework combining&#160;scenario analysis and financial instrument decomposition (i.e. Bond Plus Call Method). As of June&#160;30, 2026, the proceeds of the SAFEs on the date of issuance were $14,092,500. The details of significant unobservable inputs can refer to Note 8-Simple Agreements for Future Equity for further details.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F05_zHZNAeY0ZKUi" style="font: 10pt Times New Roman; text-align: justify; color: #0F1115; width: 0.25in"&gt;(2)&lt;/td&gt;
    &lt;td id="xdx_F18_zPCrYvRyaIu9" style="font: 10pt Times New Roman; text-align: justify"&gt;
    Equity options. On May&#160;9, 2023, the Company entered into an agreement with a third-party service provider (the &#x201c;Service Provider&#x201d;). The Service Provider received a freestanding equity-linked right exercisable, at the Service Provider&#x2019;s option, upon the closing of the Company&#x2019;s next qualified equity financing. The right provides the ability to subscribe for up to the value of $200,000 at a 25% discount price per share on the grant date. The equity option is remeasured at fair value at each reporting date, with changes in fair value recognized in earnings. As of June&#160;30, 2025 and 2026, the fair value of the equity option was $53,333, and no gain or loss from changes in fair value was recognized for the periods presented. The fair value measurement of the equity option is categorized within Level 3 of the fair value hierarchy and was determined using a scenario-based analysis, which incorporates significant unobservable inputs and management judgment regarding the probability and timing of potential future financing outcomes.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A9_zkFXRL8dM1qj" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;











</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000751">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zhxYnM9H7Lt7" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair value measurements (Details)"&gt;
  &lt;tr&gt;
    &lt;td id="xdx_8B5_zjPjGVSH7fOe" style="font: 10pt Times New Roman; display: none; vertical-align: top; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Schedule of fair value assets and liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value measurement at reporting date using&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: left"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value &lt;br/&gt;as of&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Quoted Prices in&lt;br/&gt;Active Markets for&lt;br/&gt;Identical Assets &lt;br/&gt;(Level 1)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Significant Other&lt;br/&gt;Observable Inputs &lt;br/&gt;(Level 2)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Significant &lt;br/&gt;Unobservable Inputs &lt;br/&gt;(Level 3)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; background-color: #CCEEFF; text-align: left; padding-left: 0.125in; text-indent: -0.125in; width: 52%"&gt;Liabilities:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Simple agreements for future equity&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_z0S06p9rf5j9" title="Liability"&gt;18,243,885&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zulSkZKh1Ezi" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0755"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zNU0JeqVorsa" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0757"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zRV1LFttYZpd" title="Liability"&gt;18,243,885&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; background-color: #CCEEFF; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Other payable related to the equity option&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_zBhsJm0fT5q8" title="Liability"&gt;53,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_z1k9UHWpqHS6" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0763"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_zjZg7jiY44yc" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0765"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_ziOHelHtFwHj" title="Liability"&gt;53,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value measurement at reporting date using&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: left"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value &lt;br/&gt;as of&lt;br/&gt;June&#160;30, &lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Quoted Prices in&lt;br/&gt;Active Markets for&lt;br/&gt;Identical Assets &lt;br/&gt;(Level 1)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Significant Other&lt;br/&gt;Observable Inputs &lt;br/&gt;(Level 2)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Significant &lt;br/&gt;Unobservable Inputs &lt;br/&gt;(Level 3)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-left: 0.125in; text-indent: -0.125in; width: 52%"&gt;Liabilities:&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Simple agreements for future equity&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zAnEPtPYmin5" title="Liability"&gt;29,121,268&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zSyY3m3cap18" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0771"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zCyQInY6LRJ" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0773"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: justify"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--SimpleAgreementsForFutureEquityMember_fKDEp_zGTXMwOg7hL8" title="Liability"&gt;29,121,268&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Other payable related to the equity option&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_zoxcbfG8aw48" title="Liability"&gt;53,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_zIS4i7rdirBb" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0779"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_zh0v94iFaG2" title="Liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0781"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0d_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByLiabilityClassAxis__custom--OtherPayableRelatedToTheEquityOptionMember_fKDIp_ziAW1Dx7hTu8" title="Liability"&gt;53,333&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F09_zu5TYSd8UFYe" style="font: 10pt Times New Roman; width: 0.25in; text-align: justify"&gt;(1)&lt;/td&gt;
    &lt;td id="xdx_F18_zcuWR4PfyQ44" style="text-align: justify"&gt; 
    
                    &lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company classifies its SAFEs as financial liabilities measured at fair value. The value of these agreements depends significantly on future financing activities, liquidity events, or other material milestones, and their valuation relies on significant inputs that are not observable in the public market. Accordingly, they are classified within Level 3 of the fair value hierarchy.&lt;/p&gt;
                    &lt;p style="font: 10pt Times New Roman; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
                    &lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value measurement is based on an integrated framework combining&#160;scenario analysis and financial instrument decomposition (i.e. Bond Plus Call Method). As of June&#160;30, 2026, the proceeds of the SAFEs on the date of issuance were $14,092,500. The details of significant unobservable inputs can refer to Note 8-Simple Agreements for Future Equity for further details.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F05_zHZNAeY0ZKUi" style="font: 10pt Times New Roman; text-align: justify; color: #0F1115; width: 0.25in"&gt;(2)&lt;/td&gt;
    &lt;td id="xdx_F18_zPCrYvRyaIu9" style="font: 10pt Times New Roman; text-align: justify"&gt;
    Equity options. On May&#160;9, 2023, the Company entered into an agreement with a third-party service provider (the &#x201c;Service Provider&#x201d;). The Service Provider received a freestanding equity-linked right exercisable, at the Service Provider&#x2019;s option, upon the closing of the Company&#x2019;s next qualified equity financing. The right provides the ability to subscribe for up to the value of $200,000 at a 25% discount price per share on the grant date. The equity option is remeasured at fair value at each reporting date, with changes in fair value recognized in earnings. As of June&#160;30, 2025 and 2026, the fair value of the equity option was $53,333, and no gain or loss from changes in fair value was recognized for the periods presented. The fair value measurement of the equity option is categorized within Level 3 of the fair value hierarchy and was determined using a scenario-based analysis, which incorporates significant unobservable inputs and management judgment regarding the probability and timing of potential future financing outcomes.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember"
      decimals="0"
      id="Fact000753"
      unitRef="USD">18243885</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember"
      decimals="0"
      id="Fact000759"
      unitRef="USD">18243885</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember"
      decimals="0"
      id="Fact000761"
      unitRef="USD">53333</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember"
      decimals="0"
      id="Fact000767"
      unitRef="USD">53333</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2026-06-30_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember"
      decimals="0"
      id="Fact000769"
      unitRef="USD">29121268</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2026-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SimpleAgreementsForFutureEquityMember"
      decimals="0"
      id="Fact000775"
      unitRef="USD">29121268</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2026-06-30_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember"
      decimals="0"
      id="Fact000777"
      unitRef="USD">53333</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2026-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_OtherPayableRelatedToTheEquityOptionMember"
      decimals="0"
      id="Fact000783"
      unitRef="USD">53333</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CryptoAssetTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000788">&lt;p id="xdx_809_eus-gaap--CryptoAssetTextBlock_z5J9K3eeBe54" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;5. &lt;span id="xdx_82A_zxcXS7yPN6tf"&gt;Crypto assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company uses crypto assets like USDT and USDC as medium of exchange for collecting and settling business-related payments and for receiving investment proceeds. As of June&#160;30, 2025 and 2026, the Company held nil and $&lt;span id="xdx_901_eus-gaap--PaymentsForProceedsFromInvestments_c20250701__20260630_zL1B8c90INO9" title="Investment proceeds"&gt;&lt;span id="xdx_90A_eus-gaap--PaymentsForProceedsFromInvestments_c20240701__20250630_zC7QzX4qcE74" title="Investment proceeds"&gt;2,160,746&lt;/span&gt;&lt;/span&gt; of USDT and USDC, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company commenced the use of crypto assets in December&#160;2025. The movements in digital assets and USDC for the year ended June&#160;30, 2026 are set out below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--CryptoAssetActivityTableTextBlock_zRAHbK0ULhId" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Crypto assets (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B3_zDAKvaYASiul" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of digital assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;USDT&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;USDC&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Balance as of June&#160;30, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90E_eus-gaap--CryptoAssetFairValue_iS_pp0d_c20250701__20260630__srt--CryptoAssetAxis__custom--USDTMember_zP9O2LrCe2Yh" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0796"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90D_eus-gaap--CryptoAssetFairValue_iS_pp0d_c20250701__20260630__srt--CryptoAssetAxis__custom--USDCMember_zXKlN6Ti4B8i" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0798"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Additions&lt;sup&gt;(i)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--CryptoAssetPurchase_pp0d_c20250701__20260630__srt--CryptoAssetAxis__custom--USDTMember_fKGkp_zUond4dWZ4Rc" title="Additions"&gt;991,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--CryptoAssetPurchase_pp0d_c20250701__20260630__srt--CryptoAssetAxis__custom--USDCMember_fKGkp_zrt5eiO2urwj" title="Additions"&gt;6,275,251&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Disposals - sold for US dollars&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--CryptoAssetSale_iN_pp0d_di_c20250701__20260630__srt--CryptoAssetAxis__custom--USDTMember_z6ZUPDKCOUmd" title="Disposals - sold for US dollars"&gt;(596,852&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--CryptoAssetSale_iN_pp0d_di_c20250701__20260630__srt--CryptoAssetAxis__custom--USDCMember_zUg1xJgEvHBj" title="Disposals - sold for US dollars"&gt;(809,669&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Disposals&lt;sup&gt;(ii)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--CryptoAssetDisposition_iN_pp0d_di_c20250701__20260630__srt--CryptoAssetAxis__custom--USDTMember_fKGlpKQ_____zJgxIIZfLEMk" title="Disposals"&gt;(394,749&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--CryptoAssetDisposition_iN_pp0d_di_c20250701__20260630__srt--CryptoAssetAxis__custom--USDCMember_fKGlpKQ_____zPxvW9edhXSc" title="Disposals"&gt;(3,304,836&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance as of June&#160;30, 2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_901_eus-gaap--CryptoAssetFairValue_iE_pp0d_c20250701__20260630__srt--CryptoAssetAxis__custom--USDTMember_ztC5FI8Iqozb" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0812"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_908_eus-gaap--CryptoAssetFairValue_iE_pp0d_c20250701__20260630__srt--CryptoAssetAxis__custom--USDCMember_ziIGwxmNPu3i" title="Ending balance"&gt;2,160,746&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F02_zJYzl8uXTjN6" style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;
    &lt;td id="xdx_F1C_zGxnNhgDktKh" style="text-align: justify"&gt;
    The Company acquired a total of 991,601 USDT at a cost of $991,601 from revenues and other current assets. The Company acquired a total of 6,275,251 USDC at a cost of $ 6,275,251 from revenues, USDC rewards, other current assets and investment proceeds from SAFEs.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_z0lzmnu3jOjb" style="width: 0.25in; text-align: left"&gt;(ii)&lt;/td&gt;
    &lt;td id="xdx_F1A_zFfkkhVoguRc" style="text-align: justify"&gt;
    The Company uses digital assets and USDC to settle professional services fees and other expenditures, and any digital assets held may be converted into USDC, as needed.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AA_zXrjfn7lRJe" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s balances related to digital assets are USD-pegged stablecoins. No fair value gain or loss on digital assets was recognized for the year ended June&#160;30, 2026 considering the low volatility in the fair value of USDT during the year ended June&#160;30, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The following table summarizes other operating activities settled in digital assets and USDC:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--CashFlowOperatingCapitalTableTextBlock_zNoPLqG8H6H2" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Crypto assets (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B3_z7UQQcbO1HZa" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of operating activities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250701__20260630__srt--CryptoAssetAxis__custom--DigitalAssetsAndUSDCMember_zS4GSsL6IFFk" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;For the&lt;br/&gt; Year Ended&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Revenues_iN_di_maTOASIzVyN_zPHBKkNW0zw3" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Revenue&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(2,798,918&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--OtherCurrentAssets_msTOASIzVyN_zYxGwhTTbjed" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other receivables&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(1,452,102&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CostsAndExpenses_msTOASIzVyN_zF5GKc6gRINl" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cost and expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;3,699,585&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--UsdcRewards_iN_pp0d_di_maTOASIzVyN_zn6wYZ5L8H3k" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;USDC rewards&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(15,832&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--TotalOperatingActivitiesSettledInDigitalAssetsAndUsdc_iNT_di_mtTOASIzVyN_z8930fxkxSq3" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total operating activities settled in digital assets and USDC&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(567,267&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A2_zSktC7dJnfY7" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;











</us-gaap:CryptoAssetTextBlock>
    <us-gaap:PaymentsForProceedsFromInvestments
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000790"
      unitRef="USD">2160746</us-gaap:PaymentsForProceedsFromInvestments>
    <us-gaap:PaymentsForProceedsFromInvestments
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000792"
      unitRef="USD">2160746</us-gaap:PaymentsForProceedsFromInvestments>
    <us-gaap:CryptoAssetActivityTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000794">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--CryptoAssetActivityTableTextBlock_zRAHbK0ULhId" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Crypto assets (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B3_zDAKvaYASiul" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of digital assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;USDT&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;USDC&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Balance as of June&#160;30, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90E_eus-gaap--CryptoAssetFairValue_iS_pp0d_c20250701__20260630__srt--CryptoAssetAxis__custom--USDTMember_zP9O2LrCe2Yh" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0796"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90D_eus-gaap--CryptoAssetFairValue_iS_pp0d_c20250701__20260630__srt--CryptoAssetAxis__custom--USDCMember_zXKlN6Ti4B8i" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0798"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Additions&lt;sup&gt;(i)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--CryptoAssetPurchase_pp0d_c20250701__20260630__srt--CryptoAssetAxis__custom--USDTMember_fKGkp_zUond4dWZ4Rc" title="Additions"&gt;991,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--CryptoAssetPurchase_pp0d_c20250701__20260630__srt--CryptoAssetAxis__custom--USDCMember_fKGkp_zrt5eiO2urwj" title="Additions"&gt;6,275,251&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Disposals - sold for US dollars&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--CryptoAssetSale_iN_pp0d_di_c20250701__20260630__srt--CryptoAssetAxis__custom--USDTMember_z6ZUPDKCOUmd" title="Disposals - sold for US dollars"&gt;(596,852&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--CryptoAssetSale_iN_pp0d_di_c20250701__20260630__srt--CryptoAssetAxis__custom--USDCMember_zUg1xJgEvHBj" title="Disposals - sold for US dollars"&gt;(809,669&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Disposals&lt;sup&gt;(ii)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--CryptoAssetDisposition_iN_pp0d_di_c20250701__20260630__srt--CryptoAssetAxis__custom--USDTMember_fKGlpKQ_____zJgxIIZfLEMk" title="Disposals"&gt;(394,749&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--CryptoAssetDisposition_iN_pp0d_di_c20250701__20260630__srt--CryptoAssetAxis__custom--USDCMember_fKGlpKQ_____zPxvW9edhXSc" title="Disposals"&gt;(3,304,836&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance as of June&#160;30, 2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_901_eus-gaap--CryptoAssetFairValue_iE_pp0d_c20250701__20260630__srt--CryptoAssetAxis__custom--USDTMember_ztC5FI8Iqozb" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0812"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_908_eus-gaap--CryptoAssetFairValue_iE_pp0d_c20250701__20260630__srt--CryptoAssetAxis__custom--USDCMember_ziIGwxmNPu3i" title="Ending balance"&gt;2,160,746&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F02_zJYzl8uXTjN6" style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;
    &lt;td id="xdx_F1C_zGxnNhgDktKh" style="text-align: justify"&gt;
    The Company acquired a total of 991,601 USDT at a cost of $991,601 from revenues and other current assets. The Company acquired a total of 6,275,251 USDC at a cost of $ 6,275,251 from revenues, USDC rewards, other current assets and investment proceeds from SAFEs.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_z0lzmnu3jOjb" style="width: 0.25in; text-align: left"&gt;(ii)&lt;/td&gt;
    &lt;td id="xdx_F1A_zFfkkhVoguRc" style="text-align: justify"&gt;
    The Company uses digital assets and USDC to settle professional services fees and other expenditures, and any digital assets held may be converted into USDC, as needed.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:CryptoAssetActivityTableTextBlock>
    <us-gaap:CryptoAssetPurchase
      contextRef="From2025-07-012026-06-30_custom_USDTMember"
      decimals="0"
      id="Fact000800"
      unitRef="USD">991601</us-gaap:CryptoAssetPurchase>
    <us-gaap:CryptoAssetPurchase
      contextRef="From2025-07-012026-06-30_custom_USDCMember"
      decimals="0"
      id="Fact000802"
      unitRef="USD">6275251</us-gaap:CryptoAssetPurchase>
    <us-gaap:CryptoAssetSale
      contextRef="From2025-07-012026-06-30_custom_USDTMember"
      decimals="0"
      id="Fact000804"
      unitRef="USD">596852</us-gaap:CryptoAssetSale>
    <us-gaap:CryptoAssetSale
      contextRef="From2025-07-012026-06-30_custom_USDCMember"
      decimals="0"
      id="Fact000806"
      unitRef="USD">809669</us-gaap:CryptoAssetSale>
    <us-gaap:CryptoAssetDisposition
      contextRef="From2025-07-012026-06-30_custom_USDTMember"
      decimals="0"
      id="Fact000808"
      unitRef="USD">394749</us-gaap:CryptoAssetDisposition>
    <us-gaap:CryptoAssetDisposition
      contextRef="From2025-07-012026-06-30_custom_USDCMember"
      decimals="0"
      id="Fact000810"
      unitRef="USD">3304836</us-gaap:CryptoAssetDisposition>
    <us-gaap:CryptoAssetFairValue
      contextRef="AsOf2026-06-30_custom_USDCMember"
      decimals="0"
      id="Fact000814"
      unitRef="USD">2160746</us-gaap:CryptoAssetFairValue>
    <us-gaap:CashFlowOperatingCapitalTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000818">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--CashFlowOperatingCapitalTableTextBlock_zNoPLqG8H6H2" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Crypto assets (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B3_z7UQQcbO1HZa" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of operating activities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250701__20260630__srt--CryptoAssetAxis__custom--DigitalAssetsAndUSDCMember_zS4GSsL6IFFk" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;For the&lt;br/&gt; Year Ended&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Revenues_iN_di_maTOASIzVyN_zPHBKkNW0zw3" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Revenue&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(2,798,918&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--OtherCurrentAssets_msTOASIzVyN_zYxGwhTTbjed" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other receivables&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(1,452,102&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CostsAndExpenses_msTOASIzVyN_zF5GKc6gRINl" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cost and expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;3,699,585&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--UsdcRewards_iN_pp0d_di_maTOASIzVyN_zn6wYZ5L8H3k" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;USDC rewards&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(15,832&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--TotalOperatingActivitiesSettledInDigitalAssetsAndUsdc_iNT_di_mtTOASIzVyN_z8930fxkxSq3" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total operating activities settled in digital assets and USDC&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(567,267&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:CashFlowOperatingCapitalTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2025-07-012026-06-30_custom_DigitalAssetsAndUSDCMember"
      decimals="0"
      id="Fact000820"
      unitRef="USD">2798918</us-gaap:Revenues>
    <xlabw:OtherCurrentAssets
      contextRef="From2025-07-012026-06-30_custom_DigitalAssetsAndUSDCMember"
      decimals="0"
      id="Fact000822"
      unitRef="USD">-1452102</xlabw:OtherCurrentAssets>
    <us-gaap:CostsAndExpenses
      contextRef="From2025-07-012026-06-30_custom_DigitalAssetsAndUSDCMember"
      decimals="0"
      id="Fact000824"
      unitRef="USD">3699585</us-gaap:CostsAndExpenses>
    <xlabw:UsdcRewards
      contextRef="From2025-07-012026-06-30_custom_DigitalAssetsAndUSDCMember"
      decimals="0"
      id="Fact000826"
      unitRef="USD">15832</xlabw:UsdcRewards>
    <xlabw:TotalOperatingActivitiesSettledInDigitalAssetsAndUsdc
      contextRef="From2025-07-012026-06-30_custom_DigitalAssetsAndUSDCMember"
      decimals="0"
      id="Fact000828"
      unitRef="USD">567267</xlabw:TotalOperatingActivitiesSettledInDigitalAssetsAndUsdc>
    <us-gaap:AccountsAndNontradeReceivableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000831">&lt;p id="xdx_80F_eus-gaap--AccountsAndNontradeReceivableTextBlock_zKHAMWTrp0l3" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;6. &lt;span id="xdx_82E_zXYo7pRfmV2e"&gt;Accounts receivable&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Accounts receivable consisted of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z4ayVEYtpq15" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts receivable (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BA_zPG1ipfebbob" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of accounts receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250630_zfGAUoDQ6194" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20260630_zQZIpNwmdb9d" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableNetCurrent_iI_pp0d_maARNzNuI_ztL7vptNl5Ai" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Accounts receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;152,536&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;1,145,232&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iNI_pp0d_di_msARNzNuI_zrKCQVGlD072" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Less: allowance for credit losses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0838"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(38,022&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccountsReceivableNet_iTI_pp0d_mtARNzNuI_zBNeinANy2ce" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Accounts receivable, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;152,536&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;1,107,210&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AB_zgg80jRFh6E2" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for credit losses for expected losses over the life of the accounts receivable using the current expected credit loss methodology. The Company determines the allowance based on historical loss experience, current conditions, and reasonable and supportable forecasts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For the years ended June&#160;30, 2025 and 2026, the movement of allowance for expected credit losses were as below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfMovementOfAllowanceForExpectedCreditLosses_z5GNEDivF6a1" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts receivable (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B7_z00GHasyRiq6" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of movement of allowance for expected credit losses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20240701__20250630_zpp3EcWPq5Ke" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250701__20260630_zo2pbbpq1x7c" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsAndFinancingReceivableAllowanceForCreditLoss_iS_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Balance at beginning of the year&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0846"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0847"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ProvisionForDoubtfulAccounts_i_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Addition&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0849"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;38,022&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccountsAndFinancingReceivableAllowanceForCreditLoss_iE_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at end of the year&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0852"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;38,022&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A7_zqVoRE0o7EEa" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:AccountsAndNontradeReceivableTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000833">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z4ayVEYtpq15" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts receivable (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BA_zPG1ipfebbob" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of accounts receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250630_zfGAUoDQ6194" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20260630_zQZIpNwmdb9d" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableNetCurrent_iI_pp0d_maARNzNuI_ztL7vptNl5Ai" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Accounts receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;152,536&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;1,145,232&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iNI_pp0d_di_msARNzNuI_zrKCQVGlD072" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Less: allowance for credit losses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0838"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(38,022&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccountsReceivableNet_iTI_pp0d_mtARNzNuI_zBNeinANy2ce" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Accounts receivable, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;152,536&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;1,107,210&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000835"
      unitRef="USD">152536</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000836"
      unitRef="USD">1145232</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000839"
      unitRef="USD">38022</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000841"
      unitRef="USD">152536</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000842"
      unitRef="USD">1107210</us-gaap:AccountsReceivableNet>
    <xlabw:ScheduleOfMovementOfAllowanceForExpectedCreditLosses contextRef="From2025-07-01to2026-06-30" id="Fact000844">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfMovementOfAllowanceForExpectedCreditLosses_z5GNEDivF6a1" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts receivable (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B7_z00GHasyRiq6" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of movement of allowance for expected credit losses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20240701__20250630_zpp3EcWPq5Ke" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250701__20260630_zo2pbbpq1x7c" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsAndFinancingReceivableAllowanceForCreditLoss_iS_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Balance at beginning of the year&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0846"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0847"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ProvisionForDoubtfulAccounts_i_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Addition&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0849"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;38,022&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccountsAndFinancingReceivableAllowanceForCreditLoss_iE_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at end of the year&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0852"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;38,022&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</xlabw:ScheduleOfMovementOfAllowanceForExpectedCreditLosses>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000850"
      unitRef="USD">38022</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AccountsAndFinancingReceivableAllowanceForCreditLoss
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000853"
      unitRef="USD">38022</us-gaap:AccountsAndFinancingReceivableAllowanceForCreditLoss>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000855">&lt;p id="xdx_80F_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zsetNJ6waaba" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;7. &lt;span id="xdx_82C_zG845PZl8rZa"&gt;Equipment, net&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Equipment, net consisted of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--PropertyPlantAndEquipmentTextBlock_zzzFmzZbWygh" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equipment, net (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BC_zEoHZDE6Oce4" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20250630_zK99f1GaSGB1" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20260630_zXaOqcFtZL3j" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0d_maPPAEOz5k8_zwgijLNi2Hil" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 9%; text-align: right"&gt;29,944&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 9%; text-align: right"&gt;29,198&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentOtherNet_iTI_pp0d_mtPPAEOz5k8_maPPAENz0U3_zdNw03SyAEa8" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;29,944&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;29,198&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentOtherAccumulatedDepreciation_iNI_pp0d_di_msPPAENz0U3_zwWe6BbBZT07" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Less: accumulated depreciation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(10,344&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(16,358&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0d_mtPPAENz0U3_zRUOQc4FtDk5" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Net carrying amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;19,600&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;12,840&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Depreciation expenses for the years ended June&#160;30, 2025 and 2026 were $&lt;span id="xdx_900_eus-gaap--Depreciation_c20240701__20250630_pp0p" title="Depreciation expenses"&gt;6,234&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--Depreciation_c20250701__20260630_pp0p" title="Depreciation expenses"&gt;6,760&lt;/span&gt;, respectively.&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000857">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--PropertyPlantAndEquipmentTextBlock_zzzFmzZbWygh" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equipment, net (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BC_zEoHZDE6Oce4" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20250630_zK99f1GaSGB1" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20260630_zXaOqcFtZL3j" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0d_maPPAEOz5k8_zwgijLNi2Hil" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 9%; text-align: right"&gt;29,944&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 9%; text-align: right"&gt;29,198&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentOtherNet_iTI_pp0d_mtPPAEOz5k8_maPPAENz0U3_zdNw03SyAEa8" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;29,944&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;29,198&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentOtherAccumulatedDepreciation_iNI_pp0d_di_msPPAENz0U3_zwWe6BbBZT07" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Less: accumulated depreciation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(10,344&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(16,358&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0d_mtPPAENz0U3_zRUOQc4FtDk5" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Net carrying amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;19,600&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;12,840&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000859"
      unitRef="USD">29944</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000860"
      unitRef="USD">29198</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentOtherNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000862"
      unitRef="USD">29944</us-gaap:PropertyPlantAndEquipmentOtherNet>
    <us-gaap:PropertyPlantAndEquipmentOtherNet
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000863"
      unitRef="USD">29198</us-gaap:PropertyPlantAndEquipmentOtherNet>
    <us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000865"
      unitRef="USD">10344</us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000866"
      unitRef="USD">16358</us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000868"
      unitRef="USD">19600</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000869"
      unitRef="USD">12840</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000871"
      unitRef="USD">6234</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000873"
      unitRef="USD">6760</us-gaap:Depreciation>
    <xlabw:SimpleAgreementsForFutureEquityTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000876">&lt;p id="xdx_80A_ecustom--SimpleAgreementsForFutureEquityTextBlock_zTyxuTV9ad7i" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;8. &lt;span id="xdx_828_zBrZ49KqEEh6"&gt;Simple agreements for future equity&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company has entered into SAFEs with various investors that were classified as liabilities on the Company&#x2019;s balance sheets and accounted for at fair value, subject to remeasurement each reporting period. SAFEs have no maturity date, does not bear any interest and provides the investor with the right to convert into a variable number of shares of future equity in the Company at the stated conversion amount, if certain events or conditions are triggered.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;During the period from October&#160;2022 through June&#160;30, 2026, the Company entered into Simple Agreements for Future Equity with third-party investors, receiving aggregate gross proceeds of $&lt;span id="xdx_90E_eus-gaap--ProceedsFromOtherEquity_c20221001__20260630_pp0p" title="Aggregate gross proceeds"&gt;14,092,500&lt;/span&gt;. For the years ended June&#160;30, 2025 and 2026, the Company received SAFEs proceeds of $&lt;span id="xdx_902_eus-gaap--ProceedsFromOtherEquity_c20240701__20250630_pp0p" title="Aggregate gross proceeds"&gt;4,307,500&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--ProceedsFromOtherEquity_c20250701__20260630_pp0p" title="Aggregate gross proceeds"&gt;3,500,000&lt;/span&gt;, respectively. No issuance costs were incurred in connection with these arrangements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On August&#160;27, 2026, the Company consummated
the Business Combination contemplated by the Agreement and Plan of Merger dated January&#160;11, 2026. Upon the De-SPAC closing, all outstanding
SAFEs of the Company were cancelled and converted into the right to receive shares of PubCo Class A common stock based on the applicable
SAFE holders&#x2019; implied ownership percentages. The shares of PubCo Class A common stock received in connection with the SAFE conversion
constituted full satisfaction of their rights under the applicable SAFEs and were subject to a six-month lock-up period following the
Closing Date. No additional cash consideration was payable upon such conversion.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The SAFEs agreements grant investors the right to participate in the Company&#x2019;s future equity financing events. The agreements contain various conversion and redemption provisions, including conversion upon an equity financing event, as well as settlement in the event of a liquidity event or dissolution of the Company. Key terms of the SAFEs are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Equity Financing&lt;/i&gt;&lt;/b&gt;&#160;&#x2013; Upon the occurrence of an equity financing event, the SAFE instruments convert into shares of the Company&#x2019;s Standard Preferred shares as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Price-based SAFEs: each SAFEs automatically converts into a greater of (a)&#160;the number of shares
    of preferred shares equal to SAFEs purchase amount divided by the lowest price per share paid for the standard preferred shares or
    (b)&#160;the number of shares of preferred shares equal to the SAFEs purchase amount divided by the SAFEs price.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&#x201c;SAFEs price&#x201d; is calculated by dividing a fixed post-money valuation cap by the Company capitalization, a defined term that includes all outstanding equity and convertible instruments.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&#x201c;Equity Financing&#x201d; means a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant to which the Company issues and sells preferred share at a fixed valuation, including but not limited to, a pre-money or post-money valuation.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; color: #0F1115; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;(ii)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Fixed-percentage SAFEs: on the initial closing of such Equity Financing, the SAFE automatically
    converts into that number of shares of the Standard Preferred Share representing&#160;a fixed percentage&#160;of total issued and
    outstanding shares of the Company immediately after the Closing.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Not all SAFEs agreements contain the equity financing conversion provision described above. Certain SAFEs are structured without an Equity Financing conversion feature and are generally settled only upon a Liquidity Event or a Dissolution Event (as defined in the respective SAFEs agreements). The Company considered the contractual terms of the SAFEs, including whether an Equity Financing conversion feature is present and the settlement provisions upon a Liquidity Event or a Dissolution Event, in the valuation and measurement of these instruments. As of June&#160;30, 2026, &lt;span id="xdx_90B_ecustom--EquityFinancingDescription_pp0d_c20250701__20260630_zU1R9iiCM1W7" title="Equity financing description"&gt;SAFEs with an aggregate purchase amount of $13,632,500 include an Equity Financing conversion feature, while SAFEs with an aggregate purchase amount of $460,000 do not include this feature and are generally settled only upon a Liquidity Event or a Dissolution Event, in accordance with their terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company does not have any preferred shares outstanding as of the date these consolidated financial statements are issued; therefore, an equity financing event has not been triggered.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Liquidity Event&lt;/i&gt;&lt;/b&gt;&#160;&#x2013; If there is a liquidity event before the conversion of each SAFE, the holder of each SAFEs will automatically be entitled to the greater of (i) SAFEs purchase amount, or (ii)&#160;the amount payable on the number of shares of common stock equal to the purchase amount divided by the Liquidity Price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&#x201c;Liquidity Price&#x201d; is calculated by dividing the post-money valuation cap by the separately defined capital base, referred to as &#x201c;liquidity capitalization&#x201d; in the SAFEs agreements.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&#x201c;Liquidity Event&#x201d; means a change of control, a direct Listing or an initial public offering.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Dissolution Event&lt;/i&gt;&lt;/b&gt;&#160;&#x2013; If there is a dissolution event before the conversion of each SAFE, the holder of each SAFEs will automatically be entitled to receive a portion of proceeds equal to SAFEs purchase amount.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company classifies its SAFEs as financial liabilities measured at fair value. Since the value of these instruments depends on significant unobservable inputs, including future financing activities and liquidity events, they are classified as Level 3 within the fair value hierarchy.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value measurement utilizes a combined scenario analysis and financial instrument decomposition approach. Based on management&#x2019;s assessment of the Company&#x2019;s prospects, probability distributions are assigned to potential settlement-triggering events. Valuation is performed using a &#x201c;debt plus option&#x201d; model: the debt component is valued using a discounted cash flow method with key assumptions including expected settlement timing, risk-free interest rate, and credit spread; the embedded conversion right is treated as a call option and valued using the Black-Scholes model, with key inputs including the fair value of common stock, expected term, and volatility. The overall fair value represents the probability-weighted sum across all scenarios, supported by an independent third-party valuation specialist.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of June&#160;30, 2025 and 2026, the SAFE liabilities were measured at fair value using the above Level 3 methodology. Significant unobservable inputs&#x2014;including timing of events, volatility, and credit spreads&#x2014;are based on management&#x2019;s reasonable estimates as of each valuation date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Major valuation inputs adopted in the valuation of the SAFE Instruments are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zEHaPxg8Vlib" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Simple agreements for future equity (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BE_z4Vfv5ESc2ff" style="font: 10pt Times New Roman; display: none; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Schedule of share based payment award stock options valuation assumptions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Volatility&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20240701__20250630_fKDEp_z3EdQrWVWEM2" title="Volatility"&gt;78.6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20250701__20260630_fKDEp_z6MoTw5TslA4" title="Volatility"&gt;88.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Risk-free rate&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240701__20250630_fKDIp_zNpFzvT73T99" title="Risk-free rate"&gt;4.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20250701__20260630_fKDIp_z7quSxv21Vrb" title="Risk-free rate"&gt;3.9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Credit spread&lt;sup&gt;(3)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--CreditSpread_dp_c20240701__20250630_fKDMp_z9xyYg5mdLt" title="Credit spread"&gt;8.9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CreditSpread_dp_c20250701__20260630_fKDMp_z2iaLRvEo5Q6" title="Credit spread"&gt;9.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Discount rate&lt;sup&gt;(4)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_dp_c20240701__20250630_fKDQp_z3AdlgHnnKG7" title="Discount rate"&gt;12.8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_dp_c20250701__20260630_fKDQp_zcTJ0Jg1P0rd" title="Discount rate"&gt;13.6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Dividend yield&lt;sup&gt;(5)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240701__20250630_fKDUp_zDwgqPAmOZQ5" title="Dividend yield"&gt;0.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20250701__20260630_fKDUp_zFIM44mv3rqk" title="Dividend yield"&gt;0.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F09_z3LpFds3GFR4" style="width: 0.25in; text-align: left"&gt;(1)&lt;/td&gt;
    &lt;td id="xdx_F1C_zluxfcNUEZ3d" style="text-align: justify"&gt;
    Volatility: Derived with reference to historical price volatility of comparable companies&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F03_zmUoQxTU06Va" style="width: 0.25in; text-align: left"&gt;(2)&lt;/td&gt;
    &lt;td id="xdx_F18_zYkHCEesEXmc" style="text-align: justify"&gt;
    Risk-free rate: Derived with reference to U.S. sovereign bond yield&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F04_z0X3RDuKzsb2" style="width: 0.25in; text-align: left"&gt;(3)&lt;/td&gt;
    &lt;td id="xdx_F10_zP8oQOHmC3e3" style="text-align: justify"&gt;
    Credit spread: Risk premium over the risk-free rate, derived with reference to the spread of CCC rated bonds&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F0E_z2T5954rtSnb" style="width: 0.25in; text-align: left"&gt;(4)&lt;/td&gt;
    &lt;td id="xdx_F17_z7ONJfEyiYB9" style="text-align: justify"&gt;
    Discount rate: Sum of risk-free rate and credit spread&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F0D_zhKHZiHtamdg" style="width: 0.25in; text-align: left"&gt;(5)&lt;/td&gt;
    &lt;td id="xdx_F1D_za67peCrqjg3" style="text-align: justify"&gt;
    Dividend yield: Derived with reference to historical dividend record of the Company&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A6_zsPInDwfqVpe" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The following tables set forth a summary of the activity of the SAFE liabilities, respectively, which represents a recurring fair value measurement at the end of each reporting period:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zHnQoljiZbKe" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Simple agreements for future equity (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B3_z9aY0EiW4KN6" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of fair value measurement&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Balance at June&#160;30, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90E_ecustom--SimpleAgreementsForFutureEquity_iS_pp0d_c20240701__20250630_zTn7EPv2LZoa" title="Balance at beginning"&gt;9,321,564&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Issuance of simple agreements for future equity&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--IssuanceOfSimpleAgreementsForFutureEquity_c20240701__20250630_pp0p" title="Issuance of simple agreements for future equity"&gt;4,307,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Change in fair value&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ChangeInFairValue_c20240701__20250630_pp0p" title="Change in fair value"&gt;4,614,821&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Balance at June&#160;30, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--SimpleAgreementsForFutureEquity_iS_pp0d_c20250701__20260630_zrjX6qMWhFb7" title="Balance at beginning"&gt;18,243,885&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Issuance of simple agreements for future equity&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--IssuanceOfSimpleAgreementsForFutureEquity_c20250701__20260630_pp0p" title="Issuance of simple agreements for future equity"&gt;3,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Change in fair value&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ChangeInFairValue_c20250701__20260630_pp0p" title="Change in fair value"&gt;7,377,383&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at June&#160;30, 2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90A_ecustom--SimpleAgreementsForFutureEquity_iE_pp0d_c20250701__20260630_zRChOqenTkG7" title="Balance at ending"&gt;29,121,268&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A3_zAFL4SnBEyLc" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</xlabw:SimpleAgreementsForFutureEquityTextBlock>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2022-10-012026-06-30"
      decimals="0"
      id="Fact000878"
      unitRef="USD">14092500</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000880"
      unitRef="USD">4307500</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000882"
      unitRef="USD">3500000</us-gaap:ProceedsFromOtherEquity>
    <xlabw:EquityFinancingDescription contextRef="From2025-07-01to2026-06-30" id="Fact000884">SAFEs with an aggregate purchase amount of $13,632,500 include an Equity Financing conversion feature, while SAFEs with an aggregate purchase amount of $460,000 do not include this feature and are generally settled only upon a Liquidity Event or a Dissolution Event, in accordance with their terms.</xlabw:EquityFinancingDescription>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000889">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zEHaPxg8Vlib" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Simple agreements for future equity (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BE_z4Vfv5ESc2ff" style="font: 10pt Times New Roman; display: none; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Schedule of share based payment award stock options valuation assumptions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Volatility&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20240701__20250630_fKDEp_z3EdQrWVWEM2" title="Volatility"&gt;78.6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20250701__20260630_fKDEp_z6MoTw5TslA4" title="Volatility"&gt;88.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Risk-free rate&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240701__20250630_fKDIp_zNpFzvT73T99" title="Risk-free rate"&gt;4.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20250701__20260630_fKDIp_z7quSxv21Vrb" title="Risk-free rate"&gt;3.9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Credit spread&lt;sup&gt;(3)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--CreditSpread_dp_c20240701__20250630_fKDMp_z9xyYg5mdLt" title="Credit spread"&gt;8.9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CreditSpread_dp_c20250701__20260630_fKDMp_z2iaLRvEo5Q6" title="Credit spread"&gt;9.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Discount rate&lt;sup&gt;(4)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_dp_c20240701__20250630_fKDQp_z3AdlgHnnKG7" title="Discount rate"&gt;12.8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_dp_c20250701__20260630_fKDQp_zcTJ0Jg1P0rd" title="Discount rate"&gt;13.6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Dividend yield&lt;sup&gt;(5)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240701__20250630_fKDUp_zDwgqPAmOZQ5" title="Dividend yield"&gt;0.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20250701__20260630_fKDUp_zFIM44mv3rqk" title="Dividend yield"&gt;0.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F09_z3LpFds3GFR4" style="width: 0.25in; text-align: left"&gt;(1)&lt;/td&gt;
    &lt;td id="xdx_F1C_zluxfcNUEZ3d" style="text-align: justify"&gt;
    Volatility: Derived with reference to historical price volatility of comparable companies&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F03_zmUoQxTU06Va" style="width: 0.25in; text-align: left"&gt;(2)&lt;/td&gt;
    &lt;td id="xdx_F18_zYkHCEesEXmc" style="text-align: justify"&gt;
    Risk-free rate: Derived with reference to U.S. sovereign bond yield&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F04_z0X3RDuKzsb2" style="width: 0.25in; text-align: left"&gt;(3)&lt;/td&gt;
    &lt;td id="xdx_F10_zP8oQOHmC3e3" style="text-align: justify"&gt;
    Credit spread: Risk premium over the risk-free rate, derived with reference to the spread of CCC rated bonds&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F0E_z2T5954rtSnb" style="width: 0.25in; text-align: left"&gt;(4)&lt;/td&gt;
    &lt;td id="xdx_F17_z7ONJfEyiYB9" style="text-align: justify"&gt;
    Discount rate: Sum of risk-free rate and credit spread&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F0D_zhKHZiHtamdg" style="width: 0.25in; text-align: left"&gt;(5)&lt;/td&gt;
    &lt;td id="xdx_F1D_za67peCrqjg3" style="text-align: justify"&gt;
    Dividend yield: Derived with reference to historical dividend record of the Company&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000891"
      unitRef="Ratio">0.786</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000893"
      unitRef="Ratio">0.887</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000895"
      unitRef="Ratio">0.040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000897"
      unitRef="Ratio">0.039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <xlabw:CreditSpread
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000899"
      unitRef="Ratio">0.089</xlabw:CreditSpread>
    <xlabw:CreditSpread
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000901"
      unitRef="Ratio">0.097</xlabw:CreditSpread>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000903"
      unitRef="Ratio">0.128</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000905"
      unitRef="Ratio">0.136</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000907"
      unitRef="Ratio">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000909"
      unitRef="Ratio">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000919">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zHnQoljiZbKe" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Simple agreements for future equity (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B3_z9aY0EiW4KN6" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of fair value measurement&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Balance at June&#160;30, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90E_ecustom--SimpleAgreementsForFutureEquity_iS_pp0d_c20240701__20250630_zTn7EPv2LZoa" title="Balance at beginning"&gt;9,321,564&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Issuance of simple agreements for future equity&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--IssuanceOfSimpleAgreementsForFutureEquity_c20240701__20250630_pp0p" title="Issuance of simple agreements for future equity"&gt;4,307,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Change in fair value&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ChangeInFairValue_c20240701__20250630_pp0p" title="Change in fair value"&gt;4,614,821&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Balance at June&#160;30, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--SimpleAgreementsForFutureEquity_iS_pp0d_c20250701__20260630_zrjX6qMWhFb7" title="Balance at beginning"&gt;18,243,885&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Issuance of simple agreements for future equity&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--IssuanceOfSimpleAgreementsForFutureEquity_c20250701__20260630_pp0p" title="Issuance of simple agreements for future equity"&gt;3,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Change in fair value&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ChangeInFairValue_c20250701__20260630_pp0p" title="Change in fair value"&gt;7,377,383&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at June&#160;30, 2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_90A_ecustom--SimpleAgreementsForFutureEquity_iE_pp0d_c20250701__20260630_zRChOqenTkG7" title="Balance at ending"&gt;29,121,268&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <xlabw:SimpleAgreementsForFutureEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000921"
      unitRef="USD">9321564</xlabw:SimpleAgreementsForFutureEquity>
    <xlabw:IssuanceOfSimpleAgreementsForFutureEquity
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000923"
      unitRef="USD">4307500</xlabw:IssuanceOfSimpleAgreementsForFutureEquity>
    <xlabw:ChangeInFairValue
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000925"
      unitRef="USD">4614821</xlabw:ChangeInFairValue>
    <xlabw:SimpleAgreementsForFutureEquity
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000927"
      unitRef="USD">18243885</xlabw:SimpleAgreementsForFutureEquity>
    <xlabw:IssuanceOfSimpleAgreementsForFutureEquity
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000929"
      unitRef="USD">3500000</xlabw:IssuanceOfSimpleAgreementsForFutureEquity>
    <xlabw:ChangeInFairValue
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact000931"
      unitRef="USD">7377383</xlabw:ChangeInFairValue>
    <xlabw:SimpleAgreementsForFutureEquity
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000933"
      unitRef="USD">29121268</xlabw:SimpleAgreementsForFutureEquity>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000935">&lt;p id="xdx_801_eus-gaap--IncomeTaxDisclosureTextBlock_ztmHQmewP4hl" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;9. &lt;span id="xdx_82B_zo5EPy3p0sx9"&gt;Income taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Exascale Labs Inc. is incorporated in the State of Delaware and is subject to U.S. federal income tax and Delaware corporate income tax, as well as income taxes in other jurisdictions where it conducts business. The statutory corporate income tax rate is &lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c20240701__20250630_pd" title="Federal income tax rate"&gt;&lt;span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c20250701__20260630_pd" title="Federal income tax rate"&gt;21%&lt;/span&gt;&lt;/span&gt; for U.S. federal purposes. Delaware imposes a corporate income tax at a rate of &lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c20240701__20250630__us-gaap--IncomeTaxAuthorityNameAxis__custom--DelawareMember_zr6JQUGipicd" title="State income tax rate"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c20250701__20260630__us-gaap--IncomeTaxAuthorityNameAxis__custom--DelawareMember_zcjTQCY8J8a5" title="State income tax rate"&gt;8.7%&lt;/span&gt;&lt;/span&gt; on corporate taxable income. In addition, the Company is subject to state and local income taxes in other states in which it operates, calculated under applicable state law using apportionment methods (or similar rules) that allocate income among jurisdictions based on factors such as sales.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In addition, the Company files income or franchise tax returns in various other U.S. states and is subject to the applicable statutory tax rates in each jurisdiction based on income apportioned to those states.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Evana Alpha Pte. Ltd. is incorporated in Singapore and is subject to the statutory corporate income tax rate of &lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20240701__20250630__us-gaap--IncomeTaxAuthorityNameAxis__custom--EvanaAlphaPteLtdMember_pd" title="Effective income tax rate"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20250701__20260630__us-gaap--IncomeTaxAuthorityNameAxis__custom--EvanaAlphaPteLtdMember_pd" title="Effective income tax rate"&gt;17%&lt;/span&gt;&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The current and deferred components of income tax expense reflected in the statements of operations and comprehensive loss were nil for the year ended June&#160;30, 2025 and 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The following table reconciles the statutory rate to the Company&#x2019;s effective tax rate. The effective tax rate reconciliation is based on the U.S. federal statutory rate of 21%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zoNjA5yn4H87" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BE_z4hfcI2qHUu1" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of effective tax rate reconciliation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;US Statutory income tax rate&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20240701__20250630_zZlClluNUpZj" title="US Statutory income tax rate"&gt;21&lt;/span&gt;.0&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20250701__20260630_za6Fc4iACwZc" title="US Statutory income tax rate"&gt;21&lt;/span&gt;.0&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;State income tax&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20240701__20250630_zIUNcLQd0Z08" title="State income tax rate"&gt;8.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20250701__20260630_zpGLhzFKRMBf" title="State income tax rate"&gt;2.3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Tax differences from other jurisdictions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20240701__20250630_zqBI6cGoFoB9" title="Tax differences from other jurisdictions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0959"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20250701__20260630_zXirRZRISAQ8" title="Tax differences from other jurisdictions"&gt;(0.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;R&amp;amp;D expense super deduction&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductions_dp_c20250701__20260630_zuWgVHoJaQmc" title="R&amp;amp;D expense super deduction"&gt;(2.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Change in fair value of simple agreements for future equity&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20240701__20250630_zcttnXnQJBV3" title="Change in fair value of simple agreements for future equity"&gt;(17.9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20250701__20260630_zTxPVMIvhV18" title="Change in fair value of simple agreements for future equity"&gt;(9.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Change in valuation allowance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20240701__20250630_z0R0xVuC57b6" title="Changes in valuation allowance"&gt;(11.8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20250701__20260630_zcoEAJjGp3v7" title="Changes in valuation allowance"&gt;(11.2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Effective income tax rate&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp0_c20240701__20250630_z0emwG5Aq4zb" title="Effective income tax rate"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp0_c20250701__20260630_z8F5TsNUie7f" title="Effective income tax rate"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A1_z5iXv1H1gbLi" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s effective income tax rate was&#160;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20240701__20250630_pd" title="Effective income tax rate"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20250701__20260630_pd" title="Effective income tax rate"&gt;0%&lt;/span&gt;&lt;/span&gt;&#160;for both years ended June&#160;30, 2025 and 2026. This is primarily attributable to the&#160;recognition of a full valuation allowance against the net deferred tax assets, as the Company has concluded that it is not more likely than not that these assets will be realized in the foreseeable future. Accordingly, no tax benefit has been recognized for the losses incurred during these periods.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The principal components of deferred tax assets and deferred tax liabilities were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zpXeaITXMlz" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B8_zGtSW7ZhBnmj" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of deferred tax assets liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20250630_z6MeokpuKdT6" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20260630_z1kAYP3XLhbi" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsGrossAbstract_iB_zxghqE58GYqh" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Deferred tax assets&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0d_maDTAGz3OT_zNUqvIUzItv" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Net operating loss carry forward&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,652,998&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;2,679,040&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0d_maDTAGz3OT_z7kMv6vd5Zx5" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;R&amp;amp;D expense super deduction&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;322,388&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_i01I_pp0d_maDTAGz3OT_zEjWejIE0J06" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Bad provision&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0995"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;7,985&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0d_mtDTAGz3OT_maDTANzthq_zjoUrdU3tdh6" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Total deferred tax assets&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;1,652,998&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;3,009,413&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0d_di_msDTANzthq_z8jK3nSvoPfl" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Less: valuation allowance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(1,652,998&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(3,009,413&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0d_mtDTANzthq_zEUvdl4vR1Y7" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total deferred tax assets, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1004"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1005"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A8_zuXUIwyWHta5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The changes in valuation allowance for the years ended June&#160;30, 2025 and 2026 were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--SummaryOfValuationAllowanceTextBlock_zqpTK4dsx773" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B8_zBcSsXdf5ws9" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of valuation allowance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20240701__20250630_zvGdWQipbBL5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20250701__20260630_zbNWzeCsTd27" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended &lt;br/&gt;June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pp0d_di_z6EO3zY67pcd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance at the beginning of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(748,679&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(1,652,998&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_i_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Additions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(904,319&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(1,356,415&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pp0d_di_zlZL1NVUYTB1" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at the end of the year&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(1,652,998&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(3,009,413&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A6_zyVN0DmJLJih" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of June&#160;30, 2025 and 2026, Exascale Labs Inc. had net operating loss carryforwards (&#x201c;NOLs&#x201d;) of $&lt;span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20250630__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--DomesticCountryMember_zHiL9f5Pclyh" title="Net operating loss carryforwards"&gt;5.6&lt;/span&gt; million and $&lt;span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20260630__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--DomesticCountryMember_z7VTSM6fjtCk" title="Net operating loss carryforwards"&gt;9.9&lt;/span&gt; million for U.S. federal income tax purposes and $&lt;span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20250630__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--StateAndLocalJurisdictionMember_z4mQPOhrnycj" title="Net operating loss carryforwards"&gt;5.6&lt;/span&gt; million and $&lt;span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20260630__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--StateAndLocalJurisdictionMember_znXkLAhM8wf4" title="Net operating loss carryforwards"&gt;6.1&lt;/span&gt; million for state income tax purposes.&#160;The federal NOLs&#160;do not expire but are subject to an annual deduction limit of 80% of taxable income.&#160;The Company&#x2019;s NOLs can be carried forward to offset current year profit for Delaware and California corporate income tax purposes, subject to certain limitations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Evana Alpha Pte. Ltd. had NOLs of $&lt;span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20260630__us-gaap--IncomeTaxAuthorityNameAxis__custom--EvanaAlphaPteLtdMember_zCktTF8r5dW8" title="Net operating loss carryforwards"&gt;0.4&lt;/span&gt; million for the year ended June&#160;30, 2026. Under Singapore tax rules, the company&#x2019;s unutilized tax losses and capital allowances may be carried forward indefinitely, subject to the shareholding and same business tests (generally requiring at least 50% shareholder continuity). Current-year losses may also be carried back up to SGD 100,000.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company recognizes deferred tax assets if it is more likely than not that those deferred tax assets will be realized. Management reviews deferred tax assets periodically for recoverability and makes estimates and judgments regarding the expected geographic sources of taxable income in assessing the need for a valuation allowance to reduce deferred tax assets to their estimated realizable value. Realization of the Company&#x2019;s deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company had &lt;span id="xdx_90A_eus-gaap--UnrecognizedTaxBenefits_iI_pp0d_do_c20250630_zbkT5sTpAm9f" title="Unrecognized tax benefits"&gt;&lt;span id="xdx_902_eus-gaap--UnrecognizedTaxBenefits_iI_pp0d_do_c20260630_ztlhGcZI4Lef" title="Unrecognized tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits as of June&#160;30, 2025 and 2026. The Company currently files income tax returns in the U.S., as well as Delaware. All tax years are open for examination. The Company currently has no federal or state tax examinations in progress.&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000937"
      unitRef="Ratio">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000939"
      unitRef="Ratio">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2024-07-012025-06-30_custom_DelawareMember"
      decimals="INF"
      id="Fact000941"
      unitRef="Ratio">0.087</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2025-07-012026-06-30_custom_DelawareMember"
      decimals="INF"
      id="Fact000943"
      unitRef="Ratio">0.087</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2024-07-012025-06-30_custom_EvanaAlphaPteLtdMember"
      decimals="INF"
      id="Fact000945"
      unitRef="Ratio">0.17</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2025-07-012026-06-30_custom_EvanaAlphaPteLtdMember"
      decimals="INF"
      id="Fact000947"
      unitRef="Ratio">0.17</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000949">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zoNjA5yn4H87" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BE_z4hfcI2qHUu1" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of effective tax rate reconciliation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;US Statutory income tax rate&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20240701__20250630_zZlClluNUpZj" title="US Statutory income tax rate"&gt;21&lt;/span&gt;.0&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20250701__20260630_za6Fc4iACwZc" title="US Statutory income tax rate"&gt;21&lt;/span&gt;.0&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;State income tax&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20240701__20250630_zIUNcLQd0Z08" title="State income tax rate"&gt;8.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20250701__20260630_zpGLhzFKRMBf" title="State income tax rate"&gt;2.3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Tax differences from other jurisdictions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20240701__20250630_zqBI6cGoFoB9" title="Tax differences from other jurisdictions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0959"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20250701__20260630_zXirRZRISAQ8" title="Tax differences from other jurisdictions"&gt;(0.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;R&amp;amp;D expense super deduction&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductions_dp_c20250701__20260630_zuWgVHoJaQmc" title="R&amp;amp;D expense super deduction"&gt;(2.7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Change in fair value of simple agreements for future equity&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20240701__20250630_zcttnXnQJBV3" title="Change in fair value of simple agreements for future equity"&gt;(17.9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20250701__20260630_zTxPVMIvhV18" title="Change in fair value of simple agreements for future equity"&gt;(9.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Change in valuation allowance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20240701__20250630_z0R0xVuC57b6" title="Changes in valuation allowance"&gt;(11.8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20250701__20260630_zcoEAJjGp3v7" title="Changes in valuation allowance"&gt;(11.2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Effective income tax rate&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp0_c20240701__20250630_z0emwG5Aq4zb" title="Effective income tax rate"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp0_c20250701__20260630_z8F5TsNUie7f" title="Effective income tax rate"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000951"
      unitRef="Ratio">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000953"
      unitRef="Ratio">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000955"
      unitRef="Ratio">0.087</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000957"
      unitRef="Ratio">0.023</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000961"
      unitRef="Ratio">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductions
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000963"
      unitRef="Ratio">-0.027</us-gaap:EffectiveIncomeTaxRateReconciliationDeductions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000965"
      unitRef="Ratio">-0.179</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000967"
      unitRef="Ratio">-0.090</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000969"
      unitRef="Ratio">-0.118</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000971"
      unitRef="Ratio">-0.112</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000973"
      unitRef="Ratio">-0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000975"
      unitRef="Ratio">-0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact000977"
      unitRef="Ratio">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact000979"
      unitRef="Ratio">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact000984">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zpXeaITXMlz" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B8_zGtSW7ZhBnmj" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of deferred tax assets liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20250630_z6MeokpuKdT6" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20260630_z1kAYP3XLhbi" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsGrossAbstract_iB_zxghqE58GYqh" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Deferred tax assets&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0d_maDTAGz3OT_zNUqvIUzItv" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Net operating loss carry forward&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,652,998&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;2,679,040&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0d_maDTAGz3OT_z7kMv6vd5Zx5" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;R&amp;amp;D expense super deduction&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;322,388&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_i01I_pp0d_maDTAGz3OT_zEjWejIE0J06" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Bad provision&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0995"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;7,985&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0d_mtDTAGz3OT_maDTANzthq_zjoUrdU3tdh6" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Total deferred tax assets&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;1,652,998&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;3,009,413&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0d_di_msDTANzthq_z8jK3nSvoPfl" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Less: valuation allowance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(1,652,998&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(3,009,413&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0d_mtDTANzthq_zEUvdl4vR1Y7" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total deferred tax assets, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1004"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1005"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000989"
      unitRef="USD">1652998</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000990"
      unitRef="USD">2679040</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000993"
      unitRef="USD">322388</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000996"
      unitRef="USD">7985</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000998"
      unitRef="USD">1652998</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000999"
      unitRef="USD">3009413</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001001"
      unitRef="USD">1652998</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact001002"
      unitRef="USD">3009413</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:SummaryOfValuationAllowanceTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact001007">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--SummaryOfValuationAllowanceTextBlock_zqpTK4dsx773" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B8_zBcSsXdf5ws9" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Schedule of valuation allowance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20240701__20250630_zvGdWQipbBL5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20250701__20260630_zbNWzeCsTd27" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended &lt;br/&gt;June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pp0d_di_z6EO3zY67pcd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance at the beginning of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(748,679&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(1,652,998&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_i_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Additions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(904,319&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(1,356,415&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pp0d_di_zlZL1NVUYTB1" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at the end of the year&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(1,652,998&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(3,009,413&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001009"
      unitRef="USD">748679</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001010"
      unitRef="USD">1652998</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001012"
      unitRef="USD">-904319</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001013"
      unitRef="USD">-1356415</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001015"
      unitRef="USD">1652998</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact001016"
      unitRef="USD">3009413</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2025-06-30_us-gaap_DomesticCountryMember"
      decimals="-5"
      id="Fact001018"
      unitRef="USD">5600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2026-06-30_us-gaap_DomesticCountryMember"
      decimals="-5"
      id="Fact001020"
      unitRef="USD">9900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2025-06-30_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="Fact001022"
      unitRef="USD">5600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2026-06-30_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="Fact001024"
      unitRef="USD">6100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2026-06-30_custom_EvanaAlphaPteLtdMember"
      decimals="-5"
      id="Fact001026"
      unitRef="USD">400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001028"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact001030"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact001033">&lt;p id="xdx_808_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_z6jnAdixVoj5" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;10. &lt;span id="xdx_82D_zGECkepdF2vd"&gt;Share-based compensation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For the years ended June&#160;30, 2025 and 2026, total share-based compensation expenses recognized were $&lt;span id="xdx_900_eus-gaap--ShareBasedCompensation_c20240701__20250630_pp0p" title="Share-based compensation expenses"&gt;153,266&lt;/span&gt; and &lt;span id="xdx_902_eus-gaap--ShareBasedCompensation_c20250701__20260630_pp0p" style="display: none" title="Share-based compensation expenses"&gt;0&lt;/span&gt; nil, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;(1)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Employee&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On January&#160;6, 2025, with the approval from the Board of the Company, an employee was granted equity award from inception of the employment agreement, which represented 0.1% of the Company&#x2019;s total shares outstanding at issuance date (the &#x201c;0.1% Award&#x201d;, i.e., 1.5 shares). The equity award had a vesting period of 24 months after grant, but with no requisite service period. Alongside the employee&#x2019;s separation in September&#160;2025, the equity award remained its vesting pace under the 24-month vesting schedule. As of June&#160;30, 2026, &lt;span id="xdx_90E_ecustom--SharesDescription_c20250701__20260630__srt--CounterpartyNameAxis__custom--EmployeeMember_zUzm87fsGk21" title="Shares description"&gt;1.125 shares of the Company were vested, with remaining 0.375 shares unvested.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;(2)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Non-employee&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On December&#160;2, 2024, with the approval from the Board of the Company, a contractor was granted equity award from inception of the contractor agreement representing 0.053333% of the Company&#x2019;s total shares outstanding at issuance date (&#x201c;0.05% Award&#x201d;, i.e., 0.8 shares). The equity award had a vesting period of 24 months after grant, with half vested as of April&#160;1, 2025 and remaining as of November&#160;1, 2026, but with no requisite service period. As of June&#160;30, 2026, the first half of the equity award had been vested, the remaining half had been outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s share-based compensation awards are expected to be settled through transfers of existing shares of common stock held by the controlling shareholder, rather than through the issuance of new shares by the Company. The underlying shares of common stock are included in the issued and outstanding shares as of the balance sheet date; accordingly, such settlement is not expected to increase the Company&#x2019;s total issued and outstanding shares. The vested shares are not recorded in the individual names of the holders on the Company&#x2019;s shares ledger, but held by the controlling shareholder on their behalf, mainly due to the plan to a direct register of shares under the listed company during De-SPAC transaction. The Company, as well as the controlling shareholder deemed the grant as the time when the employee and non-employees are entitled to economic benefits and risks of the subsequent changes in fair value of the granted shares accordingly to the agreed vesting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001035"
      unitRef="USD">153266</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001037"
      unitRef="USD">0</us-gaap:ShareBasedCompensation>
    <xlabw:SharesDescription
      contextRef="From2025-07-012026-06-30_custom_EmployeeMember"
      id="Fact001039">1.125 shares of the Company were vested, with remaining 0.375 shares unvested.</xlabw:SharesDescription>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact001041">&lt;p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zSLc9FP3Smha" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;11. &lt;span id="xdx_82B_zl18ydMIe0K4"&gt;Related party transactions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Hoansoo Lee serves as the Company&#x2019;s Chief Executive Officer and Chief Financial Officer. The Company has entered into a consulting services agreement with Hoansoo Lee, pursuant to which Hoansoo Lee provides strategic consulting and advisory services to the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For the years ended June&#160;30, 2025 and 2026, the Company incurred consulting service fees of $&lt;span id="xdx_904_ecustom--ConsultingFees_c20240701__20250630_pp0p" title="Consulting fees"&gt;100,150&lt;/span&gt; and $&lt;span id="xdx_906_ecustom--ConsultingFees_c20250701__20260630_pp0p" title="Consulting fees"&gt;27,000&lt;/span&gt;, respectively. As of June&#160;30, 2025 and 2026, there were &lt;span id="xdx_90E_ecustom--OutstandingBalancesPayable_iI_pp0d_do_c20260630_zSNl2O8FVdW6" title="Outstanding balances payable"&gt;&lt;span id="xdx_90F_ecustom--OutstandingBalancesPayable_iI_pp0d_do_c20250630_zDLcwunok0r4" title="Outstanding balances payable"&gt;no&lt;/span&gt;&lt;/span&gt; outstanding balances payable to Hoansoo Lee as all amounts had been fully settled during the respective periods.&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <xlabw:ConsultingFees
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001043"
      unitRef="USD">100150</xlabw:ConsultingFees>
    <xlabw:ConsultingFees
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001045"
      unitRef="USD">27000</xlabw:ConsultingFees>
    <xlabw:OutstandingBalancesPayable
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact001047"
      unitRef="USD">0</xlabw:OutstandingBalancesPayable>
    <xlabw:OutstandingBalancesPayable
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001049"
      unitRef="USD">0</xlabw:OutstandingBalancesPayable>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact001052">&lt;p id="xdx_806_eus-gaap--EarningsPerShareTextBlock_zl3au2TNB9Lk" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;12. &lt;span id="xdx_82B_zxI1u4M3Piv4"&gt;Basic and diluted net loss per share&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Basic loss per share and diluted loss per share have been calculated in accordance with ASC 260, &#x201c;&lt;i&gt;Earnings Per Share&lt;/i&gt;&#x201d; on computation of earnings per share for the years ended June&#160;30, 2025 and 2026 as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zFGCfqpapES9" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basic and diluted net loss per share (Details)"&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B1_zixKGKP5jQX" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of basic share and diluted&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240701__20250630_zorm1QzY7v8h" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250701__20260630_zBOnfWEn34Xh" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt;Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net loss attributable to common shareholders&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(7,659,667&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(12,162,391&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DenominatorAbstract_iB_zpUuOUDHU98g" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Denominator:&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Weighted-average shares of common stock outstanding&lt;sup&gt;(i)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240701__20250630_fKGkp_zJiDYypG5cQd" title="Weighted-average shares of common stock outstanding, Basic"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20250630_fKGkp_zXS7b1BYo6vf" title="Weighted-average shares of common stock outstanding, Diluted"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250701__20260630_fKGkp_zcakAhXaBG7d" title="Weighted-average shares of common stock outstanding, Basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250701__20260630_fKGkp_zBMfDpvEH05d" title="Weighted-average shares of common stock outstanding, Diluted"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Basic and diluted loss per share&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareBasic_c20240701__20250630_zBPryCBZXRhi" title="Basic loss per share"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20240701__20250630_z3jnOkU9nzPh" title="Diluted loss per share"&gt;(5,106.44&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_c20250701__20260630_zF9lHpL9TKm8" title="Basic loss per share"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareDiluted_c20250701__20260630_zuFQrvvwwEjd" title="Diluted loss per share"&gt;(8,108.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F02_zh5tnZPjqar6" style="font: 10pt Times New Roman; width: 0.25in; text-align: justify"&gt;(i)&lt;/td&gt;
    &lt;td id="xdx_F13_zOVJGRTw9kd9" style="font: 10pt Times New Roman; text-align: justify"&gt;
    In January&#160;2026, the Company adopted an Amended and Restated Certificate of Incorporation, which established a dual-class common stock structure. Under this new structure, the Company&#x2019;s equity is divided into 303 shares of Class A common stock and 1,197 shares of Class B common stock, which are entitled to one (1) vote and twenty (20) votes per share, respectively. Despite the differential in voting power, Class A common stock and Class B common stock rank pari passu in all other respects, sharing ratably in dividends and any distributions upon liquidation.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;(ii)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;For the fiscal years ended June 30, 2026 and 2025, diluted net loss per share was calculated in the same manner as basic net loss per
share because there were no potential common stock equivalents outstanding during the periods presented.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AB_zmokSc1S2Tk9" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact001054">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zFGCfqpapES9" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basic and diluted net loss per share (Details)"&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B1_zixKGKP5jQX" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of basic share and diluted&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240701__20250630_zorm1QzY7v8h" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250701__20260630_zBOnfWEn34Xh" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt;Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net loss attributable to common shareholders&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(7,659,667&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(12,162,391&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DenominatorAbstract_iB_zpUuOUDHU98g" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Denominator:&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Weighted-average shares of common stock outstanding&lt;sup&gt;(i)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240701__20250630_fKGkp_zJiDYypG5cQd" title="Weighted-average shares of common stock outstanding, Basic"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20250630_fKGkp_zXS7b1BYo6vf" title="Weighted-average shares of common stock outstanding, Diluted"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250701__20260630_fKGkp_zcakAhXaBG7d" title="Weighted-average shares of common stock outstanding, Basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250701__20260630_fKGkp_zBMfDpvEH05d" title="Weighted-average shares of common stock outstanding, Diluted"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Basic and diluted loss per share&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareBasic_c20240701__20250630_zBPryCBZXRhi" title="Basic loss per share"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20240701__20250630_z3jnOkU9nzPh" title="Diluted loss per share"&gt;(5,106.44&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_c20250701__20260630_zF9lHpL9TKm8" title="Basic loss per share"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareDiluted_c20250701__20260630_zuFQrvvwwEjd" title="Diluted loss per share"&gt;(8,108.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F02_zh5tnZPjqar6" style="font: 10pt Times New Roman; width: 0.25in; text-align: justify"&gt;(i)&lt;/td&gt;
    &lt;td id="xdx_F13_zOVJGRTw9kd9" style="font: 10pt Times New Roman; text-align: justify"&gt;
    In January&#160;2026, the Company adopted an Amended and Restated Certificate of Incorporation, which established a dual-class common stock structure. Under this new structure, the Company&#x2019;s equity is divided into 303 shares of Class A common stock and 1,197 shares of Class B common stock, which are entitled to one (1) vote and twenty (20) votes per share, respectively. Despite the differential in voting power, Class A common stock and Class B common stock rank pari passu in all other respects, sharing ratably in dividends and any distributions upon liquidation.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;(ii)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;For the fiscal years ended June 30, 2026 and 2025, diluted net loss per share was calculated in the same manner as basic net loss per
share because there were no potential common stock equivalents outstanding during the periods presented.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001056"
      unitRef="USD">-7659667</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001057"
      unitRef="USD">-12162391</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact001062"
      unitRef="Shares">1500</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact001064"
      unitRef="Shares">1500</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact001066"
      unitRef="Shares">1500</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact001068"
      unitRef="Shares">1500</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact001070"
      unitRef="USDPShares">-5106.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012025-06-30"
      decimals="INF"
      id="Fact001072"
      unitRef="USDPShares">-5106.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact001074"
      unitRef="USDPShares">-8108.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-07-01to2026-06-30"
      decimals="INF"
      id="Fact001076"
      unitRef="USDPShares">-8108.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact001079">&lt;p id="xdx_809_eus-gaap--SegmentReportingDisclosureTextBlock_z6koPpbzpAN1" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;13. &lt;span id="xdx_82F_zb5kOOmCMqve"&gt;Segment information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company manages its business in a centralized manner and operates as a single segment and accordingly has only one operating and reportable segment, the provision of GPU computing platform services. The Company&#x2019;s Chief Executive Officer serves as the CODM. The CODM regularly reviews entity-wide operating results and reviews consolidated revenues and net loss as reported in the statement of operations and comprehensive loss when making decisions about allocating resources and assessing performance of the segment, and hence, the Company has only&#160;one&#160;reportable segment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The primary measures of segment revenue and profitability for the Company&#x2019;s operating segment&#160;are considered to be&#160;consolidated&#160;revenue and net loss.&#160;The CODM uses consolidated revenue to assess market performance and growth, and net loss to evaluate segment profitability and cost management. Both measures are used together to allocate resources, including employee or capital resources. Significant expense categories regularly provided to and reviewed by the CODM include those presented in the statements of operations and comprehensive loss as well as disaggregated expenses of staff costs and employee benefits, professional service expenses, share-based compensation, and other general and administrative expenses.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The following table presents the segment information of the Company for the measurement of segment profitability for the years ended June&#160;30, 2025 and 2026:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zOqUszyka2Bl" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment information (Details)"&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B4_zcyNwDHMMudg" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of segment information&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20240701__20250630_zNJCgoM3a293" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20250701__20260630_zK0rfIwBUqyf" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Revenues_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Revenues&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;7,015,512&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;14,822,799&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CostOfRevenue_iN_di_zgW9jDTNp39j" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Cost of revenues&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(5,910,315&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(12,404,546&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--GrossProfit_iB_zYJTaQuAiYYe" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;1,105,197&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;2,418,253&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ResearchAndDevelopmentExpenseAbstract_i" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Research and development expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--OutsourcingResearchAndDevelopmentExpenses_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#x2013; Outsourcing research and development expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(2,787,346&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(4,079,430&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ComputingPowerCostsAndOthers_i_pp0p" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#x2013; Computing power costs and others&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(10,560&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(1,410,755&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--SellingAndMarketingExpenseAbstract_i" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Selling and marketing expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--StaffCostsEmployeeBenefitsAndOfficeExpenses_i_pp0p" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#x2013; Staff costs, employee benefits and office expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(835,889&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(499,392&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ShareBasedCompensations_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#x2013; Share-based compensation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(153,266&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1111"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--SellingGeneralAndAdministrativeExpenseAbstract_iB_zUwBsR3zRo5d" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;General and administrative expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--StaffCostsEmployeeBenefitsAndOthers_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#x2013; Staff costs, employee benefits and Others&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(328,662&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(444,259&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ProfessionalAndContractServicesExpense_iN_pp0d_di_zn3OQPojoPFa" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#x2013; Professional service expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(34,320&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(785,257&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingIncomeLoss_i_pp0p" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Loss from operations&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(3,044,846&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(4,800,840&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ChangeInFairValueOfSimpleAgreementsForFutureEquity_iN_pp0d_di_zXgjSzaS84yb" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Change in fair value of simple agreements for future equity&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(4,614,821&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(7,377,383&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OtherIncome_i_pp0p" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1128"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;15,832&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeTaxExpenseBenefit_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Income tax expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1131"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1132"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Net loss&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(7,659,667&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(12,162,391&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A1_zMSUPjqlQn43" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Substantially all of the Company&#x2019;s long-lived assets are located in the United States. The following table presents the Company&#x2019;s revenue from major geographical areas for the periods indicated.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_ziOid3POqdcc" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment information (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B1_zvJtdaeibkld" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of geographic information&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Hong Kong&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--Revenues_c20240701__20250630__srt--StatementGeographicalAxis__country--HK_pp0p" title="Total"&gt;600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--Revenues_c20250701__20260630__srt--StatementGeographicalAxis__country--HK_pp0p" title="Total"&gt;4,539,901&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;United States of America&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--Revenues_c20240701__20250630__srt--StatementGeographicalAxis__country--US_pp0p" title="Total"&gt;2,085,579&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--Revenues_c20250701__20260630__srt--StatementGeographicalAxis__country--US_pp0p" title="Total"&gt;3,913,744&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Canada&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--Revenues_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_pp0p" title="Total"&gt;1,443,306&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--Revenues_c20250701__20260630__srt--StatementGeographicalAxis__country--CA_pp0p" title="Total"&gt;3,679,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Singapore&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--Revenues_c20240701__20250630__srt--StatementGeographicalAxis__country--SG_pp0p" title="Total"&gt;2,484,905&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--Revenues_c20250701__20260630__srt--StatementGeographicalAxis__country--SG_pp0p" title="Total"&gt;2,023,271&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;United Kingdom&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--Revenues_c20240701__20250630__srt--StatementGeographicalAxis__country--GB_pp0p" title="Total"&gt;391,722&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--Revenues_c20250701__20260630__srt--StatementGeographicalAxis__country--GB_pp0p" title="Total"&gt;666,103&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Others&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--Revenues_c20240701__20250630__srt--StatementGeographicalAxis__custom--OthersMember_pp0p" title="Total"&gt;10,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--Revenues_c20250701__20260630__srt--StatementGeographicalAxis__custom--OthersMember_pp0p" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1161"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_907_eus-gaap--Revenues_pp0d_c20240701__20250630_z9oFiJsi2ZMb" title="Total"&gt;7,015,512&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_904_eus-gaap--Revenues_pp0d_c20250701__20260630_zV34b9u5DQS6" title="Total"&gt;14,822,799&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AB_zuZUQEhHCDpd" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;











</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact001084">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zOqUszyka2Bl" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment information (Details)"&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B4_zcyNwDHMMudg" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of segment information&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20240701__20250630_zNJCgoM3a293" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20250701__20260630_zK0rfIwBUqyf" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Revenues_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Revenues&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;7,015,512&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;14,822,799&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CostOfRevenue_iN_di_zgW9jDTNp39j" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Cost of revenues&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(5,910,315&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(12,404,546&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--GrossProfit_iB_zYJTaQuAiYYe" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;1,105,197&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;2,418,253&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ResearchAndDevelopmentExpenseAbstract_i" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Research and development expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--OutsourcingResearchAndDevelopmentExpenses_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#x2013; Outsourcing research and development expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(2,787,346&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(4,079,430&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ComputingPowerCostsAndOthers_i_pp0p" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#x2013; Computing power costs and others&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(10,560&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(1,410,755&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--SellingAndMarketingExpenseAbstract_i" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Selling and marketing expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--StaffCostsEmployeeBenefitsAndOfficeExpenses_i_pp0p" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#x2013; Staff costs, employee benefits and office expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(835,889&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(499,392&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ShareBasedCompensations_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#x2013; Share-based compensation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(153,266&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1111"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--SellingGeneralAndAdministrativeExpenseAbstract_iB_zUwBsR3zRo5d" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;General and administrative expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--StaffCostsEmployeeBenefitsAndOthers_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#x2013; Staff costs, employee benefits and Others&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(328,662&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(444,259&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ProfessionalAndContractServicesExpense_iN_pp0d_di_zn3OQPojoPFa" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#x2013; Professional service expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(34,320&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(785,257&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingIncomeLoss_i_pp0p" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Loss from operations&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(3,044,846&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(4,800,840&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ChangeInFairValueOfSimpleAgreementsForFutureEquity_iN_pp0d_di_zXgjSzaS84yb" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Change in fair value of simple agreements for future equity&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(4,614,821&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(7,377,383&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OtherIncome_i_pp0p" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1128"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;15,832&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeTaxExpenseBenefit_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Income tax expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1131"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1132"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Net loss&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(7,659,667&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;(12,162,391&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001086"
      unitRef="USD">7015512</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001087"
      unitRef="USD">14822799</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001089"
      unitRef="USD">5910315</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001090"
      unitRef="USD">12404546</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001092"
      unitRef="USD">1105197</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001093"
      unitRef="USD">2418253</us-gaap:GrossProfit>
    <xlabw:OutsourcingResearchAndDevelopmentExpenses
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001098"
      unitRef="USD">-2787346</xlabw:OutsourcingResearchAndDevelopmentExpenses>
    <xlabw:OutsourcingResearchAndDevelopmentExpenses
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001099"
      unitRef="USD">-4079430</xlabw:OutsourcingResearchAndDevelopmentExpenses>
    <xlabw:ComputingPowerCostsAndOthers
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001101"
      unitRef="USD">-10560</xlabw:ComputingPowerCostsAndOthers>
    <xlabw:ComputingPowerCostsAndOthers
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001102"
      unitRef="USD">-1410755</xlabw:ComputingPowerCostsAndOthers>
    <xlabw:StaffCostsEmployeeBenefitsAndOfficeExpenses
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001107"
      unitRef="USD">-835889</xlabw:StaffCostsEmployeeBenefitsAndOfficeExpenses>
    <xlabw:StaffCostsEmployeeBenefitsAndOfficeExpenses
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001108"
      unitRef="USD">-499392</xlabw:StaffCostsEmployeeBenefitsAndOfficeExpenses>
    <xlabw:ShareBasedCompensations
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001110"
      unitRef="USD">-153266</xlabw:ShareBasedCompensations>
    <xlabw:StaffCostsEmployeeBenefitsAndOthers
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001116"
      unitRef="USD">-328662</xlabw:StaffCostsEmployeeBenefitsAndOthers>
    <xlabw:StaffCostsEmployeeBenefitsAndOthers
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001117"
      unitRef="USD">-444259</xlabw:StaffCostsEmployeeBenefitsAndOthers>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001119"
      unitRef="USD">34320</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001120"
      unitRef="USD">785257</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001122"
      unitRef="USD">-3044846</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001123"
      unitRef="USD">-4800840</us-gaap:OperatingIncomeLoss>
    <xlabw:ChangeInFairValueOfSimpleAgreementsForFutureEquity
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001125"
      unitRef="USD">4614821</xlabw:ChangeInFairValueOfSimpleAgreementsForFutureEquity>
    <xlabw:ChangeInFairValueOfSimpleAgreementsForFutureEquity
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001126"
      unitRef="USD">7377383</xlabw:ChangeInFairValueOfSimpleAgreementsForFutureEquity>
    <us-gaap:OtherIncome
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001129"
      unitRef="USD">15832</us-gaap:OtherIncome>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001134"
      unitRef="USD">-7659667</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001135"
      unitRef="USD">-12162391</us-gaap:ProfitLoss>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact001137">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_ziOid3POqdcc" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment information (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B1_zvJtdaeibkld" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of geographic information&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Years Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Hong Kong&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--Revenues_c20240701__20250630__srt--StatementGeographicalAxis__country--HK_pp0p" title="Total"&gt;600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--Revenues_c20250701__20260630__srt--StatementGeographicalAxis__country--HK_pp0p" title="Total"&gt;4,539,901&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;United States of America&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--Revenues_c20240701__20250630__srt--StatementGeographicalAxis__country--US_pp0p" title="Total"&gt;2,085,579&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--Revenues_c20250701__20260630__srt--StatementGeographicalAxis__country--US_pp0p" title="Total"&gt;3,913,744&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Canada&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--Revenues_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_pp0p" title="Total"&gt;1,443,306&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--Revenues_c20250701__20260630__srt--StatementGeographicalAxis__country--CA_pp0p" title="Total"&gt;3,679,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Singapore&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--Revenues_c20240701__20250630__srt--StatementGeographicalAxis__country--SG_pp0p" title="Total"&gt;2,484,905&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--Revenues_c20250701__20260630__srt--StatementGeographicalAxis__country--SG_pp0p" title="Total"&gt;2,023,271&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;United Kingdom&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--Revenues_c20240701__20250630__srt--StatementGeographicalAxis__country--GB_pp0p" title="Total"&gt;391,722&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--Revenues_c20250701__20260630__srt--StatementGeographicalAxis__country--GB_pp0p" title="Total"&gt;666,103&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Others&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--Revenues_c20240701__20250630__srt--StatementGeographicalAxis__custom--OthersMember_pp0p" title="Total"&gt;10,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--Revenues_c20250701__20260630__srt--StatementGeographicalAxis__custom--OthersMember_pp0p" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1161"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_907_eus-gaap--Revenues_pp0d_c20240701__20250630_z9oFiJsi2ZMb" title="Total"&gt;7,015,512&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;b&gt;&lt;span id="xdx_904_eus-gaap--Revenues_pp0d_c20250701__20260630_zV34b9u5DQS6" title="Total"&gt;14,822,799&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_country_HK"
      decimals="0"
      id="Fact001139"
      unitRef="USD">600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-012026-06-30_country_HK"
      decimals="0"
      id="Fact001141"
      unitRef="USD">4539901</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_country_US"
      decimals="0"
      id="Fact001143"
      unitRef="USD">2085579</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-012026-06-30_country_US"
      decimals="0"
      id="Fact001145"
      unitRef="USD">3913744</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_country_CA"
      decimals="0"
      id="Fact001147"
      unitRef="USD">1443306</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-012026-06-30_country_CA"
      decimals="0"
      id="Fact001149"
      unitRef="USD">3679780</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_country_SG"
      decimals="0"
      id="Fact001151"
      unitRef="USD">2484905</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-012026-06-30_country_SG"
      decimals="0"
      id="Fact001153"
      unitRef="USD">2023271</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_country_GB"
      decimals="0"
      id="Fact001155"
      unitRef="USD">391722</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-012026-06-30_country_GB"
      decimals="0"
      id="Fact001157"
      unitRef="USD">666103</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_custom_OthersMember"
      decimals="0"
      id="Fact001159"
      unitRef="USD">10000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001163"
      unitRef="USD">7015512</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-07-01to2026-06-30"
      decimals="0"
      id="Fact001165"
      unitRef="USD">14822799</us-gaap:Revenues>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact001168">&lt;p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zzoSMWa6Hah6" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;14. &lt;span id="xdx_825_zScWJmuzLH1k"&gt;Commitments and contingencies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;From inception to date, the Company has not been a party to any legal proceedings, claims, or disputes arising in the ordinary course of business. As of June&#160;30, 2026, the Company had no outstanding litigation, and there were no commitments or contingencies that management believes would have a material effect on the consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2025-07-01to2026-06-30" id="Fact001170">&lt;p id="xdx_80F_eus-gaap--SubsequentEventsTextBlock_zInwVQra7TS1" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;15. &lt;span id="xdx_820_zyaXqVJZ0n0d"&gt;Subsequent events&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company evaluated all events and transactions that occurred after June&#160;30, 2026, up through September&#160;28, 2026, which is the date that these consolidated financial statements are issued, unless as disclosed elsewhere and below, no other material subsequent events occurred that would require recognition or disclosure in the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;SAFEs&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;From July&#160;1, 2026 to September&#160;28, 2026, an investor provided $&lt;span id="xdx_908_eus-gaap--ProceedsFromSaleOfNotesReceivable_pn5n6_c20260701__20260928__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8CNVrziR3Mk" title="Proceeds from safes"&gt;1.0&lt;/span&gt; million to the Company in the form of a SAFE.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Convertible Loan&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On July&#160;16, 2026, the Company, as lender, entered into a convertible loan agreement with a third party in the principal amount of approximately $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20260716__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zRpIB34iYrTa" title="Principal amount"&gt;1.5&lt;/span&gt; million. The full loan amount was disbursed in July&#160;2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Business combination and Conversion of SAFEs instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0; color: #24272F"&gt;On August&#160;27, 2026, Exascale Labs Holdings Inc. consummated the transactions contemplated by the Agreement and Plan of Merger dated January&#160;11, 2026, by and among BCAR, PubCo, Merger Sub and the Company (the &#x201c;Business Combination&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0; color: #24272F"&gt;Prior to the Acquisition Merger, BCAR completed its domestication from the British Virgin Islands to Delaware by merging with and into PubCo, with PubCo surviving as a Delaware corporation. In connection with the Domestication Merger, PubCo changed its name from &#x201c;D. Boral ARC Merger Corporation&#x201d; to &#x201c;Exascale Labs Holdings Inc.&#x201d; Following the Domestication Merger, Merger Sub merged with and into the Company, with the Company surviving as a wholly owned subsidiary of PubCo.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0; color: #24272F"&gt;In connection with the Acquisition Merger, the
outstanding equity interests of the Company were cancelled and converted into shares of PubCo common stock. The outstanding SAFEs of the
Company were cancelled and converted into the right to receive shares of PubCo Class A common stock based on the applicable SAFE holders&#x2019;
implied ownership percentages. The shares of PubCo Class A common stock received in connection with the SAFE conversion constituted full
satisfaction of their rights under the applicable SAFEs and were subject to a six-month lock-up period following the Closing Date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0; color: #24272F"&gt;Upon the closing of the Business Combination, the &lt;span id="xdx_90C_ecustom--ClosingDateDescription_c20260801__20260827__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zFyla5DULno5" title="Closing date description"&gt;Company&#x2019;s former securityholders received an aggregate of 19,354,261 shares of PubCo Class A common stock and 30,645,739 shares
of PubCo Class B Common stock, representing aggregate merger consideration of $500.0 million based on a deemed value of $10.00 per share.
The Class B Common stock have 20 votes per share, while the Class A common stock have one vote per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0; color: #24272F"&gt;The Business Combination was accounted for as a reverse recapitalization, with the Company identified as the accounting acquirer and BCAR identified as the accounting acquiree for financial reporting purposes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0; color: #24272F"&gt;The Class A common stock and warrants of PubCo
commenced trading on Nasdaq on August&#160;28, 2026 under the symbols &#x201c;XLAB&#x201d; and &#x201c;XLABW,&#x201d; respectively.&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Non-Binding Memorandum of Understanding for Potential Data Center Collaboration&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0; color: #24272F"&gt;On July&#160;21, 2026, the Company entered into a non-binding memorandum of understanding with a third party to explore the joint development and commercialization of multiple data centers in Japan with an aggregate targeted capacity of at least 20 MW, including the potential deployment of the Company&#x2019;s GaaS and cluster management solutions on the third party&#x2019;s infrastructure. The memorandum of understanding is not legally binding, other than with respect to customary confidentiality and termination provisions, and does not obligate either party to enter into a definitive agreement, and there can be no assurance that any transaction or definitive agreement will be consummated.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0; color: #171A21"&gt;&lt;b&gt;&lt;i&gt;Compute Service Agreement for GPU Capacity&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On July&#160;15, 2026, the &lt;span id="xdx_900_ecustom--ComputeServiceAgreementDescription_c20260701__20260715__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh0xdK52VWcl" title="Compute service agreement description"&gt;Company entered into a Compute Service Agreement with a third party to secure GPU compute capacity of approximately 4,000 PFLOPS (FP16) over a three-year term, for total contracted service fees of approximately $71 million. As of the date of this report, service delivery under the agreement has not commenced and no payment obligations have arisen.&lt;/span&gt;&lt;/p&gt;



</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ProceedsFromSaleOfNotesReceivable
      contextRef="From2026-07-012026-09-28_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact001172"
      unitRef="USD">1000000.0</us-gaap:ProceedsFromSaleOfNotesReceivable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-07-16_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact001174"
      unitRef="USD">1500000</us-gaap:DebtInstrumentFaceAmount>
    <xlabw:ClosingDateDescription
      contextRef="From2026-08-012026-08-27_us-gaap_SubsequentEventMember"
      id="Fact001176">Company&#x2019;s former securityholders received an aggregate of 19,354,261 shares of PubCo Class A common stock and 30,645,739 shares
of PubCo Class B Common stock, representing aggregate merger consideration of $500.0 million based on a deemed value of $10.00 per share.
The Class B Common stock have 20 votes per share, while the Class A common stock have one vote per share.</xlabw:ClosingDateDescription>
    <xlabw:ComputeServiceAgreementDescription
      contextRef="From2026-07-012026-07-15_us-gaap_SubsequentEventMember"
      id="Fact001181">Company entered into a Compute Service Agreement with a third party to secure GPU compute capacity of approximately 4,000 PFLOPS (FP16) over a three-year term, for total contracted service fees of approximately $71 million. As of the date of this report, service delivery under the agreement has not commenced and no payment obligations have arisen.</xlabw:ComputeServiceAgreementDescription>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2025-07-01to2026-06-30" id="Fact001182">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2025-07-01to2026-06-30" id="Fact001183">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2025-07-01to2026-06-30" id="Fact001184">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2025-07-01to2026-06-30" id="Fact001185">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000753"
          xlink:label="Fact000753"
          xlink:type="locator"/>
        <link:footnote id="Footnote000784" xlink:label="Footnote000784" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0">The Company classifies its SAFEs as financial liabilities measured at fair value. The value of these agreements depends significantly on future financing activities, liquidity events, or other material milestones, and their valuation relies on significant inputs that are not observable in the public market. Accordingly, they are classified within Level 3 of the fair value hierarchy.</xhtml:p><xhtml:p style="font: 10pt Times New Roman; margin: 0; text-align: justify">&#160;</xhtml:p><xhtml:p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0">The fair value measurement is based on an integrated framework combining&#160;scenario analysis and financial instrument decomposition (i.e. Bond Plus Call Method). As of June&#160;30, 2026, the proceeds of the SAFEs on the date of issuance were $14,092,500. The details of significant unobservable inputs can refer to Note 8-Simple Agreements for Future Equity for further details.</xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000753"
          xlink:to="Footnote000784"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0755"
          xlink:label="xdx2ixbrl0755"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0755"
          xlink:to="Footnote000784"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0757"
          xlink:label="xdx2ixbrl0757"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0757"
          xlink:to="Footnote000784"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000759"
          xlink:label="Fact000759"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000759"
          xlink:to="Footnote000784"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000769"
          xlink:label="Fact000769"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000769"
          xlink:to="Footnote000784"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0771"
          xlink:label="xdx2ixbrl0771"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0771"
          xlink:to="Footnote000784"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0773"
          xlink:label="xdx2ixbrl0773"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0773"
          xlink:to="Footnote000784"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000775"
          xlink:label="Fact000775"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000775"
          xlink:to="Footnote000784"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000761"
          xlink:label="Fact000761"
          xlink:type="locator"/>
        <link:footnote id="Footnote000785" xlink:label="Footnote000785" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Equity options. On May&#160;9, 2023, the Company entered into an agreement with a third-party service provider (the &#x201c;Service Provider&#x201d;). The Service Provider received a freestanding equity-linked right exercisable, at the Service Provider&#x2019;s option, upon the closing of the Company&#x2019;s next qualified equity financing. The right provides the ability to subscribe for up to the value of $200,000 at a 25% discount price per share on the grant date. The equity option is remeasured at fair value at each reporting date, with changes in fair value recognized in earnings. As of June&#160;30, 2025 and 2026, the fair value of the equity option was $53,333, and no gain or loss from changes in fair value was recognized for the periods presented. The fair value measurement of the equity option is categorized within Level 3 of the fair value hierarchy and was determined using a scenario-based analysis, which incorporates significant unobservable inputs and management judgment regarding the probability and timing of potential future financing outcomes.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000761"
          xlink:to="Footnote000785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0763"
          xlink:label="xdx2ixbrl0763"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0763"
          xlink:to="Footnote000785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0765"
          xlink:label="xdx2ixbrl0765"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0765"
          xlink:to="Footnote000785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000767"
          xlink:label="Fact000767"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000767"
          xlink:to="Footnote000785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000777"
          xlink:label="Fact000777"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000777"
          xlink:to="Footnote000785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0779"
          xlink:label="xdx2ixbrl0779"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0779"
          xlink:to="Footnote000785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0781"
          xlink:label="xdx2ixbrl0781"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0781"
          xlink:to="Footnote000785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000783"
          xlink:label="Fact000783"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000783"
          xlink:to="Footnote000785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000800"
          xlink:label="Fact000800"
          xlink:type="locator"/>
        <link:footnote id="Footnote000815" xlink:label="Footnote000815" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company acquired a total of 991,601 USDT at a cost of $991,601 from revenues and other current assets. The Company acquired a total of 6,275,251 USDC at a cost of $ 6,275,251 from revenues, USDC rewards, other current assets and investment proceeds from SAFEs.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000800"
          xlink:to="Footnote000815"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000802"
          xlink:label="Fact000802"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000802"
          xlink:to="Footnote000815"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000808"
          xlink:label="Fact000808"
          xlink:type="locator"/>
        <link:footnote id="Footnote000816" xlink:label="Footnote000816" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company uses digital assets and USDC to settle professional services fees and other expenditures, and any digital assets held may be converted into USDC, as needed.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000808"
          xlink:to="Footnote000816"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000810"
          xlink:label="Fact000810"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000810"
          xlink:to="Footnote000816"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000891"
          xlink:label="Fact000891"
          xlink:type="locator"/>
        <link:footnote id="Footnote000910" xlink:label="Footnote000910" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Volatility: Derived with reference to historical price volatility of comparable companies</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000891"
          xlink:to="Footnote000910"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000893"
          xlink:label="Fact000893"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000893"
          xlink:to="Footnote000910"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000895"
          xlink:label="Fact000895"
          xlink:type="locator"/>
        <link:footnote id="Footnote000911" xlink:label="Footnote000911" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Risk-free rate: Derived with reference to U.S. sovereign bond yield</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000895"
          xlink:to="Footnote000911"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000897"
          xlink:label="Fact000897"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000897"
          xlink:to="Footnote000911"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000899"
          xlink:label="Fact000899"
          xlink:type="locator"/>
        <link:footnote id="Footnote000912" xlink:label="Footnote000912" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Credit spread: Risk premium over the risk-free rate, derived with reference to the spread of CCC rated bonds</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000899"
          xlink:to="Footnote000912"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000901"
          xlink:label="Fact000901"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000901"
          xlink:to="Footnote000912"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000903"
          xlink:label="Fact000903"
          xlink:type="locator"/>
        <link:footnote id="Footnote000913" xlink:label="Footnote000913" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Discount rate: Sum of risk-free rate and credit spread</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000903"
          xlink:to="Footnote000913"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000905"
          xlink:label="Fact000905"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000905"
          xlink:to="Footnote000913"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000907"
          xlink:label="Fact000907"
          xlink:type="locator"/>
        <link:footnote id="Footnote000914" xlink:label="Footnote000914" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Dividend yield: Derived with reference to historical dividend record of the Company</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000907"
          xlink:to="Footnote000914"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000909"
          xlink:label="Fact000909"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000909"
          xlink:to="Footnote000914"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001062"
          xlink:label="Fact001062"
          xlink:type="locator"/>
        <link:footnote id="Footnote001077" xlink:label="Footnote001077" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In January&#160;2026, the Company adopted an Amended and Restated Certificate of Incorporation, which established a dual-class common stock structure. Under this new structure, the Company&#x2019;s equity is divided into 303 shares of Class A common stock and 1,197 shares of Class B common stock, which are entitled to one (1) vote and twenty (20) votes per share, respectively. Despite the differential in voting power, Class A common stock and Class B common stock rank pari passu in all other respects, sharing ratably in dividends and any distributions upon liquidation.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001062"
          xlink:to="Footnote001077"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001064"
          xlink:label="Fact001064"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001064"
          xlink:to="Footnote001077"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001066"
          xlink:label="Fact001066"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001066"
          xlink:to="Footnote001077"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001068"
          xlink:label="Fact001068"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001068"
          xlink:to="Footnote001077"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
